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HIV is a potentially fatal and highly stigmatized disease such that diagnosis 
with the disease is often met with high anxiety. Many people who test positive for 
HIV may not receive sufficient linkage to HIV care or do not remain engaged in 
continuous HIV medical care once they have entered care. While a considerable 
amount of research exists on referral, access, personal characteristics, and mental 
illness barriers associated with engagement in HIV medical care, far less attention has 
been given to psychosocial factors, specifically denial and perceived HIV stigma as 
important barriers to engaging in HIV medical care. 
  
The purpose of this study was to determine whether denial and/or perceived 
HIV stigma are associated with engagement in HIV medical care for African-
American people living with HIV/AIDS (PLWHA). Data were collected as part of a 
peer-based community health worker program (CHW), based in Washington DC, 
designed to link PLWHA to HIV medical care and services. Logistic regression 
analyses were performed to determine whether the psychosocial variables were 
predictors of engagement in HIV medical care. 
 Results indicated that disclosure is a major issue for this population, as 46% 
of the participants had not disclosed their HIV status to others.  Separate analyses 
were conducted for the total sample (n=262) and with the disclosed sample (n=120). 
Results in the total sample revealed that disclosure of HIV status was associated with 
engagement in HIV status. PLWHA who disclosed HIV status to others were 2.1 
times more likely to engage in HIV medical care than persons who had not disclosed 
HIV status.  In the disclosed sample, gender, educational level and employment status 
were also associated with engagement in HIV medical care. Women and persons with 
low educational level and unemployed were less likely to engage in HIV medical 
care.  Denial and perceived HIV stigma were not found to be independent predictors 
of engagement in HIV medical care when other covariates were included in the 
model. Disclosure of HIV status, gender and educational level were predictors of 
engagement in HIV medical care for this population. These obstacles to care may be 
amenable to disclosure and gender-specific interventions; and, therefore, warrant 
better understanding to improve outreach interventions to PLWHA who are not 
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Chapter 1: Introduction 
 
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) 
continues to be a significant public health problem in the United States (U.S.), even as we enter 
the fourth decade of the epidemic. At the end of 2010 there were approximately 33 million 
people worldwide living with HIV/AIDS (UNAIDS, 2012). According to the Centers for Disease 
Control and Prevention (CDC), approximately 1.2 million persons are living with HIV in the 
United States (CDC, 2012). 
The HIV/AIDS epidemic is not equally distributed in the U.S.  Studies have shown that 
African Americans are disproportionately burdened by the epidemic (CDC, 2012; Hall et al., 
2008; Kaiser Family Foundation, 2012; Prejean et al., 2011). African Americans make up 44% 
of persons infected with HIV/AIDS even though they comprise 12% of the United States 
population (CDC, 2013; Kaiser Family Foundation, 2012; Prejean et al., 2011).  Prejean and 
colleagues’ surveillance study showed that from 2006-2009, African Americans had the highest 
rate of new infections annually compared to all other races and they represented 64% of the new 
HIV infections in the United States.  
In the District of Columbia (DC), the epidemic is also highest among African Americans. 
According to DC’s HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA),African 
Americans in DC have an HIV prevalence rate of 3.9%, which is very close to World Health 
Organization’s (WHO) definition of a concentrated epidemic (HAHSTA, 2012 WHO, 2013). 
Given the epidemic rate of HIV/AIDS globally, nationally, and locally and among African 
Americans in particular, it remains a high priority that people living with HIV/AIDS have access 
to both immediate and continuous HIV medical care.  




Effective HIV treatment with Highly Active Antiretroviral Treatment (HAART) has significantly 
decreased deaths from HIV/AIDS. Fang et al.’s (2008) analysis showed that patients with newly 
diagnosed asymptomatic HIV infection on HAART could expect to survive on average 21 years 
after HIV diagnosis.  Equally important are results by Rodger and colleagues (2013) who 
reported that PLWHA who are on HAART and have a normal CD4 count1 could expect to have 
similar life expectancies to persons who are not infected with HIV. Recent developments 
proclaim that engagement in HIV medical care and treatment with HAART contributes to the 
overall health and well-being of PLWHA, and is crucial to the prevention of new HIV infections 
(Cheever, 2007; Cohen et al., 2011; Giordano et al., 2007). Yet, continuous engagement in 
HIV/AIDS medical care remains a major public health problem.  
Barriers to continuous engagement in HIV medical care for PLWHA could stem from 
many factors.  For example, Garland and colleagues (2011) reported that after HIV counseling 
and testing, lack of referral to appropriate HIV medical care is one barrier. In addition, limited 
access to care is also barrier (Garland et al., 2011). Turner et al. (2000) found that among persons 
diagnosed with HIV who did not have health insurance or a usual source of care they delayed 
entering medical care more than 3 months after diagnosis (Turner et al., 2000). Similarly, 
Rajabiun et al. (2007) found that limited capacity to navigate a fragmented HIV medical care 
system impacts engagement in medical care because some PLWHA cannot get an appointment 
with their doctors in a timely manner, which can cause gaps in care. Other studies attribute 
limited engagement in medical care to mental health issues such as depression, anxiety, and 
substance abuse  (Whetten, Reif, Whetten & Murphy-McMillian, 2008) and psychosocial 
                                                







factors: social support, denial, and stigma (Konkle-Parker, Erlen & Dubbert, 2008; Ryan, 
Forehand, Solomon, & Miller, 2008). Among these psychosocial factors denial and stigma are 
found to be associated with poorer health outcomes (Konkle-Parker, Erlen & Dubbert, 2008). 
Statement of the Problem 
 A considerable amount of research exists on barriers associated with HIV medical care 
and treatment such as structural factors (e.g.  access to care), personal characteristics, risk 
behavior (e.g. risky sexual behaviors and intravenous drug use), and mental illness factors (e.g. 
depression)(Heckman et al., 1998; Konkle-Parker, Erlan & Dubbert, 2008; McCoy et al., 2009; 
Pollini et al., 2011;Samet et al., 1994,1998; Tobias et al. 2007).  However, far less attention has 
been paid by researchers to psychosocial factors as barriers. Psychosocial factors are 
characterized as psychological and social factors that determine how a person manages their HIV 
disease, including their acceptance or denial of their status as a PLWHA and their perception of 
stigma associated with HIV and PLWHA. Many of the studies conducted by researchers 
examining the predictors of engagement in HIV medical care, including that on denial and HIV 
stigma have been retrospective (Mugavero et al., 2009), qualitative (Beer et al., 2009; Konkle-
Parker et al., 2008/2011; Rajibium et al., 2009), based on medical record abstraction (Rumptz et 
al., 2007; Ulett et al., 2009) and/or used surveillance data (Reed et al., 2009; Torian et al., 2008). 
Current research has shown that engagement in HIV care can increase adherence to HIV 
treatment as well as decrease community viral load, transmission rates, emergent resistant HIV 
strains, and health care costs (Gardner et al., 2011; Mugarvero et al., 2007).  The recent 
qualitative  “Not in Care”, study conducted by the CDC with PLWHA not engaged in HIV 




stigma) were an issue nationwide and were not being addressed when looking at the health care 
utilization of PLWHA (Beer, Fagan, Valverde, & Bertolli, 2009; Fagan et al., 2010).  
A few quantitative studies have focused on stigma and engagement in HIV medical care. 
For example, in a cross-sectional study with 202 PLWHA in Los Angeles, one-third reported 
experiencing high levels of stigma and those persons experiencing high levels of stigma were 
five times more likely to report poor access to HIV medical care (Sayles, Wong, Kinsler, Martin 
& Cunningham, 2009). Vanable, Carey, Blair and Littlewood (2006) also reported that PLWHA 
who experienced HIV stigma were less likely to engage in medical care and have lower 
treatment adherence. The results of the studies above indicate that HIV stigma can be detrimental 
to engagement in HIV medical care and treatment for PLWHA.  
  Although several studies have focused on HIV stigma as a predictor of adherence to HIV 
treatment there have been very few on how denial is also associated with adherence to HIV 
treatment and delay engagement in HIV medical care with PLWHA. Singh and colleagues 
(1999) conducted one of the first studies with 123 PLWHA to examine how psychosocial factors 
affect adherence to HIV treatment. They found that denial was associated with lower medication 
adherence (Singh et al., 1999). While the studies above provide great insights into understanding 
the factors that impede engagement in HIV medical care, the separate study of stigma or denial 
fails to consider how both interact as synergistic barriers.  
Recent qualitative research has shown that HIV stigma and denial are major psychosocial 
barriers that contribute to PLWHA delaying entering HIV medical care (Beer et al., 2009; 
Konkle–Parker et al., 2008). Denial and HIV stigma are a double threat to engagement in HIV 
medical care and consequently the health and quality of life for of PLWHA (Beer et al., 2009; 




 There are a number of Washington, DC residents that have been diagnosed with 
HIV/AIDS. Of these, in 2010, 11% were not immediately linked to HIV medical care and 42% 
were not in continuous HIV medical care. The reasons for the low percentage of persons engaged 
in continuous care may be due to any one or combination of factors.  Specifically, this 
dissertation quantitatively examines in a prospective cohort of PLWHA the association of denial 
and perceived HIV stigma with engagement in HIV medical care, in conjunction with the receipt 
of peer community health outreach worker (CHW) support. In 2011, Positive Pathways (PP) a 
peer community health worker project began in Washington, DC. Positive Pathways uses CHWs 
to help PLWHA access needed HIV medical care and services. The current study began the 
following year and uses the infrastructure already in place by Positive Pathways, which uses 
CHWs for recruitment and data collection. The CHWs are embedded in the community, medical 
and managed care organizations used as recruitment sites for this research study. Their role 
within this study is to recruit participants and conduct the baseline and follow-up assessments. 
Beyond their roles as recruiters and data collectors for this study, the CHWs, whose other job 
roles include helping clients link to their healthcare, may serve as a bridge to HIV medical care 
for participants enrolled in the study, and this may limit the generalizability of the results to 
PLWHA without access to a CHW and engagement in HIV medical care. 
Purpose of the Study 
The purpose of this quantitative study is to examine the relationship between denial and 
perceived HIV stigma as barriers to engagement in HIV medical care, among African American 
persons diagnosed with HIV/AIDS in Washington DC. The study is guided by an adapted 
version of the Andersen Behavioral Model of Health Care Utilization (ABM).  The Andersen 




use. The psychosocial factors, denial and perceived HIV stigma, are added to the predisposing 
construct of the Andersen Behavioral Model. Specifically the study is undertaken to examine 
whether the psychosocial factors, denial and perceived HIV stigma, are independent and/or 
synergistic barriers to engagement in HIV medical care, after controlling for other predisposing, 
enabling and need factors that PLWHA experience.  The examination of denial and stigma 
together is important, as their independent and interactive influence is not thoroughly understood 
in relation to HIV medical care engagement. This study seeks to understand (1) rates of denial 
and perceived HIV stigma in African- American HIV positive persons in the Washington, DC 
area, (2) independent effects of denial and perceived HIV stigma on engagement in HIV medical 
care, and (3) the interactive relationship of denial and perceived HIV stigma on engagement in 
HIV medical care.  
Significance of Study 
This study contributes to public health research on HIV/AIDS medical care and policy. 
Identifying psychosocial barriers specifically stigma and denial may provide insight into points 
of intervention along the HIV continuum of care-specifically at the linkage and retention steps. 
The findings can have an impact on both local and federal policies on linkage and 
engagement/retention in HIV medical care.   
At the District of Columbia local level, DC has two programs that they have used to 
support engagement in HIV medical care for PLWHA. First, the red carpet program, which 
allows any DC resident newly diagnosed with HIV or persons who are not in engaged in HIV 
medical care to receive an HIV medical appointment within 1-2 days of request free of charge.  
The second, the Recapture Blitz program, focuses on reengaging PLWHA who are not accessing 




PLWHA. This study seeks to show that as part of these and other local initiatives, screening for 
denial and perceived HIV stigma at entry points into care can help shed light on barriers for 
PLWHA engaging in HIV medical care in the District. At the federal level, the National 
HIV/AIDS Strategy (NHAS) emphasizes the need to focus on increasing linkage, retention and 
access to HIV care for communities disproportionately affected by HIV/AIDS. This study may 
help to address this goal by examining barriers to care for African Americans who make up the 
greatest proportion of persons infected with HIV/AIDS.  This study can also inform Health 
Resources and Services Administration (HRSA)’s Special Projects of National Significance 
(SPNS) about barriers to linkages and access to care for PLWHA. Increasing the understanding 
of barriers that keep people out of care will help public health researchers better develop best 
practices and interventions as well as lobby for funding to increase linkage and engagement in 
HIV medical care.  
This study may also provide insight into the possible benefits of initiation of the 
Affordable Care Act (ACA) for PLWHA. Implementation of ACA includes the expansion of 
Medicaid coverage for PLWHA.  In 2011, prior to the passage of ACA, Washington, DC 
expanded its Medicaid program for PLWHA, and now has one of the highest health insurance 
coverage rates in the DC Metropolitan area. As a result of Medicaid expansion, DC has 
experienced a reduction in expenditures associated with medical care and HIV medications for 
PLWHA (DC DOH- SCSN, 2011).  The District of Columbia’s Medicaid expansion program 
can possibly serve as a model for other states implementing the ACA. Since PLWHA now have 
greater access to health insurance and quality care to help them remain engaged in HIV medical 
care, lack of insurance as a barrier is decreased.  This study may suggest that access to care does 




may help explain why PLWHA, most of whom have access to health insurance, are not in 
continuous HIV medical care.    
This study examines the differences in engagement in HIV medical care with two 
subpopulations of people living with HIV/AIDS (newly diagnosed and out of care). Newly 
diagnosed is defined as a person diagnosed with HIV within the past three months of (Shahani, et 
al., 2012). Out of care persons are defined as persons living with HIV who do not have a medical 
visit in the last 6 months (HRSA, 2011).   
 For persons newly diagnosed with HIV, it is very important that they are linked and 
begin HIV medical care and treatment early in the course of the disease. If care is not initiated 
soon after diagnosis, researchers have reported that is harder for these persons to reach an 
undetectable HIV viral load, they are more likely to transmit the virus, experience worse health 
outcomes, and even death. These studies have reported that with consistent HIV medical care 
and proper treatment PLWHA can live to an almost normal life expectancy (Hogg et al., 2013; 
Rodger et al., 2013). Unfortunately, there is a lack of surveillance information about newly 
diagnosed persons and their process of linking and engaging in continuous HIV medical care 
(Mugavero, Norton, & Saag, 2011). This study can shed some light on this process. 
On the other hand, out of care individuals who are aware of HIV status but never entered 
care or have dropped out of care are an important population to study also. In this sub-population 
at least 42% of persons are aware of their HIV status but are not engaged in regular HV medical 
care. It is important to examine barriers to care for newly diagnosed and out of care persons that 
are at different points along the HIV care continuum. In spite of the fact, that these two groups 
may be different in regard to length of HIV infection and have different familiarities with health 




HIV medical care. Screening for denial and HIV stigma may improve linkage and engagement in 
HIV medical care.  
The significance of HIV medical care utilization among PLWHA was emphasized by two 
major events that have changed the nation’s approach to HIV prevention and care.  These events 
include the National HIV/AIDS Strategy for the U.S and the HIV Prevention Trial Network 
(HPTN) 052 study. In July 2010, The White House Office of National AIDS Policy (ONAP) 
released the first ever comprehensive National HIV/AIDS Strategy for the country. The NHAS 
was developed to ensure that new infections become rare and that PLWHA receive access to the 
best medical care (NHAS, 2010). The major goals of the NHAS are to:  
(1) Decrease the number of new HIV infections,  
(2) Increase linkage, engagement and access to care for PLWHA, and  
(3) Reduce health disparities associated with HIV/AIDS.  
 
  The second was the release of findings from the HTPN 052 study. Prior to the landmark 
HTPN 052 study, HIV treatment for PLWHA with HAART had been shown to be effective in 
reducing their HIV viral load to achieve viral suppression and decrease morbidity and mortality 
associated with HIV (Anema, Wood, & Montaner, 2008; Palella et al., 1998). Subsequently, in 
recent years, in addition to stabilizing the health of PLWHA, HAART has also been seen as a 
way to reduce the transmission of HIV to others (Lima et al., 2008). In August 2011, the 
National Institutes of Health (NIH) released the results from the HPTN 052 study.2  This study 
was conducted with serodiscordant couples, and has provided evidence that PLWHA who are 
engaged in HIV medical care, on HAART and have a suppressed HIV viral load, are less likely 
                                                
2	  HTPN 052, was conducted with serodiscordant couples and has provided evidence that PLWHA that are engaged in HIV 
medical care, on Highly Active Antiretroviral Therapy (HAART) and have a suppressed HIV viral load decreases the probability 




to transmit the HIV virus to others. In this study there was a 96% reduction in HIV incidence 
among participants. This study bolstered evidence that HIV treatment can be used as a method of 
prevention. PLWHA engaged in continuous HIV medical care and on HAART have a greater 
likelihood of becoming virally suppressed which can enhance their overall health and lessens 
ones chances of transmitting the virus to others (Cohen et al. 2011). Treatment as Prevention can 
also be used to address one of the NHAS goals of decreasing the number of new HIV infections 
in the U.S. 
  In addition to the NHAS’ goal of decreasing the number of new HIV infections, another 
goal is to increase linkage and engagement in HIV medical care for PLWHA. The CDC and 
HRSA, two major HIV research and care coordinating governmental agencies, have also set 
goals to link and engage people who are diagnosed with HIV within 3 months of diagnosis.  
Findings from this study can add to the current literature on engagement in HIV medical care and   
psychosocial barriers of denial and perceived HIV stigma, by quantitatively examining these 





Conceptual Framework  
 
The conceptual model is an adapted of the Andersen Behavioral Model of Health care 
utilization (ABM; Andersen, 1995) and is used to guide the study. The Andersen Behavioral 
Model is a comprehensive model used to study medical care engagement. The model suggests 
that engagement is influenced by a combination of several factors: predisposing (e.g., 
demographics--age, gender, and race/ethnicity), enabling (personal resources--e.g. health 
insurance) and need (e.g. transportation, housing). The Andersen model was modified by adding 
to the predisposing factors (the psychosocial factors denial and perceived HIV stigma); to the 
need factor (client needs and barriers, barriers to care scale and the clinical factors-CD4 count 
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Research Questions and Hypotheses 
 
Q1. What is the rate of denial among African-American PLWHA in and HIV resources-rich 
area? 
Q2.  What is the rate of perceived HIV stigma among African-American PLWHA in an HIV 
resource -rich area?  
Q3.  Do out of care PLWHA have higher rates of denial than newly diagnosed PLWHA? 
H1:  Out of care PLWHA will have higher rates of denial than newly diagnosed 
PLWHA. 
Q4.    Do out of care PLWHA have higher rates of perceived HIV stigma than newly diagnosed 
PLWHA? 
H2: Out of care PLWHA will have higher rates of perceived HIV stigma than 
newly diagnosed PLWHA. 
Q5.  Does denial impact engagement in HIV medical care even after controlling for other 
potential predictors?   
H3. Denial will be an independent predictor of engagement in HIV medical 
care. 
H4. Denial will be a stronger independent predictor of engagement in HIV 
medical care than other factors.  
Q6. Does perceived HIV stigma impact engagement in HIV medical care even after 
controlling for other potential predictors of engagement in HIV medical care?   





Q7. Do denial and stigma interact in their prediction of engagement in HIV medical care? 
H6. Denial and stigma have a synergistic relationship when predicting 





Key Variables and Definition of Terms  
 
Human Immunodeficiency Virus (HIV): HIV is the virus that causes AIDS. HIV 
attacks the immune system by destroying CD4 positive (CD4+) T cells, a type of white blood 
cell that is vital to fighting off infection. The destruction of these cells leaves people infected 
with HIV vulnerable to other infections, diseases and other complications. (National Institute of 
Allergy and Infectious Disease [NIAID], 2012) 
http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/Pages/whatAreHIVAIDS.aspx 
 
Acquired Immunodeficiency Virus (AIDS): AIDS is the final stage of HIV infection. A 
person infected with HIV is diagnosed with AIDS when he or she has one or more opportunistic 
infections, such as pneumonia or tuberculosis, and has a dangerously low number of CD4+ T 
cells (less than 200 cells per cubic millimeter of blood) (NIAID, 2012). 
http://www.niaid.nih.gov/topics/HIVAIDS/Understanding/Pages/whatAreHIVAIDS.aspx 
 
Denial: The refusal to believe that the stressor (HIV) exists or “trying to push the reality 
of the situation away” or act as though the HIV is not real. The opposite of denial is a person 
who accepts the reality of the stressful situation and is engaged in the attempt to deal with the 
situation (Carver, Weintraub, & Sheier, 1989). 
 
Perceived HIV Stigma: The personal experiences, fears of rejection, and perceived 
negative consequences of other people knowing that a person has HIV (Berger, Ferrans, & 
Lashley, 2001).  
 
Chronic illness: Any disorder that persists over a long period and affects physical, 
emotional, intellectual, vocational, social or spiritual functioning. Chronic illness cannot be 
prevented by vaccine or cured by medication nor do they just disappear, but they can be 





CD4 count: CD4 - T-cells (or T-lymphocytes) are white blood cells that play important 
roles in the immune system. There are two main types of T-cells. One type has molecules called 
CD4 on its surface; the “helper” cells organize the immune system’s response to bacteria, fungi 
and viruses.  http://www.AIDSmap.com/CD4-cell-counts/page/1044596/ 
 
HIV Viral load:  HIV viral load is the term used to describe the amount of HIV in the 
blood. The more HIV in the blood, the faster a person’s CD4 cells (immune system cells that 
fight infection) reduce, and the greater risk of them developing symptoms in the next few years. 
http://www.AIDSmap.com/Viral-load/page/1044622/ 
 
HIV viral suppression: An undetectable HIV viral load is defined as <50 copies/ml 
(Gardner et al. 2011). 
 
HIV medical care: Engagement in HIV medical care:  received first set of follow-up 
HIV medical care visits after HIV diagnosis.  http://www.cdc.gov/hiv/pwp/linkage.html 
 
Linkage to HIV medical care: Received initial HIV medical visit after HIV diagnosis or 
reengagement (CDC) at http://www.cdc.gov/hiv/pwp/linkage.html 
 
  Highly Active Antiretroviral Therapy: HAART is the name given to aggressive 
treatment regimens used to suppress HIV viral replication and the progression of HIV disease. 
The usual HAART regimen combines three or more different drugs such as two nucleoside 
reverse transcriptase inhibitors (NRTIs) and a protease inhibitor (PI), two NRTIs and a non-
nucleoside reverse transcriptase inhibitor (NNRTI) or other such combinations. These HAART 
regimens have proven to reduce the amount of active virus and in some cases can lower the 
number of active virus until it is undetectable by current blood testing techniques. 
http://AIDS.about.com/od/hivAIDSletterh/g/haartdef.htm 
 
Psychosocial Factors: Psychological and social factors that determine how a person 
copes or deals with a chronic disease /illness. (http://guidewhois.com/2011/04/what-is-




Community Health Worker: CHWs are frontline public health workers who are trusted 
members of and/or have an unusually close understanding of the community served. This 
trusting relationship enables CHWs to serve as a liaison, link, or intermediary between 
health/social services and the community to facilitate access to services and improve the quality 
and cultural competence of service delivery. CHWs also build individual and community 
capacity by increasing health knowledge and self-sufficiency through a range of activities such 
as outreach, community education, informal counseling, social support, and advocacy (American 
Public Health Association [APHA], 2009). 
 
Newly Diagnosed: a person with their first HIV seropositive diagnosis within the past 3 
months (Shahani, 2012; Graham et al., 2013).  
 
Out of care: A person diagnosed with HIV and failing to have a medical visit in the last 
6 months of the measurement year (HRSA, 2011). 
 
Continuous Engagement in HIV Medical care: a person diagnosed with HIV who 











Chapter 2: Literature Review 
Overview and Organization of Chapter 
 
This chapter describes the literature on the HIV/AIDS epidemic nationally and in the 
District of Columbia. It presents a historical background and related statistics on HIV. Next, it 
highlights the importance of engagement in HIV treatment and medical care, the predictors of 
engagement, specifically the psychosocial predictors (perceived HIV stigma and denial). Finally, 
it describes the theoretical framework that guided this study, the Andersen Behavioral Model of 
Health Care Utilization. 
HIV/AIDS Historical Background 
Over 30 years ago, in June 1981, the United States was grappling with a disease in which 
five young previously healthy men were presenting to hospitals in New York and California with 
symptoms (e.g. Pneumocystis carinii, Pneumonia, Karposi Sarcoma, and Cytomegalovirus) 
causing them to be gravely ill. The treatment received by the men helped alleviate symptoms 
experienced by these patients but doctors did not know what was causing the symptoms or why 
these individuals were critically ill.  At least two of the five patients died within 7 months of the 
incident cases (CDC, 1981; Kaplan et al., 1987).  
Fast -forward almost four decades and it is now known that those five young men had 
AIDS and the cause was the HIV virus. Today, being diagnosed with HIV/AIDS in the United 
States is not an automatic death sentence. Studies have reported that HIV/AIDS is now a chronic 
illness that can be managed with antiretroviral treatment (Reynolds, 2011; Volberding & Deeks, 
2010). These treatments are effective in decreasing opportunistic infections associated with HIV, 
HIV viral load, and morbidity and mortality for persons living with HIV/AIDS (Anema, Wood, 




experiencing improvement in life expectancy with appropriate HIV medical care and treatment 
(Fang et al., 2007; Reynolds, 2011; Rodger et al., 2013; Sáez-Cirión et al., 2013).  As life 
expectancy increases, it is important for PLWHA to have access to and remain engaged in 
continuous HIV medical care to ensure maximum benefits of antiretroviral therapy treatments.  
Despite effective antiretroviral treatments there are still approximately 33-54% of persons 
diagnosed with HIV/AIDS who are not engaging in regular HIV medical care (Fleming et al., 
2002; Marks et al., 2010).  
 
Snapshot of HIV Epidemic 
It is estimated that approximately 1.2 million people are living with HIV in the United 
States, and each year there are approximately 40,000 new HIV infections (CDC, 2012).   A 
recent study on the HIV/AIDS epidemic in the United States reported that from 2006-2009 the 
HIV incidence has remained stable. However, African Americans continue to see HIV incidence 
rates 7 times the rate of whites (Prejean et al., 2011). 
African Americans and HIV/AIDS in the United States 
African Americans are disproportionately affected by the HIV epidemic. African 
Americans make up 44% of persons infected with HIV/AIDS even though they comprise 12% of 
the United States population (CDC, 2013; Kaiser Family Foundation, 2012).  The disparities 
seen in African Americans include higher numbers of HIV infections and AIDS diagnosis 
coupled with a greater number of blacks being diagnosed at advance stages in their illness. 
Studies measuring HIV incidence in the United States have recently been conducted and 
showcase the disparities. For example, one study examined HIV incidence using surveillance 
data from 16 states and cities, and found that blacks accounted for 42-46% of new infections, and 




measured HIV incidence based on confirmed HIV antibody and serological tests from 39,000 
newly infected persons, also reported that blacks made up 45 % of new HIV infections (Hall et 
al., 2008). In addition to having the highest incidence rates blacks also had the highest rates of 
new AIDS diagnosis. Specifically, African American men had a rate of 753, and African 
American women a rate of about 34 (CDC, 2012). Furthermore, HIV/AIDS incidence rates for 
other racial/ethnic groups have been decreasing or remained stable over time, but rates remain 
highest for blacks. Figure 2.1 shows that from 2008 to 2011, African Americans comprised the 
largest percentage of diagnoses of HIV infection each year (CDC, 2012). 
 
 
Figure 2-1 Rates of Diagnosis of HIV Infection among Adults and Adolescents by Race/Ethnicity, 2008-2011 
 Source: CDC, HIV Surveillance by Race/Ethnicity 2012  
In addition to higher rates of HIV/AIDS among African Americans, it is reported that late 
diagnosis of HIV is also an issue.  Approximately one-third of all blacks living with HIV have 
progressed to AIDS within one year after diagnosis. This can indicate that they have been living 
with the HIV for a long period of time before they were diagnosed or made the decision to seek 
treatment. Moreover, late diagnosis may also lead to higher mortality rates among African 
                                                




Americans. The mortality rate for African Americans living with HIV/AIDS 29.3/100,000 
population is higher than all other race/ethnic groups (CDC, 2012).  
Many studies report that the causes of high mortality among blacks occur because they 
are more likely to have never accessed HIV medical care, delayed entry into care after diagnosis, 
late initiation of HAART, entered care with advanced HIV infection, distrust medical providers 
and fear of stigma (Fagan et al., 2010; Rumptz et al., 2007; Tripath et al., 2011; Ulett et al., 
2009; Whetten, 2008; Zaller et al., 2011). Taken together, these results continue to highlight the 
disparities in HIV infections in the United States for African Americans.   
Washington, DC HIV/AIDS Epidemic  
The District of Columbia, the site of the research study, has the highest HIV/AIDS 
diagnosis in the United States (CDC, 2009). Approximately 2.5% of the DC population is living 
with HIV. This exceeds the World Health Organization’s definition of a generalized epidemic 
(1%); and ranks DC as top among all U.S. states and territories for U.S. AIDS cases (AIDS 
Lifecycle, 2012; HAHSTA, 2013). The disease also disproportionately burdens African 
Americans, as 75 % of the District’s residents living with HIV are black (2.5% prevalence rate) 
(HAHSTA, 2013). Black women have a 2.4% prevalence rate and black males have a prevalence 
rate two times that of women at 5.7% (HAHSTA, 2013). 
Washington DC Health Care Infrastructure  
 
The District of Columbia has one of the largest HIV populations, and an abundance of 
HIV health care organizations, providers, and community- based organizations that provide HIV 
medical care and services. The DC Department of Health has made it a priority to increase HIV 




continuous HIV medical care and treatment. One service that is provided, “treatment on 
demand,” is also known as the red carpet service. This service ensures any PLWHA newly 
diagnosed or who is not in engaged in HIV medical care can receive an HIV medical 
appointment within 1-2 days of request, free of charge.  Red carpet service is provided at about 
11 HIV organizations around the city (DC DOH- SCSN, 2011). This service reduces the barrier 
of access to HIV medical care in the District of Columbia. 
As several studies report that a barrier to engagement in HIV medical care is the lack of 
health insurance (Bamford et al., 2007; Palacio et al., 1999; Turner et al., 2000). This is not the 
case in the District of Columbia. It is reported that over 90 % of DC residents have some form of 
health insurance, including persons that are 400 percent below poverty level (DC, DOH, 2011). 
Despite the abundance of HIV medical care and services in the District of Columbia and the 
majority of residents having health insurance, 42 % of PLWHA living in DC are not engaged in 
continuous HIV medical care and an even lower percentage are virally suppressed (HAHSTA, 
2012). 
Engagement in HIV Medical Care 
Persons who receive a positive HIV test result should be linked to HIV medical care 
immediately after diagnosis.  Entry into HIV medical care can provide the necessary treatment to 
help reduce the morbidity and mortality associated with the disease.  Engagement in HIV 
medical care is a broad concept with different definitions. HRSA defines “engagement in care” 
as a spectrum of patient care, ranging from initial HIV diagnosis to full engagement HIV medical 
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Figure 2-2 HRSA Engagement in HIV Care Continuum 
Source: Cheever LW Clin Infect Dis 2007; 44:1500-2 
The continuum spectrum ranges from persons unaware of their HIV infection to the other 
PLWHA fully engaged in HIV medical care. Engagement in HIV medical care encompasses all 
stages in the continuum such as linkage, retention, lost to follow-up and fully engaged in care 
(Cheever, 2007). One limitation of trying to measure engagement is that entry and exit into the 
continuum is often cyclic and overlap can occur in many of the stages (Gardner, 2012; Rajabiun 
et al., 2007). Persons may engage in medical care immediately following diagnosis, have a gap 
in care and then reengage after years of being out of care. Using the HIV care continuum, this 
study examined to what extent is denial and perceived HIV stigma pose barriers to PLWHA 
engaging in HIV medical care.  Are denial and/ or HIV stigma the most important barrier(s), 
particularly at the initial stage in the continuum (newly diagnosed) or during reengagement in 
HIV medical care (out of care)? Are these two factors present singularly and/or in combination?  
Engagement in HIV medical care is a national priority.  The goal of engagement in 
medical HIV care and treatment is to get all PLWHA in continuous HIV medical care, on 
antiretroviral medication and to maintain viral suppression (HAHSTA, 2012; NHAS, 2010). The 
HIV treatment cascade developed by Gardner et al., (2011) and CDC (2011) appears in Figure 




suppression in the United States. Nationally, about 79% of persons are aware of their HIV 
positive status; of those persons who are aware of their HIV status only about 40 % are engaged 
in regular HIV medical care; and of the 40 % engaged in regular HIV medical care about 75% 
are on antiretroviral medication; and, finally, of those persons on antiretroviral medication, 
approximately 19% are virally suppressed.  This figure presents the grave details about the lack 
of engagement in HIV medical care in the United States.  This study focused on perceived HIV 
stigma and denial and the extent to which these two factors are barriers to engagement in along 
the HIV care continuum.  
 
Figure 2-3 United States Engagement in HIV Care Cascade 
Source: MMWR December 2, 2011 / 60(47); 1618-1623 
Similar to the national cascade, the DC Engagement in HIV care cascade (Figure 2.4) 
reflects the national engagement in care numbers with about 44% of PLWHA not engaged in 





Figure 2-4 Washington DC Engagement in HIV Care Cascade 
Source:  DC DOH, HAHSTA 2011 Annual report   
Studies on engagement in HIV medical care 
 
Engagement in HIV care and treatment is a lifelong commitment and is important for the 
management of HIV/AIDS and prevention of new HIV infections.  Since approximately 20 % of 
PLWHA have maintained HIV viral load suppression more needs to be done to ensure 
engagement in HIV medical care. Mugavero (2008) noted that there needs to be improvements in 
engagement in HIV medical care as PLWHA and the population at large will not be able to reap 
the benefits of advances in HIV treatment.  The lack of research in this area recently led the 
editorial staff of the Journal of Clinical Infectious Diseases, in 2011 to devote an entire issue to 
engagement in HIV medical care.  
The articles included in this journal focused on predictors of engagement in HIV care 
among particular subpopulations in the United States. For example, in their article on men who 
have sex with men (MSM) Christopoulos, Das, and Colfax (2011), suggested that engagement in 
care has not been thoroughly studied in this population; and found that predictors of engagement 
in care for MSM include race/ethnicity, sexual orientation and intravenous drug use.  For 




American, and poverty (Aziz & Smith, 2011); and for heterosexual men the major barriers were 
stigma, distrust, incarceration and drug abuse (Zaller, Fu Nunn & Beckwith, 2011). These studies 
all showed that African Americans are disproportionally affected by HIV/AIDS and have lower 
engagement in HIV medical care relative to other groups. This study focused specifically on 
African American PLWHA.  
National initiatives to address engagement in HIV medical care 
 
Engagement in HIV medical care has become a worldwide and national priority. The 
high rates of PLWHA who are not engaged in continuous HIV medical care in the United Stated 
has led federal agencies (e.g., CDC, HRSA, ONAP) to implement a variety of initiatives to 
increase HIV testing and engagement in HIV medical care. First, in 2006, CDC released an HIV 
testing recommendation that provided for routine HIV opt- out testing in medical care settings. 
This recommendation was necessary because it is estimated that 25 % of persons with HIV are 
not aware of their HIV status (CDC, 2006; Marks et al., 2006). In addition, the recommendation 
allows for routine screening in medical facilities, where patients can be tested for HIV unless 
they inform their doctor they do not want to be tested for HIV. Also, the recommendation has led 
to additional focus on HIV testing and immediate linkage to medical care after HIV diagnosis, 
both nationally and locally. Mugavero et al. (2009) suggest that because of this recommendation 
more PLWHA will be identified and need to be linked and engaged in HIV medical care.  
In addition to recommendations on HIV testing, many federal agencies released 
recommendations to increase PLWHA’s engagement in HIV medical care. This is in response to 
the only 40% of PLWHA engaged in continuous HIV medical care after diagnosis in the United 
States (Gardner et al., 2005). In 2007, CDC released its HIV Strategic Prevention Plan, with the 




CDC released their plan, the NHAS released its linkage goal but added a time frame that by 
2015, 85% of people diagnosed with HIV in the U.S. will be linked to HIV medical care within 3 
months of diagnosis. These recommendations are important because of their potential to provide 
evidence for the effectiveness of HIV treatment as prevention research and initiatives. They also 
demonstrate the need for additional research on barriers to PLWHA engaging in HIV medical 
care. Moreover, identifying barriers to engagement in care across the HIV care continuum is vital 
to get as many PLWHA from diagnosis to viral suppression maintenance.  The shorter the time is 
from diagnosis to viral suppression, the bigger the public health impact that can be made on the 
HIV epidemic and on individual and population health.   
Effective strategies and interventions have been investigated to determine the best way to 
engage PLWHA in HIV medical care as early as possible. One of the most widely used strategy 
that has proven to be effective at keeping PLWHA in medical care has been the use of case 
management services. The first randomized control trial testing the effectiveness of case 
management was the CDC-funded Antiretroviral Treatment Access Study (ARTAS) study. 
Gardner et al. (2005) developed ARTAS to determine if newly diagnosed persons with HIV 
referred to case managers vs. receiving information about HIV services and resources would 
increase linkage to medical care within 90 days of diagnosis. They found that persons who were 
referred to case management services were more likely to have a medical visit within 6 months 
of diagnosis as compared to those who only received information about HIV services and 
resources (Gardner et al., 2005). 
Also, results from HRSA’s Special Programs of National Significance (SPNS) results 
also showed that utilization of case management services increased engagement in HIV medical 




retaining persons in HIV medical care. Despite research initiatives that are aimed at increasing 
engagement in care and research showing that case management is an effective engagement 
strategy, lack of engagement in HIV medical care persist for a large proportion of PLWHA. 
Thus, more research is needed to demonstrate the best ways to ensure that PLWHA are engaged 
in care (Gardner et al., 2011). Another strategy that has been suggested is the use of peer–based 
community health workers to link and engage people in HIV medical care (Bradford et al., 
2007). 
CHW Strategy to Promote engagement in HIV medical care 
 
Community Health Worker Model  
 
Community Health Workers have been called by various names over the years such as: 
peer navigators, lay health workers, community advisors and outreach worker (Hardy et al., 
2005; Lewin et al., 2006; Wells et al., 2008). The American Public Health Association (APHA) 
has presented a broad definition of a Community health worker stating that, CHWs are frontline 
public health workers who are trusted members of and/or have an unusually close understanding 
of the community served. This trusting relationship enables CHWs to serve as a liaison, link, or 
intermediary between health/social services and the community to facilitate access to services 
and improve the quality and cultural competence of service delivery. CHWs also build individual 
and community capacity by increasing health knowledge and self-sufficiency through a range of 
activities such as outreach, community education, informal counseling, social support, and 
advocacy.  
One of a CHWs primary goal can be to provide individualized assistance to connect 
persons in need of health care to medical care. The assistance provided by the CHW can include: 
reminding clients of medical appointments, educating and answering clients questions about their 




been shown to be effective in helping persons manage medical care for chronic diseases such as 
diabetes (Norris et al., 2006), cancer (Wells et al., 2008), and hypertension (Brownstein et al., 
2007). With the success of CHWs in other chronic illnesses, their use has received increased 
focus as an effective strategy to linking and engaging PLWHA.   A peer community health 
worker can be a person infected and /or affected by a particular disease, or a trusted member 
from the community.  
A peer CHW can have the unique ability to connect with PLWHA, in addition to 
providing social support needed to navigate the sometimes-complex health care system. Social 
support has been shown to have a positive relationship with medical care access in PLWHA 
(Galvan et al., 2008). The use of CHWs has been increasing with People living with HIV/AIDS 
to help them adhere to their HIV antiretroviral medications.  Furthermore, CHWs can be 
effective in helping PLWHA with reduction of barriers to engagement in HIV medical care.   
 
Bradford et al. (2007) found that using HIV patient navigators and paraprofessionals in a 
12-month longitudinal study to were effective in helping increase PLWHA’s engagement and 
retention in HIV medical care. These researchers examined financial, structural and personal 
barriers to HIV medical care.  They reported that all barriers to care were significantly reduced at 
6-month and 12-month follow-ups; and, as a result, many patients had fewer missed medical 
appointments (Bradford et al., 2007).  A more recent study of the Positive Choices program 
enrolled 449 PLWHA in Indiana to increase HIV medication adherence. Participants were 
randomly assigned to the treatment group (lay health worker + case management) and a control 
group (standard of care-case management only) and followed for one year.  The Positive Choices 
treatment group within a year had greater HIV antiretroviral treatment adherence than the control 




evidence to the benefit of CHWs in helping reduce barriers associated with engagement in HIV 
medical care along the HIV continuum of care.  In addition to viral suppression, they have been 
used  to help increase retention in HIV medical care and medication adherence, a few researchers 
in sub-Saharan African countries have reported that CHWs have also been effective in reducing 
stigma associated with HIV treatment adherence (Apondi et al., 2007; Arem et al., 2011; Johnson 
& Khanna, 2004). The effectiveness of CHWs in decreasing denial and stigma in PLWHA has 
not been examined in the United States.  
DC Initiatives for engagement in HIV medical care 
  
In 2011, the Positive Pathways (PP) program began in DC as a strategy to help link and 
engage PLWHA in HIV medical care. PP uses the peer community CHW model to provide 
support to newly diagnosed and out of care PLWHA to become fully engaged in HIV medical 
care. Despite health insurance, HIV medical care, case management and CHW strategies in place 
there are still approximately 40 % of PLWHA not engaged in HIV medical care, as reported by 
Gardner’s cascade and locally by the DC Department of Health. Moreover, the results suggest 
that there are additional barriers outside of the above-mentioned strategies that hinder 
engagement in HIV medical care. This study hypothesized that perceived HIV stigma and denial 
that are keeping PLWHA from engaging in HIV medical care. This study examined, with peer 
CHW support, the level of denial and perceived HIV stigma PLWHA experienced and whether 
participants stay engaged in HIV medical care along the HIV care continuum. 
 
 
Benefits of engagement in HIV medical care  
 
The Infectious Disease Society of America recommends that primary medical care for 




antiretroviral treatment, every 3 months (Aberg et al., 2004).  In addition, some researchers also 
suggest that the optimum interval for patients to receive primary medical care, depending on 
treatment regimens is about every 3 months (Napravnik et al., 2006; Rajabiun et al., 2007). 
Early entry and engagement into HIV medical care and treatment has significant benefits.  
One such benefit is increased survival; Giordano et al. (2007) explored the relationship between 
poor retention in HIV care and survival rates in 2619 newly HIV diagnosed men who had 
received care at a Veterans Affairs hospital. Results showed that patients who had fewer medical 
visits had increased mortality (Giordano et al., 2007). 
It is has also been shown that lack of engagement in HIV medical care is associated with 
worse individual outcomes. These can include severe immune system suppression and a quicker 
progression to AIDS diagnosis (Moore & Keruly, 2007). Engagement in medical care is essential 
if people living with HIV are going to benefit from life-prolonging HIV care and antiretroviral 
treatment (Rumptz et al., 2007). As engagement in care is beneficial, it is important to identify 
predictors of engagement in HIV medical care for PLWHA to determine where along the 
continuum of care interventions may be needed. 
Predictors of engagement in HIV medical care  
 
A significant amount of researchers have focused on identifying predisposing, enabling 
and need predictors of engagement in HIV medical care and treatment; Samet et al., (1994, 1998, 
2001) identified gender, drug use, immigrant status, poor social support, age, and method of HIV 
result notification); Mugavero et al. 2009 found age, gender, minority group status, substance 
use, and lack of health insurance (Mugavero et al., 2009).  Turner et al.(2000) identified African 
Americans, lack of trust/confidence in health care, insurance, and usual place of care as 




correctional system, race-nonwhite, born outside the US , and injection drug user (IDU) were 
significant predictors (Torian et al., 2008; Turner et al.,2000).  Predictors can act as barriers or 
facilitators to PLWHA engaging in HIV medical care.  
Many researchers have been reported on the predictors for delay in engagement in HIV 
medical by people living with HIV/AIDS. The predisposing factors of age (Bamford et al., 2010; 
Giordano et al., 2005;Mugavero et al., 2009; Pollini et al., 2011); gender (Aziz  & Smith, 
2011;Mugavero et al., 2009,); race ( Giordano et al., 2005; Mugavero et al., 2009; Simard et al., 
2012;Turner et al., 2000; Ulett et al., 2009); marital status (Samet et al., 1998) and educational 
level (Simard et al., 2012) all have been shown to be predictors of PLWHA engagement in HIV 
medical care. 
Factors that that have been shown to enable PLWHA to get into care are health insurance 
(Mugavero et al., 2009, Pollini et al., 2011, Turner et al., 2000); income (Aziz & Smith, 2011); 
and having a medical home/usual place of medical care (Turner et al., 2000). PLWHA have 
reported to needing financial assistance, housing, benefits assistance, transportation, mental 
health care, food, and substance abuse treatment to help them receive medical care (Rumptz et 
al., 2007). Barriers to receiving care can include: transportation, homelessness, and lack of 
money or insurance (Beer et al., 2009; Heckman et al., 1998); and clinical need indicators such 
as CD4 count and HIV viral load (Ulett et al., 2009).  
Predisposing psychosocial factors that have been mentioned as barriers to PLWHA 
attending medical care are denial (Beer et al., 2009; Konkle-Parker et al.2011; Singh et al., 
1999); and perceived HIV stigma (Berger et al., 2001; Heckman et al., 1998; Zaller et al., 2011). 
In the next section, the psychosocial factors will be explored further. Many of the studies 




retrospectively or qualitatively. Mayer indicated that many providers and other studies discount 
the importance of psychosocial barriers in assessing why PLWHA are not engaged in medical 
care (Mayer, 2011).  This study will add to the literature by looking prospectively at the 






Goffman (1963) was one of the first social psychologists to write about stigma and in 
particular health-related stigma. He defined stigma as an attribute that is deeply discrediting, and 
the social identity of the sick person is labeled as “spoiled identity”. He further explains how the 
stigma constitutes a relationship between the attribute and the stereotype attached to the person 
(Goffman, 1963).  After Goffman’s initial research on stigma other researchers attempted to 
conceptualize it from a broad to a more a focused concept. For example, Link, and Phelan (2001) 
set out to define stigma as the inter-relatedness of labeling, stereotyping, separation, status loss 
and discrimination. The successive conceptualizations of stigma allow for clearer understanding 




Health related Stigma 
  
Health-related stigma is defined as a “personal experience that can be characterized by 
exclusion, rejection, blame, or devaluation” (pg.2) which results from anticipation of 
discrimination because of diagnosis with a specific health condition (Caltado, Jahan & 
Pongquan, 2012; Scambler, 2009). Studies have examined ways in which stigma is associated 




mental illness (Babic, 2010;Boyd, 2003; Corrigan & Watson, 2004); disabilities (Tate et al., 
1994), sexually transmitted diseases (STDs) (Fortenbery et al., 2002;Rusch et al. 2008); cancer 
(Lebel & Devins, 2008; Caltado, Jahan & Pongquan, 2012); substance use disorders (Rao et al. 
2009); and HIV/AIDS (Galvan et al., 2008; Sayles et al., 2009).  For example, a national study 
conducted with 192 persons diagnosed with lung cancer, found that lung cancer stigma was 
associated with greater depression and lower quality of life (Caltado, Jahan & Pongquan, 2012). 
 Earnshaw and Quinn (2012) conducted a cross-sectional study examining the influence 
of stigma from workers in health care settings on the quality of life for persons diagnosed with 
chronic illnesses. They studied 184 college students living with chronic illnesses in Connecticut. 
Participants were asked to complete an online survey that measured internalized, experienced 
and anticipated stigma on quality of life. Findings showed that persons, who internalized, 
experienced and anticipated stigma from health care workers accessed health care less and had 
lower quality of life. This study is important to show how stigma affects persons with chronic 
diseases.  A limitation of this study is that the sample did not include any PLWHA (Earnshaw 
and Quinn, 2012). 
 Health-related stigma associated with chronic illnesses can have a negative impact on a 
person’s quality of life and their decisions to access medical care needed to treat their illness. 
Fear of stigma can create increased psychological and psychiatric problems, non- disclosure of 
illness to others, and delays in seeking medical care and treatment (Van Brakel, 2006). These 
issues can also be seen in persons diagnosed with HIV/AIDS. 
HIV/AIDS Related Stigma  
 
HIV/AIDS is a highly stigmatizing health condition because it is a potentially fatal 
disease and a communicable disease. There is also a lack of population knowledge about HIV 




marginalized populations such as sexual minorities, racial/ethnic minorities, and intravenous 
drug users (Bunn et al., 2007; Herek, 2002; Parker & Aggleton, 2003).  HIV/AIDS stigma 
experienced by marginalized populations can cause PLWHA to identify with the “spoiled 
identity” term described by Goffman (Goffman, 1963; Parker& Aggelton, 2003). Herek (1999) 
defines HIV/AIDS stigma as a result of” prejudice, bias and discrimination directed at PLWHA.”  
Marginalized populations are greatly affected by HIV/AIDS. Several researchers have 
examined the effects of stigma on marginalized populations who carry the greatest burden of the 
HIV/AIDS epidemics (Darrow, Montanea, & Gladwin, 2009; Galvan et al., 2008; Radcliffe et 
al., 2010).  For instance, Swendeman et al. (2006) conducted a study with 147 young people 
living with HIV/AIDS in California and New York.  They found that gay and bisexual youth had 
experienced more HIV stigma than heterosexual youth and more than half of the youth 
experienced stigma since their diagnosis (Swendeman et al., 2006).  Also, in a study by Galvan 
et al. (2008) conducted with HIV positive African Americans in Los Angeles, California they 
examined predictors of HIV stigma in this population. They suggested that HIV stigma is 
greatest for African Americans since they bear the greatest burden of the HIV disease (Galvan et 
al., 2008).   In contrast, Rao et al. (2008) examined cross-cultural differences of PLWHA, and 
they reported no difference in felt stigma between African Americans and Whites but that the 
two groups did perceive and experienced stigma differently. Blacks experienced more 
discrimination than other groups and Whites expressed the need to keep their HIV status a secret 
for fear of experiencing prejudice or discrimination (Rao et al., 2008).  HIV/AIDS Stigma can 
negatively affect PLWHA, and subsequently how they experience stigma could have an effect on 






Types of HIV Stigma 
A review of the literature reveals PLWHA can experience various forms of stigma after 
diagnosis with HIV stigma both socially and individually. Within the stigma literature, 
HIV/AIDS stigma can be conceptualized in three main ways: enacted, internalized, and 
perceived HIV stigma.  First, enacted stigma occurs from interactions with others where the 
PLWHA may experience discrimination, prejudice and stereotyping (Bunn et al, 2007; Galvan, 
et al., 2008; Van Brakel, 2006; Varni et al., 2012). For instance, Varni and colleagues (2012) 
measured the psychological consequences of enacted and felt stigma on outcomes with PLWHA. 
Increased enacted stigma was suggested to increase anxiety for PLWHA (Varni et.al, 2012). 
Second, internalized stigma comes about when people internalize negative beliefs and 
stereotypes associated with a diagnosis of HIV (Link, 1987; Sayles et al., 2009). PLWHA 
experience internalized stigma as feelings of shame, guilt and non-disclosure of HIV status 
(Kalichman et al., 2009). Third, perceived stigma is the PLWHA’s belief, fear, and anticipation 
that disclosure of HIV status will lead to discrimination (Berger et al., 2001; Galvan et al., 2008; 
Varni et al., 2012).  
 Perceived HIV stigma is associated with increased depression, decreased disclosure and 
access to health care. One study by Sowell et al. (1997) in rural Georgia examined the extent that 
perceived HIV stigma, needed resources and disclosure were present in the sample of HIV 
positive women receiving HIV medical care and services from health care and community based 
organizations. They recruited about 82 women and conducted interviews with them on questions 
about demographics, HIV resources available, and perceptions of stigma and disclosure patterns. 
Results showed that approximately 40 % of women reported the presence of perceived stigma 
and fear of discrimination by others. The perception of how people (e.g. family, friends and 




medical care (Sowell et al., 1997).  Perceived HIV stigma has been indicated as an important and 
major barrier to HIV testing, and also for PLWHA disclosing status to others and entering 
medical care (Derlega et al., 2002). 
 
HIV Stigma and Health Care Environment 
 
In the United States and Washington, DC a number of PLWHA are not taking advantage 
of HIV medical care and antiretroviral treatment necessary to decrease morbidity and mortality 
associated with HIV disease.  Understanding how HIV/AIDS stigma affects gaps in HIV medical 
care and treatment is important to lessen negative health outcomes for persons diagnosed with 
HIV.  
Research has shown that PLWHA who encounter or perceive HIV/AIDS stigma from 
health care professionals are less likely to engage in HIV medical care (Kinsler et al., 2007; 
Sayles et al., 2007, 2009). Engaging in HIV medical care helps keep the HIV infection under 
control and can enhance the health and quality of quality of life for PLWHA. Some researchers 
have examined attitudes and perceptions of health care professionals in providing care to 
PLWHA (Ding et al., 2005; Reis et al., 2005). A cross-sectional study in the US examining 
physician’s attitudes towards their HIV positive IDU patients found that about 23% percent of 
the physicians had negative attitudes toward their patients. It is suggested that the negative 
attitudes of physicians toward IDU patients contributed to lower percentage of patients receiving 
HIV antiretroviral medications (Ding et al., 2005). 
 At the same time, PLWHA also have negative views of health care professionals and 
medical care environments, as they may have experienced and/or perceive stigma from medical 
providers. Perceived stigma by PLWHA from within the medical care settings may discourage 




and Services Utilization Study (HCSUS), a national dataset, found that approximately 26% of 
PLWHA perceive they have experienced discrimination from their health care providers 
(Schuster et al., 2005).  In another study, researchers from California conducted a study with low 
income PLWHA to assess the relationship between perceived stigma from a health care provider 
and access to medical care (Kinsler et al., 2007).  Results indicated that between 20- 25 % of the 
sample had perceived stigma from a health care provider, and this was found to be associated 
with low access to medical care.  Thus, PLWHA may delay entry to medical care, or have gaps 
in medical care because they have experienced or fear discrimination from health care 
professionals (Earnshaw & Quinn, 2012; Kinsler et al., 2007). 
 
 HIV Stigma and HIV Treatment Adherence   
 
HAART has changed HIV from a fatal to a chronic illness. Adherence to HAART is very 
important for PLWHA to achieve HIV viral load suppression, reduce morbidity and mortality 
associated with HIV, and HIV transmission to others (Cohen et al., 2011).  In addition, lack of 
adherence can lead to poorer health outcomes and possibly HIV viral resistance (Bangsberg, 
Moss & Deeks, 2004), and can present major challenges for PLWHA and providers (Beach, 
Keruly, & Moore, 2006). 
 HIV/AIDS related stigma also plays a role in PLWHA not consistently adhering to their 
antiretroviral treatment regimens. Indeed, prior research demonstrates that HIV/AIDS stigma is 
related to lower HIV treatment adherence in PLWHA (Chesney & Smith, 1999; Konkle-Parker 
et al., 2008; Rao et al., 2007; Rintamaki et al., 2006; Sayles et al., 2009; Vanable et al., 2006).  
Sayles et al. (2009) conducted a cross-sectional study in California with 202 PLWHA.  
Participants were recruited from clinical and community-based organizations. They completed 




reported access to care, regular source of HIV care, and antiretroviral therapy adherence; and to 
test whether mental health mediates these associations.  Findings showed, one-third of 
participants reported high levels of stigma; 77% reported poor access to care; 42.5% reported 
suboptimal ART adherence. The results also indicated that high internalized HIV stigma was 
associated with lower reported treatment adherence and access to care (Sayles et al., 2009). 
  Rao and colleagues (2007) conducted a qualitative study with 25 young people living 
with HIV (YPLWH) to determine barriers to medication adherence among this population.  
Respondents were asked to share experiences with HIV medication (e.g. side effects, skipping 
doses, and how to overcome barriers to non-adherence). Findings revealed that almost 50 % of 
youth skipped doses for fear of family and friends finding out about their HIV status. These 
studies are important to confirm that HIV stigma is associated with non-adherence to HIV 
medication (Rao et al., 2007). 
HIV/AIDS stigma is a predictor of non-adherence to HIV medications not only in the 
United States but internationally as well. A number of studies conducted in the United States and 
internationally have reported HIV stigma as a predictor of lack of antiretroviral treatment 
adherence and engagement in HIV medical care (Bogart et al., 2010; Sayles et al., 2009; Skinner 
& Mfecane, 2004; Sumari-de Boer et al., 2012; Wolitski et al., 2009). Only consistent use of 
HAART will help PLWHA attain and maintain HIV viral suppression. In addition to HIV 
stigma’s effects on treatment adherence it also is a root cause of lack of continuous engagement 
in HIV medical care.   
 
 HIV Stigma and Engagement in HIV Medical Care  
 
Engagement in HIV medical care is important to ensure that PLWHA receive life-




(Mayer, 2011; Mugavero, 2008; Samet et al., 2001). For this study, HIV medical care was 
operationalized as PLWHA attending HIV medical appointments with a physician who can 
prescribe HIV medications. HIV stigma has been identified as one of the most significant 
barriers to PLWHA seeking HIV medical care (Chesney & Smith, 1999; Herek et al. 2003; & 
Kalichman & Simbaya, 2003). Many studies have examined retrospectively the effects of HIV 
stigma on PLWHA delaying entry into HIV medical care (Beer et al., 2009; Konkle-Parker et al., 
2011; Rajabiun et al., 2007).  However, there are a few studies that prospectively examine 
HIV/AIDS stigma as a barrier for PLWHA entering and remaining engaged in HIV medical care.  
Reece (2003), in a cross-sectional study with 132 HIV-positive persons examined the 
association between HIV stigma and remaining in medical care. Participants were asked to 
complete surveys that assessed physical and mental health status, health beliefs and HIV stigma. 
The outcome was appointments kept, and the study examined participants who returned for their 
follow-up appointment versus those who did not return.  Results from this study showed that 
persons with higher levels of HIV-related stigma were less likely to return for medical care as 
compared to those persons with lower levels of HIV stigma (Reece, 2003).  Similar findings 
were reported by Vanable and colleagues (2006) who found in their study of 221 PLWHA in 
New York, that HIV stigma was associated with a greater number of missed appointments and 
HIV-related symptoms (Vanable et al., 2006).   
Furthermore, researchers from California using the HCSUS national dataset examined the 
association between HIV stigma and utilization of medical care and treatment adherence (Sayles, 
2009). Results indicated that persons who reported higher levels of stigma were four times as 
likely to report lower medical care utilization.  In addition to PLWHA, HIV providers also 




(2005) explored barriers to HIV medical care for PLWHA in the rural South. They surveyed 111 
HIV/AIDS case managers and over half reported that HIV stigma is a major barrier to 
engagement in medical care for PLWHA attending their urban clinic (Reif, Golin and Smith 
2005). The stigmatization associated with HIV/AIDS has been referred to as a second epidemic 
because of the considerable impact it has on the lives of PLWHA (Chesney & Smith, 1999). 
After diagnosis many persons because of the stigma associated with the disease may never 
perceive themselves in the same way and are concerned about how they will be treated by others 
(Carr & Gramling, 2004). 
In sum, HIV stigma has an impact on the health care environment, HIV treatment 
adherence and HIV medical care engagement, which can impact health outcomes for PLWHA. 
In addition to HIV stigma being a barrier to HIV care some have suggested that denial of HIV 
status in PLWHA is also another psychosocial factor that keeps people from engaging in HIV 
medical care (Beer et al., 2009). 
Measurement of HIV Stigma  
 
Perceived HIV stigma was the type of HIV stigma examined in this study.  The two HIV 
stigma measures that were considered  to measure perceived HIV stigma in this study were the 
Sowell perceived HIV stigma scale (Sowell et al., 1997) and the Berger’s HIV stigma scale – 
personalized stigma subscale (Berger, Ferrans & Lashley, 2001). The Sowell perceived HIV 
stigma scale is a 13-item scale developed by Sowell and colleagues to assess perceived HIV 
stigma in PLWHA. The scale is measured on a 4-point Likert scale from “not at all to often”, and 
measures the feelings of fear, blame or shame related to HIV stigma status. In addition it 
examines the fear of losing friends and family because of HIV positive status. This scale was 




The second scale considered was the Berger’s HIV stigma scale. The Berger HIV stigma 
scale consists of 4 subscales - the personalized stigma, disclosure concerns, negative self-image, 
and concern with public attitudes about people with HIV.  The scale is measured on a 4-point 
Likert scale from “strongly disagree to strongly agree”. The perceived stigma subscale scale 
measures the perception of the consequences from others knowing a PLWHA’s HIV status. The 
Berger’s HIV stigma and Sowell HIV stigma scales were shown to be reliable measures.  
The personalized stigma subscale of Berger HIV stigma scale was used to measure 
perceived HIV stigma in this study and will be referred to as perceived HIV stigma scale 
throughout the rest of the document.  The Berger’s HIV stigma scale was chosen over the Sowell 
scale because it has been referred to as the standard HIV stigma scale and has been used in 
psychosocial studies with PLWHA (Rao et al., 2007; Varni et al., 2012). In addition, the scale 
has been used with African Americans, and PLWHA in urban and rural areas (Bunn et al., 2007; 
Galvan et al., 2008; Reif et al., 2005). 
Denial  
 
Construct Evolution  
 
Denial is a multifaceted concept that has its origins in the psychology discipline. 
Sigmund Freud first proposed denial to be an unconscious process that “disavows reality” of an 
event taking place (Freud, 1924, cited in Livneh, 2009).  Since Freud first coined denial it has 
been defined in a variety of ways. First, denial has been examined as a form of coping and/or 
defense mechanisms originating from internal factors such as anxiety, shame or fears (Dorpat, 
1983; Wheeler and Lord, 1999). Second, denial has been hypothesized to stem from external 
factors (e.g. life threatening illness or event) (Breznitz, 1983; Carver et al., 1989; Goldberger, 
1983; Horowitz, 1983; & Lazarus, 1983). Breznitz (1983) postulated that denial refers to efforts 




originate from a combination of both internal and external factors (Lazarus, 1984; Wool and 
Goldberg 1987). Wool & Goldberg (1987) have argued that denial is an "unconscious disavowal 
of an external or internal threat".  Fourth, denial has been conceptualized as types or models that 
may occur on a continuum or in stages (e.g. mild to severe) (Breznitz, 1983; Hackett and 
Caseem, 1974; Levine et al., 1994; Wool and Goldberg, 1987). Finally, denial has been 
hypothesized as denial like tendencies (Lazarus, 1983). Lazarus suggests that denial is not all or 
nothing and is determined by time and situations. In addition, he proposes that a person can 
experience partial or minimal denial to cope with a life threatening/stressful event such as 
diagnosis with a chronic illness (Lazarus & Folkman, 1983, 1984).  
Individuals with chronic illnesses may go through processes before accepting their 
diagnosis. Having a chronic illness may change a person’s sense of self and possibly there 
interaction with other people.  As a result they can develop a “head in the sand” coping strategy 
of not wanting to deal with the diagnosis.  A person may also try to forget the reality of the 
situation especially when there are no symptoms present. In short, denial can be viewed as a 
protective strategy used to buffer the individual from the impact of anxiety and perceived threat 
associated with a chronic illness diagnosis (Livneh, 2009).  
Health Related Denial  
 
Since Freud’s first discussion of denial it has since been examined in medical and public 
health research as factors that impede a person’s recognition of diagnosis with a chronic illness 
and their subsequent engagement in medical care. Denial often describes a person’s response to 
diagnosis with a chronic illness (Telford, Kralik & Koch, 2006).  Denial has been studied 
extensively in persons diagnosed with chronic illnesses and medical conditions such as cancer 




1974; Havik & Maeland, 1986; Jacobsen & Lowery, 1992; & Levine et al., 1987), and mental 
illness (Saks, 2009).   
  However, the role of denial in chronic illnesses has been investigated with mixed results 
in regard to its effect on medical treatment delay, survival and health outcomes. For instance in 
patients diagnosed with cancer, Wool (1986) examined 20 women with breast cancer for denial 
of illness, and found that persons who were classified as deniers had an average of 20 months 
longer delay in seeking medical treatment than those who were not classified as deniers (Wool, 
1986). However in contrast, Watson and colleagues (1984) studied 24 women newly diagnosed 
with breast cancer to determine how patients coped with cancer diagnosis; did they use denial or 
accept their diagnosis. The results revealed that the majority of women used denial to cope with 
their diagnosis, but they found no relationship between denial and delay in seeking medical care 
(Watson et al., 1984). Moreover, Chakravorty et al. (1993) supported this conclusion; they 
examined 75 patients with cancer for reasons they delayed presentation to care after diagnosis. 
They reported that the approximately 90% of patients used denial to cope with diagnosis. In 
addition more than half delayed entering medical care within three months after diagnosis, but 
there was no difference in the degree of denial exhibited by patients who delayed medical care 
for 3 months versus those who did not delay medical care (Chakravorty et al., 1993). These 
studies confirm the diverse interpretations on how denial affects engagement in medical care 
after diagnosis with a chronic illness. 
Research has suggested that denial can be “beneficial and detrimental” to a patient’s 
health (Lazarus, 1983), as it can help to alleviate initial anxiety associated with chronic illness 
(Esteve et al., 1992; Folks, 1988; Julkunen & Saarinen, 1994), but can also keep individuals from 




1987).  Consequently, as HIV is now classified as a chronic illness, denial has also been 
associated with HIV diagnosis. Denial of HIV diagnosis has been examined with outcomes such 
a quality of life (Gielen et al., 2001; Kamen et al., 2012; Vosvick et al., 2003) and HIV 
medication adherence (Weaver et al., 2005). However the role of denial with PLWHA as it 
relates to engagement in HIV medical care has not been widely examined. 
 
Denial and HIV/AIDS 
 
The receipt of an HIV diagnosis can be met with high anxiety.  The emotional response 
to the diagnosis of a potentially fatal and chronic illness, such HIV can lead a person into denial. 
Denial of HIV in particular is denying the reality and significance of their HIV diagnosis says 
Raveis, Sigel and Corey (1998). In addition, Nam et al. (2008) says denial is when “a person has 
not fully adapted to their HIV status or had not accepted one’s self”. Denial can be a coping 
mechanism people use to deal with the shock of acquiring a stigmatized illness and social status 
(Nam et al., 2008). Among a sample of African-American HIV positive women, Watkins-
Haynes et al. (2012) conducted in-depth interviews, to examine the effects of HIV on these 
women and how their perceptions of their HIV diagnosis changed over time. Participants were 
recruited from HIV medical and social services agencies in Chicago, IL.  Some women reported 
being in denial after receiving diagnosis, and as a result not disclosing their HIV status to others 
for more than two years. (Watkins-Haynes et al., 2012) 
 Also as a result of being in denial many PLWHA delay entry or do not remain engaged in 
HIV medical care (Konkle–Parker et al., 2011). Psychosocial factors both positive and negative 
have been examined with HIV. Many researchers have explored the relationship between 
psychosocial factors and HIV disease progression (Antoni et al., 1995; Cole, 2008; Gore-Felton 




denial by HIV positive persons has been associated with lower immune functioning.  In a study 
with newly diagnosed HIV positive gay men, Antoni and colleagues (1995) found that those men 
who used denial as a form of coping the year following notification of positive HIV status had 
significantly lower immune function. These results point to the fact that PLWHA who use denial 
to cope with disease can potentially speed up the HIV disease progression in their bodies that 
may lead to worse health outcomes (Antoni et al., 1995). 
On the other hand, Ironside and Hayward (2008) reported that that positive psychosocial 
factors such as social support, positive coping and spirituality lead to better health outcomes for 
PLWHA (Ironside and Hayward, 2008). More research on negative psychosocial factors such as 
denial and its effect on HIV disease progression and engagement in HIV medical care is needed. 
Identifying denial in PLWHA is important in order to pinpoint which persons are at risk for non-
adherence to HIV medication or dropping out of HIV medical care (Singh 1999).  With the 
diagnosis of HIV a person can be asymptomatic for a number of years. This could possibly lead 
to a PLWHA using denial to cope with illness and be in denial for a number of years. The study 
focused on denial as a coping mechanism, in PLWHA and their refusal to believe that HIV exist 
or trying to act as though HIV is not real in their life.  
  
Denial and HIV Medication Treatment Adherence 
  
HIV medical care is important for PLWHA to receive the necessary HIV treatment, and 
disease progression monitoring to remain healthy. However, to take advantage of the benefits, 
PLWHA must remain adherent to HIV medications and remain engaged in HIV medical care 
(Nam et al., 2008). Denial has been reported to be a barrier to both HIV treatment adherence and 
engagement in HIV medical care. Undoubtedly there has been ample evidence that adherence to 




2011; Volberding & Deeks, 2010). Weaver and colleagues conducted a prospective study and 
examined the role of psychosocial factors (denial, social support), quality of life and HIV 
medication regimen on HIV treatment adherence. Participants were recruited from several 
medical centers across the United States.  They found that use of denial was significantly 
correlated to non-adherence of HIV antiretroviral medication. Further, in a randomized control 
trial with HIV positive women on HAART investigating how coping strategies relate to quality 
of life. The results indicated that denial was related to poor treatment adherence and lower 
quality of life (Weaver et al., 2004).   
More recently, Konkle-Parker and colleagues (2008) qualitative study sought to examine 
the barriers and facilitators to HIV treatment adherence in a predominantly minority population 
in Mississippi.  As one respondent said “I was mad, and I was upset, and I was in denial. And it 
took me five years to tell anybody that was close to me. So I kept that to myself for a long time, 
and I was very angry. Right now, I still don't take [the medicines] like I should” (pg. 4). Findings 
showed that denial was one of the main reasons for not adhering to medication regimens and 
disclosure of HIV status to others (Konkle-Parker et al., 2008). Adherence to HIV medication is 
important to keep PLWHA virally suppressed, but if they are not engaged in HIV medical care 
they cannot benefit from these life-preserving medications. 
 
Denial and engagement in HIV medical care 
 
Denial and delay in HIV medical care had been studied (Pollini et al. 2011, Raveis, 
Siegel& Gorey, 1998; Siegel, Schrimshaw & Deal, 1999) and found to be a significant predictor 
of PLWA delaying engagement in HIV medical care. Pollini et al. (2011) conducted a 
comparison community study in California with PLWHA, who had delayed entering HIV 




significant predictors of entering HIV medical care. HIV treatment educators administered 
surveys that contained questions about demographics, barriers to care (predisposing, enabling 
and need factors) and sexual and drug risk behaviors. Findings showed significant differences in 
denial between the two groups.  Many who had never been in care reported denial (i.e. “Didn’t 
want to think about being HIV positive”) as a barrier to initiating medical care. They were also 
three times more likely to not be engaged in HIV medical care as compared to persons currently 
in care (Pollini et al., 2011). 
This study provides support that denial is an important barrier to assessing HIV medical 
care for the newly diagnosed individuals. In addition, the researchers also suggested that 
participants did not tell others about HIV status for fear of discrimination hints that stigma is also 
a barrier to delaying entering HIV medical care. While, denial was assessed by asking 
participants one question that implicated they were in denial, more research is needed to examine 
the role of standardized measures to determine the level of denial and its influence on PLWHA’s 
decision to engage in HIV medical care.   
In another study that examined the barriers and facilitators to engagement in HIV medical 
care among HIV positive persons living in the Deep South. Researchers conducted 130 in-depth 
interviews with PLWHA who delayed entry into HIV care and/or had a gap in medical care. 
They found that denial was reported in the majority of the sample as a barrier to entering care 
and approximately one quarter said that denial was a barrier to remaining engaged in medical 
care (Konkle-Parker et al., 2011).  The above studies corroborate with previous studies that HIV 
is a highly stigmatizing condition and that denial and HIV stigma are two important factors to 






Relationship between Denial, HIV Stigma and engagement in HIV medical care  
 
Studies have supported that the two psychosocial factors HIV stigma and denial are 
associated with HIV medical care (Beer et al., 2009; Konkle-Parker, et al., 2008; & Sayles, et al., 
2007).  There are a limited number of studies that have examined how the two are associated 
with engagement in HIV medical care. This could be because the majority of the studies have 
been qualitative and point to the need for further research in this area.  Sayles et al. (2007) 
conducted a study with PLWHA (men and women) in Los Angeles, CA to explore the impact of 
stigma on health and health care. Participants were asked about their experiences and perceptions 
with HIV stigma and how it affects health and healthcare. Stigma and negative experiences 
within the health care environment caused participants to delay or drop out of care completely. 
They also reported that many participants were in denial after receipt of HIV diagnosis, and 
described using denial to cope with HIV stigma (Sayles et al., 2007). 
Additionally, the CDC sponsored “Not in Care Study, a qualitative study conducted with 
PLWHA who were not utilizing HIV medical care 6 months after diagnosis.  Participants were 
recruited from community based organizations and health departments in 5 states across the U.S. 
(IN, NJ, NY, PA, WA).  A total of 37 PLWHA participated in focus groups. They were 
questioned about personal barriers to engaging in HIV medical care after HIV diagnosis.  All 
participants stated that HIV stigma was a barrier to utilizing HIV medical care.  Specifically, 
perceived HIV stigma from medical providers where some refused to continue to provide care to 
patient after learning of HIV status. For this reason, participants decided not to engage in HIV 
medical care. Further, in all focus groups denial and disbelief of HIV diagnosis was mentioned 
also as a reason for not engaging in HIV medical care (Beer et al., 2009). Consistent with 




to think about it and hoped it would go away. This study suggests that the perception of HIV 
stigma may lead a person to use denial of HIV disease and consequently not seek medical care.  
Moreover, it is important to note that this was a nationwide study and the major barriers to 
engaging in HIV medical care among all participants were the psychosocial factors (denial and 
HIV stigma). More research is needed to discover how denial interacts or relates to HIV stigma 
among newly diagnosed persons with HIV and those persons who do not remain engaged in HIV 
medical care.  
 In another qualitative study, 40 HIV positive women, from rural Alabama, were 
recruited from community-based HIV organizations to explore perceived barriers to engaging in 
HIV medical care. The respondents were asked to explain their experience with HIV medical 
care.  Five types of barriers emerged: personal, social, financial, geographic and the health care 
system. Of the five barriers, denial and HIV stigma were the most frequently mentioned as 
barriers to accessing HIV medical care.  The women stated that denial was the most common 
response to their HIV diagnosis, which led them further away from care, as they did not want to 
think about their diagnosis. In addition, their other concern was HIV stigma specifically how 
they were perceived or treated by others finding out about their HIV status.   These women did 
not want to be seen by others accessing HIV medical care. The authors suggested that to examine 
these barriers further, the Andersen Model of Health care utilization would be an appropriate 
model to show clearly how these barriers affects PLWHA’s engagement in HIV medical care 
(Moneyham et al., 2010).  
More recently, Dr. Lisa Fitzpatrick, an infectious disease HIV physician, from 
Washington, DC, wrote an article, explaining that what she has been witnessing in her 




engagement in HIV medical care. One point she made is that, what is lacking in research is the 
examination of denial, stigma, and shame when it comes to why PLWHA are not engaging in 
HIV medical care. Further, she states that to adequately address the gaps in care that are seen 
along the HIV continuum of care and the HIV treatment cascade that these psychosocial factors 
will need to be addressed (Fitzpatrick, 2013).  
In summary, these studies underscore the need to consider how denial and perceived HIV 
stigma not only affects treatment adherence but also whether PLWHA will engage in HIV 
medical care. This study will add to the literature, as it sought to identify quantitatively, if in fact 
denial and perceived HIV stigma are the major barriers that cause PLWHA not to engage in HIV 
medical care after diagnosis with HIV. 
Measurement of Denial  
 
With many of the chronic illnesses that require medical care the measurement of denial 
can be accomplished in the clinical and community settings. First, there is clinical judgment 
/observation, where the physician believes that the person is not acknowledging their diagnosis 
and they report that the person is in denial. Second, there are clinical semi- structured interviews 
administered by clinical staff to patients (e.g. Levine Denial of Illness scale).  This type of 
measurement entails the clinical staff going thru a series of questions and scoring them to 
determine if the patient is in denial about their diagnosis (Levine et al., 1987). Third, the patient 
can self-report their psychological state by completing questionnaires that reveal whether they 
are in denial about the illness. Lastly, a behavioral indication of denial can also be when a person 
delays seeking medical care after learning of diagnosis of a chronic illness (Goldbeck, 1997; 




For this study the assessment of denial was measured by a self- report measure. There are 
a few measures that have examined how PLWHA cope with their HIV status.  These include: the 
Illness Behavior Questionnaire (IBQ), Ways of Coping Scale, and the Coping Orientation to 
Problems Experienced Scale (COPE).  The Illness Behavior Questionnaire was developed by 
Pilowski and colleagues, and examines a person’s perception of their illness. This 62-item scale 
contains seven subscales that measure: denial, hypochondriasis, disease conviction, affective 
inhibition and disturbance, irritability, and psychological vs. somatic perceptions of illness (Merz 
et al., 2013; Pilowski & Spence 1975).  This 4-item denial subscale was not chosen as it 
measures life worries, and has not been used frequently with PLWHA. 
The second measure that has been used to measure denial is the Ways of Coping measure 
developed by Folkman and Lazarus (1985). This scale measures perceptions of how people cope 
with stressful situations. This is a 66-item scale has seven subscales: confrontive coping, 
distancing, self-controlling, seeking social support, accepting responsibility, escape avoidance, 
and positive appraisal. The subscale contains one item denial that measures denial. This scale has 
been used with PLWHA, but measures escape and avoidance more so than denial (Folkman & 
Lazarus, 1985).  
   The last scale examined to measure denial was the COPE- denial subscale. This 
measure was utilized to measure denial over the Ways of Coping and Illness Behavior Scale 
because it appears to be a more face-valid measure of denial of HIV status. This scale is also 






There are a few theories that have been proposed to study HIV/AIDS and health care 
utilization for PLWHA. These include the Health Belief Model (HBM), Biopsychosocial Model, 
and the Andersen behavioral model of Health care utilization (ABM) (Mkanta & Uphold, 2006). 
The theoretical framework that was used for this research study is the Andersen Behavioral 
Model of Health care Utilization, which was originally developed by Andersen in 1968 to 
determine how families utilize health services (Andersen, 1995).  
According to the ABM, health care utilization can be influenced by three factors- 
Predisposing, Enabling and Need (PEN). The predisposing factor refers to demographic 
variables (e.g. age, gender). The enabling factors refer to resources that would help a person 
access health care (e.g. income, health insurance), and need factors refer to a persons perceived 
needs that will help them enter medical care (Andersen, 1995).  
The Andersen Behavioral Model of Health Care Utilization has been used to predict 
outcomes such as cervical cancer screening (Andrasik, Rose, Pereira & Antoni, 2008), 
Complementary and Alternative Medicine (CAM) use (Brown, Barner, Bohman, & Richards, 
2009), and long-term care use (Bradley et al., 2002).  The ABM has also been adapted to include 
psychosocial factors. Bradley and colleagues (2002) in a qualitative study adapted the ABM by 
adding psychosocial factors (e.g. attitudes, knowledge, social norms and perceived control) to 
explain race/ethnicity differences in long term care use. They found that adding psychosocial 
factors to the ABM model enhanced the utility of the model, and allowed for a more complete 
understanding of race /ethnicity differences in long term care use (Bradley et al., 2002).   
The original Andersen Behavioral Model has also been used to predict HIV treatment 




Services Utilization Survey (ACSUS) and the more recent HIV Cost and Services Utilization 
Survey (HCSUS) to predict HIV treatment adherence. The two datasets were both longitudinal 
studies that used interviews, medical and billing data to determine medical cost and use by 
persons living with HIV/AIDS. Smith & Kirking (1999) applied the ABM to the ACSUS data to 
determine if predisposing, enabling and need factors were associated with use of HIV 
medications. Results indicated that being female, between the ages of 15-24, and having a 
history of hospitalization predicted lower odds of HIV medication use.  Conversely, being 
African American, having health insurance and a usual place of care increased the odds of HIV 
medication use (Smith & Kirking, 1999). In another study by Smith, Boyd and Kirking (1999), 
also using the ACSUS data they examined the association of predisposing, enabling, and need 
factors with alternative medication use to treat HIV disease. They found that African Americans 
were less likely to use nonprescription drugs, compared to whites, enabling factors were 
associated with illicit substance use and need factors were associated with non-prescription drugs 
and vitamin use by PLWHA (Smith, Boyd and Kirking, 1999). The ABM model is an adequate 
theory to examine HIV treatment adherence and the use of non-prescription medication with 
PLWHA. Furthermore, it can be used with national data to examine PEN factors. These studies 
confirm the utility of the theory.  The limitation of these studies is that many did not include any 
health belief or attitudinal variables about HIV treatment. 
  More recently, Luseno et al (2010) examined health service utilization among HIV 
positive women in South Africa with a history of sexual and substance abuse risk factors.  Their 
findings suggest that denial of HIV status is a major barrier for women not utilizing health care.  
Certainly, this study provides evidence of the need to adapt the ABM to include denial as a 




an adapted version of Andersen Behavioral model of healthcare utilization was used to determine 
predictors of engagement in HIV medical care by PLWHA.  This adapted model included the 
psychosocial factors (e.g. denial and perceived HIV stigma). As mentioned above, adding 
psychosocial factors to the ABM has proved beneficial to the explanation of care outcomes 
(Bradley et al., 2002). This study will add to the literature by examining how these important 
psychosocial factors may affect a PLWHA’s decision to engage in HIV medical care. 
 




Chapter 3: Methods 
Study Context 
Participants in this study were recruited as part of a larger project called the Positive 
Pathways (PP). In 2011, Positive Pathways a 4-year evidence-based intervention, created by 
Washington AIDS Partnership (WAP) and the Institute Public Health Innovation (IPHI), was 
started. Positive Pathways uses community health workers to address barriers to HIV medical 
care for PLWHA in the metropolitan Washington, DC area. The main goals of Positive Pathways 
are (1) to evaluate whether the Community Health Worker model reduces barriers to HIV 
medical care as well as improve the healthcare system in Washington, DC for PLWHA; and (2) 
to reduce community HIV viral load in the targeted communities (Wards 5-8).   
CHW’s received formal training in an eight-month community health worker certificate-
training program at the University of District of Columbia. The CHW Certificate program 
provided them with the tools to be health advocates and educators in their communities. They 
also received instruction on how the healthcare system works, and appropriate ways to address 
chronic illnesses such as HIV/AIDS, and diabetes.  
In 2012, the present research study became embedded into the Positive Pathways project.  
The investigator added three standardized scales measuring denial, perceived HIV stigma and 
barriers to care to the existing baseline assessment.   
CHW Training for Data Collection on this Study 
The investigator had nothing to do with prior training of CHWs or  their management and 
oversight at their respective organizations.  For the purposes of this study, the investigator 
trained the CHW’s on administering the denial, perceived HIV stigma and barriers to care scales 
during one of their monthly trainings to ensure uniformity.  Before data collection began on this 




community health workers received the list of the questions as well as the questions downloaded 
on their ipod device.  Each measure was explained to the CHW first by going over the 
instructions and then each item on all three scales.  There was a question and answer period to 
answer any questions about the items or language that may have been unclear. The CHWs 
practiced administering each measure.  At the end of the training the CHWs understood each 
measure and they were able to successfully administer them to another person.  
Study Design 
 
A prospective cohort design was used to examine the relationship between denial, 
perceived HIV stigma and engagement in HIV medical care. This design was appropriate as the 
outcome variable (engagement in HIV medical care) and was measured after 90 days of 
enrollment in Positive Pathways. HIV positive, African Americans over the age of 18 were 
recruited into Positive Pathways from multiple HIV care and service organizations. After 
enrollment, participants completed a baseline assessment to provide data on demographic, 
clinical factors, needs, and barriers associated with engagement in HIV medical care. 
Specifically for this dissertation research, two psychosocial constructs were added (denial and 
perceived HIV stigma) and one structural construct (barriers to care), to the baseline assessment. 
Participants also completed 45 and 90-day follow-up assessments. Community health workers 
administered all three assessments. Figure 3.1 below represents the study design and participant 
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Data Collection Sites  
The study was conducted in metropolitan Washington, DC. The District of Columbia has 
the highest rate of AIDS diagnosis at 112.5 per 100K persons, which is 10 times the U.S rate for 
AIDS diagnosis (Kaiser Family Foundation, 2012).  Also, it is the metropolitan area with the 
highest HIV incidence rates in the United States (CDC, 2011).  DC is divided into eight 
geopolitical wards.  Figure (3.2) displays the eight wards in DC and the corresponding HIV 
infection rates.  Residents of wards 5-8 are disproportionately affected by the HIV/AIDS 
epidemic as they have the highest rate of persons with HIV/AIDS in Washington, DC 















Figure 3-2 Map of Washington DC with HIV rates by ward 
Source: Proportion of Adults and Adolescents Living with HIV by Ward, District of Columbia, 2010 DC DOH 







Participants were recruited from six participating sites affiliated with the Positive 
Pathways project located in Washington, DC. The participating sites fall into four different types 
of HIV services organizations: primary medical care, community-based, managed care and 
public health organizations. These organizations provide and /or link persons living with 
HIV/AIDS to HIV medical care and services. The sites included: Family & Medical Counseling 
Services, Inc., Max Robinson Center of the Whitman-Walker Clinic, The Women’s Collective, 
Our Place DC, AmeriHealth Caritas and , and  Unity Health Care.  
These sites signed a Memorandum of Agreements’ (MOAs) with the Institute for Public 
Health Innovation (IPHI) to participate in the Positive Pathways project.  The trained peer 
Community Health Workers (CHWs) were employed at the participating organizations and 
worked within their sites to recruit participants.  Many of the organizations were located in 
communities with the highest HIV/AIDS incidence (wards 5-8).  Table 3.1 below provides 










Family Medical Counseling Services (FMCS).  FMCS is a community health center 
serving the District of Columbia community for over 25 years. One of their main goals is to 
serve residents located primarily in the neighborhoods east of the Anacostia River. They 
specialize in providing comprehensive medical care for HIV/AIDS positive persons through all 
stages of illness. Their mission is to promote the emotional and physical health of families and 
individuals, regardless of income and social status, and maximize their quality of life. They 
provide medical care and services to approximately 1000 PLWHA a year.  
The Women’s Collective (TWC).  TWC is the only community based organization in 
Washington DC focused on meeting the needs of women and girls with HIV/AIDS. Since its 
inception back in the early 1990’s as a support hotline for women diagnosed with HIV, TWC has 
become a comprehensive HIV care and support services organization. They have trained women 
to become advocates, provide prevention, care and treatment and support services and to address 
the social determinants of health associated with HIV/AIDS.  
Site/organization Type Ward Number of 
CHWs 
Family Medical Counseling 
Services 
Community-based organization  8 1 
The Women’s Collective Community based organization 7 1 
Our Place- DC Community-based organization  6 1 
Unity Healthcare Primary Medical Care 7 4 
AmeriHealth Caritas Managed Care Organization 2 2 




Our Place-DC.  Our Place DC was a community- based organization in Washington DC 
dedicated to helping currently and formerly incarcerated women as they transition out of the 
criminal justice system. The HIV Services department helped connect their HIV-positive clients 
to care and services. 
AmeriHealth Caritas DC. AmeriHealth Caritas formerly Chartered Health Plan is the 
oldest Medicaid Managed Care Organization in the Nation's Capital. They currently serve over 
100,000 Medicaid eligible and uninsured recipients of the District of Columbia. AmeriHealth 
insures approximately 800 PLWHA. 
Whitman Walker Health (WWH).  WWH is a community health center that has been 
providing HIV medical care for nearly four decades. Their reputation for providing high quality 
culturally competent care to approximately 3,000 patients who are living with HIV/AIDS is 
known locally, nationally, and internationally.   
Unity Health Care.  Unity Health Care, Inc. (Unity) was founded in 1985 as the Health 
Care for the Homeless Project providing primary health care services to homeless individuals 
and families who reside in local emergency shelters or on the streets of the District of Columbia.  
Unity offers a full-range of primary health care services that reach every facet of the community, 
including the homeless, under/uninsured, the elderly, and persons living with HIV/AIDS. 
Selection Criteria and Recruitment  
 
Selection Criteria 
 The primary population for recruitment into Positive Pathways consists of HIV positive 




sampling procedures were used because participants were diagnosed with HIV, possibly 
affiliated with the participating organizations and referred to the community health worker. 
Participants were African -American, 18 years of age or older, who were newly diagnosed with 
HIV (i.e. diagnosed with HIV for less than 3 months prior to enrollment) or had been out of HIV 
medical care for at least 6 months. The Positive Pathways program had eligibility criteria that 
guided the CHW’s decision about which clients to classify as study eligible at enrollment into 
the study (e.g. newly diagnosed, out of care, and in care). The community health worker referred 
to the classification criteria before assigning participants to a particular client type. The 
participants that were classified as newly diagnosed and out of care were used in this research 
study. Participants who did not consent to participate in Positive Pathways project and persons 
who were in continuous HIV medical care were ineligible for the study ( i.e. participants who 
had 2 or more medical visits with a HIV provider at least 2 month apart during the prior year) 
(HRSA, 2011).   
 
Recruitment and Data Collection 
 
Community Health workers conducted one-on-one interviews with participants using 
three (i.e. baseline, 45-day and 90-day) assessments. Recruitment for this study was conducted 
between August 2012 and July 2014. The CHWs used multiple recruitment mechanisms to 
identify potential participants. These included: internal referrals from within their agencies (i.e. 
case managers, nurses and physicians), pharmacy records, street and peer outreach. PLWHA 
who were seeking care at participating medical and community-based sites were screened for 
eligibility and referred to the community health workers.  
 
The Community Health workers screened eligible persons for Positive Pathways and 




Pathways. Enrollment into Positive Pathways occurred primarily at the CHWs participating 
organization.  After enrolling participants, each were assigned a unique client identification 
number that was used on all assessments instead of any Protected Health Identifiers (PHI).  At 
enrollment, CHW’s conducted one-on-one interviews with participants that involved:  First, an 
overview of Positive Pathways project. Second, participants were given information about what 
it means to live with HIV. Next, participants signed an informed consent and confidentiality 
form and finally, participants completed the baseline assessment. After completion of baseline 
assessment CHWs were to offer to help clients arrange medical and case management 
appointments.  
The community health worker was responsible for contacting enrolled participants by 
telephone to complete the follow-up assessments. The follow-up assessments were completed 45 
and 90 days after enrollment. Clients had the option of completing the assessments in person or 
over the telephone.  The follow-up assessments were conducted in the same manner, with the 
CHWs reading the questions verbatim and entering responses into the iPod touch to be uploaded 
after completion to the iForm Builder server. 
Assessments were administered by the CHW using the iForm ES application (app) 
downloaded onto an iPod touch.  In July 2012, the researcher was instrumental in converting the 
Positive Pathways assessments from paper to mobile technology using iFormBuilder mobile 
platformTM. Each CHW had the iForm ES app with the assessments (i.e. baseline, 45-day, and 
90-day follow-up) downloaded on their iPod touch device. The iPod touch was password 
protected and the iForm ES application required a user name and password that was unique to 




To complete an assessment with a participant the CHW logged into the iForm ES app and 
chose the appropriate assessments (i.e. baseline, 45-day or 90 day follow-up).  The CHW read 
each question verbatim to participants and entered their responses into the iPod touch. 
Participants were told that they can refuse to respond to any question at any time during the 
assessment.  After completion of the assessment the CHW saved and submitted the assessment.  





The measures used in this study were guided by (1) the national evaluation measures for 
Positive Pathways; (2) thorough review of the literature on psychosocial variables associated 
with persons delaying entering and engaging in HIV medical care and (3) the theoretical model 
(Andersen Behavioral Model of Health Care Utilization). 
 
Baseline Assessment 
The baseline assessment was administered after enrollment into Positive Pathways. A 
copy of the baseline assessment is presented in Appendix C.   This assessment measured:  
(1) Predisposing variables (e.g. demographic variables – age and marital status) 
(2) Enabling (e.g. income and health insurance) 
(3) Need (e.g. client reported needs and health status) 
(4) Psychosocial measures (e.g. denial and perceived HIV stigma)  
Psychosocial Constructs  
Perceived HIV Stigma.  Perceived HIV stigma was operationalized as a fear of 




person’s HIV status (Berger, Ferrans, & Lashley, 2001).  The Berger’s HIV stigma scale is a 40-
item scale that measures stigma perceived by PLWHA. The scale consists of 4 subscales (1) 
personalized stigma, (2) disclosure, (3) negative self-image, and (4) public attitudes. The 
personalized stigma subscale is composed of 18 items, and was used to measure perceived HIV 
stigma in this study. Participants were asked” how much they agree with the following questions 
about experiences, feelings, and opinions about how people with HIV feel and they have been 
treated”. Sample items include: 
(1) People seem afraid of me because I have HIV 
(2) I feel set apart, isolated from the rest of the world 
(3) I have lost friends by telling them I have HIV 
Items were rated on a 4-point Likert scale with response options ranging from 1 (strongly 
disagree) to 4 (strongly agree).  Additional response options of don’t know, refused, and I 
haven’t told anyone were added, as some participants may not be able to answer the questions.  
Prior to addition of Berger’s HIV stigma scale, the assessments included stigma items which 
many participants were leaving  blank. After consulting with the CHWs, it was discovered that 
many clients were not answering the stigma items because they had not disclosed their HIV 
status to others. Because of the previous experience with stigma items on the baseline 
assessment, this led the researcher to modify the Berger’s perceived HIV stigma scale by adding 
the additional response item” I have not told anyone”.  
 Because of this, 46 % (n=104) of the participants responded “I have not told anyone” to 
at least one item on the perceived HIV stigma scale (see Appendix F). The number of 
participants who completed the perceived HIV stigma scale was 120 and this group of 




Perceived HIV stigma scale.  The total number of participants who answered any one of the 
items on the perceived HIV stigma scale was 168.  A review of the frequencies indicated that 
104 cases indicated that they had not disclosed their HIV status and hence could not answer the 
questions.  Hence, there was much missing data. This posed a dilemma for the analysis.  For 
example, some participants answered no items, while others answered only 4 items and others 
may have answered all 18 items. Using the mean scale of this sample in the analysis would be 
imperfect, because the mean scale would not be an accurate depiction of perceived HIV stigma 
in this sample.  With the great number of missing items, and variable missing across cases, a 
scale average was considered to have too much opportunity for a large error component as part 
of the variance and this was deemed unacceptable.   
 To resolve the problem related to the high number of missing data, the HIV stigma scale 
was only calculated for those persons who had disclosed their HIV status to others.  The 
perceived HIV stigma scale was created using only persons who did not answer “I have not told 
anyone” to any items on the perceived HIV stigma measure. The number of participants used to 
create this scale was 120. The 18 items were averaged to create the perceived HIV stigma mean 
scale (disclosed).This scale was a better representation of perceived HIV stigma in the sample 
than a summative scale would have been because of   the large amount of missing data, and less 
error in creating scale scores based on a variable number of completed items.  The perceived 
HIV stigma mean scale (disclosed) was used in all univariate, bivariate and multivariate analysis. 
The possible range of scores on the perceived HIV stigma mean scale was 1 to 4.  Higher scores 
indicate greater level of perceived HIV stigma by participants. For this study the alpha reliability 





Denial.  For the purpose of this study, denial was operationally defined as “refusal to 
believe HIV diagnosis or trying to act as though HIV is not real”. Denial can be used as a 
defensive coping mechanism to protect the person from feeling or dealing with HIV diagnosis.  
Carver and his colleagues developed the 60-item Coping Orientation to Problems Experienced 
Scale (COPE) (Carver, Scheier, & Weintraub, 1989). The COPE is a multidimensional scale that 
measures 13 different aspects of coping (active coping, planning, suppression of competing 
priorities, restraint coping, seeking instrumental and emotional support, positive reinterpretation, 
acceptance, turning to religion, venting, behavior disengagement, mental disengagement, 
alcohol-drug disengagement and denial).Denial of HIV status was measured using the (COPE) - 
denial subscale. Participants were asked “how often in the past month you have used each of the 
following to cope with your HIV”. The scale contains the following four questions: 
1) I say to myself “this isn’t real” 
2) I refuse to believe that it has happened 
3) I pretend that it hasn’t really happened 
4) I act as though it hasn’t even happened 
The 4 items were measured on a 4-point Likert scale with response options ranging from 1(not at 
all) to 4(often). Additional response options of don’t know and refused, were added as some 
participants may not be able to answer the questions. The 4 items were averaged to create a 
denial mean scale. Two denial mean scales were created for the total and disclosed sample. The 
possible range of scores on the denial mean scales is 1 to 4. Higher scores indicate greater use of 
denial by participants. The denial mean scale score was used in all bivariate and multivariate 




test-retest reliability .54 (Carver, Scheier, & Weintraub, 1989). In the present study, Cronbach’s 
alpha for the total and disclosed sample was .93 and .88 respectively.  
Disclosure Variable.   A binary disclosure variable was created from the perceived HIV 
stigma measure to capture disclosure status within this sample. The perceived HIV stigma scale 
included the response item “I haven’t told anyone”. Some participants were not able to answer 
certain questions on the scale because the items did not apply to them (e.g. I have lost friends by 
telling them I have HIV). First, the disclosure variable was created by examining the questions 
on the measure that had highest number of participants who responded, “I have not told anyone”.  
Second, a dichotomous variable was created to capture any participant who responded, I have not 
told anyone and they were classified as non-disclosed (n=104). All other participants were 
classified as disclosed (n=120). Finally, the lack of disclosure of HIV status among participants 
required that the analysis be completed with two different samples, the total and disclosed. The 
disclosure variable was used in the analysis specifically with the total sample and the perceived 
HIV stigma scale was used in the disclosed sample analysis. 
Predisposing Factors. They included demographic information (e.g. age (continuous), 
marital status (e.g. Single/Separated/ Divorced/Widowed and Partnered/Married, education (< 
HS education, HS education/GED, and Some College or Tech School/College Degree or 
Higher). 
Enabling Factors.  Participants responded to questions about enabling factors. The items 
included questions about income (e.g. <$15 000 and >$15,000), health insurance (e.g. Yes or 
No), employment status (e.g. Unable to work, Unemployed, able to work, and Unemployed, 




Need Factors. Participants responded to questions about need factors. The items 
included questions about client reported needs (continuous), client reported barriers to care 
(continuous), quality of life(e.g. Poor, Fair, Good, Very Good, and Excellent), and clinical 
indicators( e.g. CD4 and HIV viral load).   
 Open–ended Needs.  The participants’ self- reported needs related to obtaining HIV 
medical care and services.  Participants were prompted by the question “What services do you 
currently need?”  The CHW did not read any of the responses, but recorded the spontaneous 
needs mentioned (e.g. substance abuse treatment, housing, food).  A total of 14 needs were 
possible for participants to list.  The 14 need items were dichotomized, and if a participant did 
not list a need it was coded as 0 and a yes response was coded as 1.  The responses were summed 
and averaged to produce a continuous scale from 0 to 9.  Higher scores indicate greater number 
of needs to accessing medical care.   
Open-ended Barriers to Care Items.  Participants were asked to list what barriers they 
face getting into HIV medical care “Often people with HIV face barriers to getting HIV care”? 
What factors make it hard for you to get care?”  The CHW recorded only what the participants 
mentioned as barriers (e.g. fear denial, stigma, and homelessness). A total of 16 barriers were 
used to record their responses. The 16 barriers items were dichotomized.  If a participant does 
not list a barrier it was coded as 0 and a yes response was coded as 1. The responses were 
summed and averaged to produce a continuous scale from 0 to 8. Higher scores indicate greater 
number of barriers to accessing medical care.   
Barriers to Care Scale (BAC).  The BAC scale was used to assess participants’ 
perceptions of the availability of HIV-related services. The 12-item measure contains four 




prevent PLWHA from accessing HIV medical care and social services. (Heckman, Somlai, Otto-
Salaj, Perters, Walker, Galdabini, & Kelly et al., 1998)  Participants used a 4-point Likert scale 
to respond with response options ranging from “no problem at all” (1) to “major problem” (4). 
Additional response items included don’t know and refused which were coded as missing.  
A modified 8-item version of this scale was created and used because the four items 
pertaining to community stigma and work environment knowledge were removed from the 
barriers to care scale. These items contained high numbers of missing values, where participants 
answered ‘refused’ or ‘don’t know’. This lead the researcher to believe that participants did not 
fully understand the questions or that they did not apply to participants. The 8 items were 
averaged to create the barriers to care scale.  Higher scores indicate greater perceived barriers to 
receiving HIV medical care and services. The modified 8-item scale was used in all subsequent 
analysis. Previously the scale has adequate internal consistency in previous studies .86 and.93 
(Heckman et al., 1998; Heckman, 2003).  For this study the internal consistency was .81. The 
data analysis for this measure and engagement in HIV medical care can be found in Appendix F. 
 There were two scales used to measure barriers to care in this study, one was an open-
ended spontaneous response to barriers and the other a standardized barriers to care scale.  The 
standardized barriers to care scale was added to objectively measure common barriers to care 
faced by PLWHA.  According Reja and colleagues (2003), there are advantages and 
disadvantages to both types of data collection, but using a standardized measure accounts for 
large item non-response that can occur with open-ended questionnaires (Reja et al., 2003). 
Neither scales were significantly related to engagement in HIV medical care and were not used 




Quality of Life. Participants were asked about how they feel about their general health. 
The response choices, included (1) poor to (5) excellent.  Additional response items included 
don’t know, and refused and they were coded as missing.  
Biological Indicators.  Participant’s most recent CD4 count and HIV viral load were 
obtained from assessments and/or patient medical records, as these indicators are important 
indicators of HIV disease progression. If this information was not included in the baseline 
assessments then CHWs retrieved the information from the patients’ medical record.  
  An outlier analysis was conducted for HIV Viral load to make sure accurate associations 
were presented and there were no observations that have a large influence on the findings 
allowing for inaccurate interpretation of results. To detect any outliers in the HIV viral load 
values first, the data were organized in ascending order, second, the 25th (Q1) and 75th (Q3) 
percentile of data were obtained, third, the interquartile range was calculated (Q3 – Q1), fourth, 
this interquartile range (middle 50% of the data set) was used in the outlier labeling formula to 
calculate the upper and lower bound criteria. The Outlier labeling formula below was used to 
identify any upper and lower values that were considered outliers (Hoaglin &Iglewicz, 1987; 
“Outlier Labeling Rule”, 2012). 
Upper = Q3 (22783) + (2.2*(Q3-Q1)) 22708)  
Lower = Q1 (75)-(2.2 * (Q3-Q1)) – 49883) (no lower bound outliers)   
Any scores lower than the lower bound and greater than the upper bound were considered 
outliers. Three participant’s had HIV viral loads greater than the upper bound and were 






Forty-five day and 90- day assessments.   The community health worker contacted the 
participants to schedule an appointment to administer the follow-up assessments. The 45 and 90-
day assessments were used to determine dates of HIV medical care visits since enrollment in the 
study. The follow-up assessments were conducted in the same manner as the baseline 
assessment.  The only variables used from the follow-up assessments were the questions related 
to the dependent variable. 
Dependent variable  
Engagement in HIV medical care.  The CDC recommends that PLWHA enter medical 
care within three months of diagnosis (CDC, 2001); and the NHAS has set national goals of 
linking 85% of PLWHA within three months of diagnosis (NHAS, 2010). The main outcome for 
the study is the participant’s engagement in HIV medical care. Engagement in care was 
operationalized as having at least 1 HIV medical visits within 90 days of enrollment in the study. 
Participants were surveyed at 45 and 90-day follow-up to determine if they had completed a HIV 
medical visit. The following questions were asked on the 45-day assessment, (1) Have you been 
to a provider with prescribing privileges within the last 30 days?  (2) What was the date of your 
first HIV medical visit since we first met? The medical visit question on this assessment asked 
about the last 30 days even though recorded on the 45 day assessment. The 90-day assessment 
asked the following questions, (1) have you been to a medical visit with a provider who can 
prescribe medicine in an HIV care setting? (2) What was the date of your HIV medical visits?  
Data for the dependent variable was based on self-reported attendance with an HIV 
primary care provider. This information was obtained from the 45, 90-day assessments, and 
medical record review by the CHW to determine if participant had an HIV medical appointment. 




assessments.  It is expected that both self report and medical record review would contain 
sources of error. For example, participants may falsely report having a medical appointment 
because of social desirability or recall bias as they may not recall the exact dates of the 
appointments.  
 The follow-up assessments at two time points (45, 90-day) were necessary because of a 
concern about completion of this data collection and lack of completion limiting power in the 
sample size to detect a difference between the two groups. Participants may have been lost to 
follow-up after 45 days, thus the 45 day assessment was used to be certain that their outcome 
data were captured, if they did not return for the 90-day follow-up assessment. Also, there was a 
concern that CHWs reporting medical record review data at 90 days may be unreliable in their 
medical record review over all 90 days, but what was found is that they reported the 45-day 
medical visit information in the 90-day assessment. 
  Engagement in HIV medical care was calculated by subtracting the baseline date from 
the dates of the HIV medical visits. If the participant had a medical visit within 90 days after the 
baseline assessment they were labeled as engaged (1), and if a participant did not have any 
medical appointments in the 90 days after enrollment they were considered non-engaged (0).  
Participants who were lost to follow-up during the 90-day follow-up period up were coded as 0-
no engagement in HIV medical care.  This decision inflates the no-engagement category, but was 
done because it was assumed that if the participants were lost to follow- up then they were not 
receiving HIV medical care. Approximately 13 participants were considered lost to follow-up 





Data was uploaded by CHW’s to iFormBuilder.com.  A second version of the data set 
void of all Health Insurance Portability and Accountability Act (HIPPA) designated identifiers 
was created for the researcher to be used for analysis in this study.  Data from the version- 2 was 
imported into SPSS 21.0 for data analysis. A codebook was developed and missing data analysis 
was conducted.   
 
Missing Data   
Data were analyzed for missing data. The scales included the response options: “refused 
and don’t know”. In addition, the perceived HIV stigma measure included the response option, I 
have not told anyone. Scale items that included the above responses or had missing data were 





Data analysis was performed using SPSS 21.0 (IBM Inc., Armonk, NY) with two-tailed 
test and an alpha statistical significance level of 0.05 for all tests.   
Data Analysis Plan 
To answer the research questions and hypotheses the following analyses were conducted. 
Descriptive Statistics were used to examine the distributions for all predisposing, enabling and 
need variables (e.g. age, denial, perceived HIV stigma) to explain characteristics of study 
population. For continuous study variables the mean, standard deviation and range were 
calculated (age -mean /SD, range) and for categorical variables (e.g. education, marital status, 




reliability of psychosocial scales, descriptive statistics, bivariate (t-test, chi-square analysis); 










Hypothesis 1 and 2: To determine if differences exist between newly diagnosed and out 
of care participants’ with denial and perceived HIV stigma, t-test were performed for continuous 
variables and Chi-square analysis for categorical variables. 
 
 Hypothesis 3, 4, 5:  To determine if a relationship exists between the predisposing, 
enabling, need variables and engagement in HIV medical care, bivariate correlations were run.  




were independent predictors of engagement in HIV medical care. In the multivariate logistic 
regression analysis variables that were associated with the outcome variable were included as 
covariates in addition to the psychosocial variables. Finally, hierarchical logistic regression 
analysis using stepwise and enter method were conducted.  All predisposing and enabling 
variables that were associated with the dependent variable were included in the model in addition 
to the psychosocial variables.  
Hypothesis 6:  Hierarchical logistic regression model using stepwise and enter method 
were used to examine whether denial and perceived HIV stigma had a synergistic relationship 
when predicting engagement in HIV medical care. All predisposing and enabling factors 
associated with the dependent variable were added to the model first, next, the psychosocial 
independent variables, denial and perceived HIV stigma were added to the model. Last of all, the 
interaction term of denial and perceived HIV stigma was added to the model, to test the 
synergistic effects of the two variables over and above their individual contribution on 
engagement in HIV medical care.    
Methodological Assumptions 
The strength of the study is that it used an existing infrastructure (The Positive Pathways 
Program), with multiple study sites that had the ability to reach the target population. The scales 
that were used in this study have been tested and found to be valid and had adequate internal 
reliabilities greater than .70.  According to Nunnally and Bernstein (1994), Cronbach’s alpha of 
.70 indicates good internal consistency. Also, the CHWs conducted one-one interviews with 
participants that included reading of assessments to participants; as a result this helped overcome 




the CHWs have met educational requirements for reading as part of their CHW training program 
from the University of the District of Columbia.  
Human Subjects  
 
This study was approved by the District of Columbia Department of Health (Appendix A) and 






Chapter 4: Results 
Overview of the Chapter 
 
This chapter presents the results of data analyses conducted examining denial and 
perceived HIV stigma as barriers to engagement in HIV medical care for PLWHA. This chapter 
includes the study design flow chart showing sample recruitment and participation, an analysis of 
excluded cases, and the results related to each study hypothesis. The results are based on the 
following analysis. First, the rates were calculated on both the total and disclosed sample. 
Second, t-test and chi- analyses were conducted to determine if newly diagnosed and out of care 
persons differ by their rates on the psychosocial variables. Next, logistic regression analyses 
were conducted to examine the impact of denial and perceived HIV stigma on engagement in 
HIV medical care. Finally, hierarchical logistic regressions were conducted to determine the 
impact of the psychosocial, predisposing, enabling and need variables on the outcome variable. 
 The results are presented for the total and disclosed sample. The reason for the separation 
was that almost half the participants reported that they had not disclosed their HIV positive status 
to someone. The first analysis of the chapter is with the total sample (N=262). These analyses all 
exclude perceived HIV stigma but include the denial and disclosure variables to answer the 
research questions and hypotheses related to denial in the total sample. Next, the second set of 
analyses included only the persons who disclosed their HIV status to others (N=120). The 
disclosed sample analyses were performed with the denial and perceived HIV stigma measures, 









There were 352 persons eligible, enrolled and completed the baseline assessment. The 
flow diagram in Figure 4.1 shows how the study sample participated in the study. Participants 

















Excluded cases  
Of the 352 persons enrolled, 262 were retained in the final analysis. The other 
participants who were recruited for the study were excluded for a number of reasons. First, one 
community health worker passed away and follow-up assessment could not be completed with 
the clients. Second, a community-based participating site closed down, and finally some 
participants were recruited from a pre-release correctional facility and many were sent to prison 
and they would not be followed up about subsequent medical visits in the same manner as the 
study design required. 
Total Sample Analysis (N=262) 
 
  This analysis was conducted with the total sample (N=262).  Table 4. 1 presents the 
categorical sociodemographic characteristics of the 262 study participants. Slightly more than 
half (55%) of the participants were female, 73% were single, and 44% had obtained a high 
school diploma or GED. Sixty percent reported being unemployed and 84% had an annual 
income of $15,000 or less. Ninety percent (n=222) of participants indicated that they had health 
insurance and 79% had a medical home. Almost half (46%) of participants had not disclosed 
their HIV status to others.  
Table 4.1 also compares the characteristics of the sample by client type (newly diagnosed 
and out of care).  There were differences between the groups by disclosure status and 















(n=195)  X2 (df) 
p-
value  
Gender (n, %)       3.3(1) 0.07 
     Male 115(44) 36(54) 79(41) 
      Female 145(55) 31(46) 114(59) 
  Education (n, %)       5.7(2) 0.06 
    Less than High School 94(37) 16(25) 78(41) 
    High School Diploma or GED 115(44) 36(55) 79(41) 
    Some College or Technical 
School/College Degree or Higher 47(18) 13(20) 34(18) 
Employment Status (n, %)        5.1(2) 0.08 
    Able to Work, employed 42(16) 14(22) 28(15) 
    Able to Work, unemployed 155(60) 42(65) 113(59) 
    Unable to Work  60(23) 9(14) 51(26) 
Income (n, %)       0.43(1) 0.51 
     < 15K 217(84) 53(82) 164(85)   
     >15 K 41(16) 12(18) 29(15) 
  Marital Status (n, %)       0.92(1) 0.34 
   Single/ 
Separated/Divorced/Widowed  199(76) 48(72) 151(77) 
    Partnered/Married  63(24) 19(28) 44(23) 
Medical Home (n, %) 
   
1.1(1) 0.30 
   No 79(34) 23(39) 56(32) 
     Yes 157(66) 36(61) 121(68) 
  Health Insurance (n, %) 
   
0.24(1) 0.63 
   No 27(10) 6(9) 21(11) 
    Yes 222(90) 59(91) 163(89) 
  Disclosure (n, %)  
   
13.1(1) 0.001 
  Yes 120(54) 16(31) 104(60)   
  No 104(46) 35(69) 69(40) 
  Engagement     4.4(1) 0.03 
 Yes 188(72) 55(82) 133(68)   
 No 74(28) 12(18) 62(32)   
Engagement – 45 day     6.2(1) 0.01 
 Yes  175(67) 53(79) 122(63)   
 No 87(33) 14(21) 73(37)   
Engagement -90 day    11.1(1) 0.001 
Yes 100(38) 37(55) 63(32)   
No 162(62) 30(45) 132(68)   







Table 4.2 presents a summary of the continuous variables at baseline. Overall, 
participants had a mean age of 41years of age (range 18-65, SD= 11.9), on average they reported 
about two needs and one barrier to engaging in HIV medical care.  For clinical markers, 
participants had a mean CD4 count of 447 cells/mm3 , and an average HIV viral load of about 
20K copies /ml, with about 40% of the sample reporting  <200 copies/ml.  Examining the 
psychosocial and structural variables, on average the responses were just below or at the mean on 
each of the scales.  A comparison by client type revealed differences by age (42 vs. 35, p=.00), 
client needs (p=.02) and client reported barriers (p=.01).  Out of care persons were older, and had 
more needs and barriers to care than newly diagnosed persons. 












Out of Care 
(N=195) 
Mean 
(SD)  t (df) 
p-
value 




(11.35) -4.5(259) 0.00 
       




(315.70) -0.07(238) 0.49 
       




(43377.74) -.025(218) 0.80 








(2.02) -2.4(256) 0.02 








(1.61) -2.3(260) 0.01 
       
Quality of life  228 2.63 (1.1) 2.8(.86) 
2.59 
(1.1) 0.93(226) 0.32 
       







(0.74) -0.69(235) 0.49 










(0.95) 0.39(231) 0.69 
 Note: a The column total may not sum to total due to missing data. 
 
Table 4.3 presents the categorical characteristics of participants by engagement in HIV 
medical care. Approximately 75 % of the sample was out of HIV medical care at enrollment. 
Significant differences in engagement in HIV medical care were found by client type (p=.03) and 
marital status (p=.03). A comparison by client type showed that out of care were less likely to 
engage in HIV medical care as compared to newly diagnosed and single persons compared to 
those who were partnered or married. 
 








2 (df) p-value 
Client Type (n, %)       4.7(1) 0.03 
Newly Diagnosed 67(25) 12(16) 55(29)     
Out of Care 195(75) 62(84) 133(71)     
Gender (n, %)           
Male 114(44) 29(40) 88(45) 0.63(1) 0.43 
Female 145(55) 43(60) 102(55)     
Race (n, %)           
African American /Black  262(100)         
Education (n, %)       
1.2(2) 0.55 
Less than High School 93(37) 28(41) 66(34) 
High School Diploma or 
GED 115(45) 30(44) 85(46) 
Some College or Technical 
School/College Degree or 
Higher 
47(18) 10(15) 37(20) 
Employment Status (n, %)       
0.03(2) 0.87 Able to Work, Employed 41(16) 12(17) 30(15) Able to Work, Unemployed 155(60) 44(62) 111(61) 
Unable to Work  60(23) 15(21) 45(24) 
Income (n, %)       0.24(1) 0.63 
< 15K 217(84) 61(86) 156(83)     
    >15 K 41(16) 10(14) 31(17)     
Marital Status (n, %)       
4.8(1) 0.03 Single/Separated/Divorced/




Partnered/Married  63(24) 11(17) 52(27) 
Medical Home (n, %)       1.9(1) 0.17 
No 79(34) 17(27) 62(37)     
Yes 157(66) 47(73) 110(63)     
Health Insurance (n, %)       1.9(1) 0.17 
No 27(11) 4(6) 23(13)     
Yes 222(90) 60(94) 162(87)     
Disclosure (n, %)       1.9(1) 0.16 
No 104(46) 32(54) 72(44)     
Yes 120(54) 27(46) 93(56)     




Table 4.4 shows the continuous variables by engagement in HIV medical care. None of 
the continuous variables were associated with engagement in HIV medical care (p>.05). 
Participants who did not engage in HIV medical care reported higher average CD4 count, denial, 
and perceived HIV stigma scale scores.  
 

























       







       



























       




Scale  (0.69) (0.64) (0.78) 
       







       












Univariate descriptive analyses were performed using rates, means, standard deviations, 
percentages, and Cronbach’s alpha.  
Denial in the Total Sample  
 
Rate of Denial in the Total population  
 
The rate of denial in this population was calculated using the four items contained in the 
COPE-denial subscale.  A mean denial scale was created with the 4 items. After the creation of 
the mean scale the responses were dichotomized with “1” set to “0” and all other scores greater 
than 1, were set to “1”. All scores of “0” represented ‘no denial’ and any score greater than 1” 
denoted the ‘presence of denial’.  Denial was defined as a participant saying yes to at least 1 of 
the denial items. The total participants who reported no denial were (N=145) and the total that 
reported some level of denial a score of greater than 1 was (N=88). The total sample was 233 
because 29 participants did not answer all the denial questions. To calculate the rate of denial in 
the population the frequencies were summed to obtain the total numbers of ‘yes’ responses to 
each of the items and the total of ‘no’ responses. The total yes responses were divided by the 
total (yes responses + no responses). The rate of denial was calculated at 38% in this population. 











I say to myself this isn't real 67(25) 
I refuse to believe that is has happened 55(20) 
I pretend that it really hasn't happened 58(22) 
I act as though it hasn't even happened 56(21) 
Note: *Denial=rarely, sometimes, and often. 
 
 
Differences in Denial by Client Type  
 
To determine whether there were differences in the level of denial by client type, t-test 
analysis was conducted. The newly diagnosed persons reported higher levels of denial than out 
of care persons (1.63 vs.1.57) respectively. This difference was not statistically significant t 
(233) =0.39, p=0.69. See Table 4.4.   
 
Descriptive Statistics and Cronbach’s alpha for Denial Scale (N=262) 
Descriptive statistics and Cronbach’s alpha were calculated for the denial mean scale for 
on the total sample. The mean for this scale was 1.58 (SD=0.93). The scale had good internal 
consistency with a Cronbach’s alpha of 0.93. 
Table 4-6 Descriptive statistics and Cronbach’s alpha for the Denial Scale (N=262) 

















Bivariate Analysis  
 
Correlations for Total Sample (N=262) 
  
Bivariate correlations were conducted to determine the relationship between denial and 
the study variables in the total sample (Table 4.7). Denial was negatively correlated with both 
medical home and disclosure (p<0.01), but positively correlated with BAC (p<0.01).  
 
 Table 4-7 Pearson Correlations between Denial and Study Variables (N=262) 
Variable  Denial 
1.Client Type -0.03 
2.Age 0.01 
3.Female Gender 0.12 
4. Health Insurance 0.05 
5. Medical Home -0.22** 
6. CD4 Count -0.06 
7. HIV Viral Load 0.10 
8. Engagement -0.07 
9.Income -0.09 
10.Client Needs -0.09 
11.Client Barriers 0.06 
12. Able to Work, Employed vs. Unable to work -0.07 
13.Able to Work, Unemployed vs. Unable to Work  0.09 
14. Single/Separated/Divorced /Widowed vs. Partnered 
Married 0.09 
15. Some College/Tech School /College Education or 
Higher vs. less than High School 0.01 
16.High school/GED vs. less than High School 0.003 
17 Quality of Life -0.02 
18.Disclosure -0.23** 
19.Denial Mean Scale 1 













Regression Analysis  
 
Logistic Regression Analysis for Denial 
 
To determine the effect of denial on engagement in HIV medical care, unadjusted and 
adjusted logistic regression models were run, regressing engagement in HIV medical care on 
denial. For the adjusted logistic regression analysis two selection methods were used, enter and 
forward selection. These two methods were chosen because of the possibility of the large number 
of variables that could have been included in the model.  Specifically the concern was that the 
regression model may not be stable and a reliable measure of engagement in HIV medical care if 
a significant number of predictors were included in the model. Since the different approaches 
yielded similar results, there was more confidence in the stability and reliability of the model 
findings. 
 Results from the bivariate analysis with the total sample were used to determine which 
variables to include in the adjusted logistic regression models. Client type, marital status, 
medical home and disclosure status were found to be associated with engagement in HIV 
medical care and denial were included in the adjusted logistic regression models.  
The adjusted logistic regression analysis using the enter method contained all variables found 
associated with the dependent variable and the denial mean scale. The second method was the 
forward method.  The adjusted logistic regression analysis was conducted using forward 
stepwise method.  Client type, marital status, medical home and disclosure and denial mean scale 
were entered into the model and maintained in the model only if they were significantly 
associated with engagement in HIV medical care.  The criterion for a variable to be entered into 





Unadjusted Logistic Model 
Unadjusted Logistic regression analysis was conducted to assess the direct association of 
denial and engagement in HIV medical care. Engagement in HIV medical care was regressed on 
the denial mean scale (Table 4.8). Denial was not a significant predictor of engagement in HIV 
medical care for this population (OR=0.86; 95% CI [0.64, 1.2]; p=. 32).   
 
Table 4-8 Unadjusted Logistic regression analysis for Denial on Engagement in HIV medical care (N=262) 
Variable B S.E. Wald df p-value O.R. 95% CI 
Denial Mean Scale  -0.15 0.15 0.99 1 0.32 0.86 0.64- 1.2 




Adjusted Logistic Regression 
 
 In the adjusted logistic regression model, engagement in HIV medical care was regressed 
on denial controlling for the covariates, client type, medical home, marital status and disclosure 
status.  
 
Forward Stepwise Model  
 
   Engagement in HIV medical care was regressed on denial controlling for client type, 
medical home, marital, disclosure status). Disclosure of HIV status to others (OR= 2.2; 95%CI 
[1.2, 4.3]; p=. 01) and marital status (partnered/married) (OR=2.5; 95%CI [1.0-6.2]; p=.04) were 
significant predictors of engagement in HIV medical care.  
 
Table 4-9 Adjusted Logistic regression analysis (Forward stepwise) for Denial and Engagement in HIV 
medical care (N=262) 
Variables B S.E. Wald df Sig. O.R. 95% CI 




Partnered/Married 0.93 0.46 4.2 1 0.04 2.50 1.0-6.2 





Enter Model  
 
 Engagement in HIV medical care was regressed on denial, controlling for client type, 
medical home, single vs partnered, and disclosure. Disclosure of HIV status to others was a 
significant predictor of engagement in HIV medical care (OR= 2.6; 95% CI [1.3, 5.1]; p=. 008). 
Denial was not a significant predictor of engagement in HIV medical care (p=. 27). 
 
Table 4-10 Adjusted Logistic regression analysis (Enter Model) for Denial and Engagement in HIV medical 
care (N=262) 
Variables B S.E. Wald df p-value O.R. 95% CI 
Client Type  -0.81 0.47 3.0 1 0.08 0.44 0.18-1.1 
Medical Home  -0.67 0.39 2.8 1 0.09 0.52 0.24-1.1 
Partnered/Married 0.79 0.47 2.8 1 0.09 2.21 0.88-5.5 
Disclosure  0.94 0.35 7.1 1 .008 2.55 1.3-5.1 
Denial Mean Scale -0.20 0.18 1.2 1 0.27 0.82 0.57-1.1 




Summary of Logistic Regression for Denial   
 
  Examining the direct effect of denial on engagement in HIV medical care in the total 
sample revealed that denial was not a significant predictor of engagement in HIV medical care 




engagement in HIV medical care. None of the predisposing, enabling, and need variables were 
predictors of engagement in HIV medical care in the total sample. 
Disclosed Sample Analysis (N=120) 
 
This second analysis was completed with the participants who completed the perceived 
HIV stigma measure, and have disclosed their HIV status to others. There were 120 participants 
that disclosed their HIV status to others and were included in the analyses below.  
 
Table 4.11 presents the categorical variables for the 120 participants who had disclosed 
their HIV status by client type. Similar to the total sample, persons who disclosed HIV status 
were 55% female, 71% single, and 51% had obtained a high school diploma or GED. Fifty seven 
percent (n=67) reported being unemployed and 84% had an annual income of $15,000 or less. 
Ninety percent of participants indicated that they had health insurance and 79% had a medical 
home. Table 4.11 also compares the characteristics of newly diagnosed to out of care persons. 
There were differences in client type by gender (p=. 01). 
 







Out of Care 
(n=104) X2 (df) p-value 
Gender (n, %)       6.2(1) 0.01 
     Male 55(46) 12(74) 43(42)        Female 64(54) 4(25) 60(58)   Education (n, %)    5.1(2) 0.08      Less than High School 35(30) 1(6) 35(34) 
     High School Diploma       
or GED 61(51) 11(69) 50(49) 
   Some College or Tech               
School/College Degree or 
Higher 
   
22(19) 4(25) 18(19) 
Employment Status (n, %)     2.6(2) 0.27    Able to Work, Employed 20(17) 2(13) 29(28) 





   Unable to Work  31(26) 2(13) 29(28) 
Income (n, %)    2.4(1) 0.12    < 15K 95(81) 10(67) 85(83)   
   >15 K 22(19) 5(33) 17(17)   Marital Status (n, %)    0.0(1) 1.00 Single/Separated/Divorced/
Widowed 90(75) 12(75) 78(75) 
   Partnered/Married  30(25) 4(25) 26(25) 
Medical Home (n, %)    2.0(1) 0.16 
   No 32(29) 6(46) 26(27)      Yes 77(71) 7(54) 70(73)   
Health Insurance (n, %)    0.09(1) 0.76 
   No 10(9) 1(7) 9(9)      Yes 104(91) 14(93) 90(91)   Disclosure (n, %)         Yes 120(100) 16(13) 104(87)   Engagement     0.09(1) 0.76 
   Yes 94(78) 13(81) 81(78)   
   No 26(22) 3(19) 23(22)   
Engagement – 45 day     0.48(1) 0.49 
   Yes  89(74) 13(81) 76(73)   
   No 31(26) 3(19) 28(27)   
Engagement -90 day      
   Yes 48(40) 9(56) 39(37) 2.0(1) 0.15 
   No 72(60) 7(44) 65(63)   
Note: a The column totals may not sum to total due to missing data 
 
Table 4.12 provides a summary for the continuous variables by client type in the 
disclosed HIV status sample. Overall, participants mean age was 40 years of age (range 18-65, 
SD= 11.9), on average they reported about two needs and one barrier to engaging in HIV 
medical care.  For clinical markers participants had a mean CD4 count of 496 cells/mm3 , and an 
average HIV viral load of about 20K copies /ml, with about 40% of the sample reporting  <200 
copies/ml. Examining the psychosocial and structural variables on average the responses were 
just below or at the mean for each of the scales. A comparison by client type revealed differences 























(SD) t(df) p-value 






(12.14) -2.3(117) .021 
       







(326.06) -.008(109) 0.99 
       






(45763.88) 0.52(96) 0.60 
       
Client Reported 






(1.99) 0.11(115) 0.91 
       
Client Reported 






(1.41) -1.1(118) 0.29 
       






(1.2) 0.46(106) 0.65 
       
Barriers to Care 






(0.67) -2.0(116) 0.05 






(0.76) -1.3(116) 0.19 
       
Perceived HIV 






(0.79) -1.4(118) 0.17 
Note: aThe column totals may not sum to total due to missing data 
 
 
Table 4.13 presents categorical characteristics by disclosure status for the total sample. 
Seventy-seven percent of the sample was out of HIV medical care. More than half of the study 
participants (55%) were female, 72% single, and 47% had obtained a high school diploma or 




disclosure status; there were significant differences by client type and engagement in HIV 
medical care (p<. 05). Persons who had not disclosed their HIV status and out of care persons 
were less likely to engage in HIV medical care as compared to persons who had disclosed their 
HIV status and newly diagnosed persons. 








(n=120) X2 (df) p-value 
Client Type (n, %) 
   
13.1(1) 0.00 
Newly Diagnosed 51(23) 35(34) 16(13) 
  Out of Care 173(77) 69(66) 104(87) 
  Gender (n, %) 
   
0.05(1) 0.82 
Male 101(46) 46(45) 55(46) 
  Female 121(55) 57(55) 64(54) 
  Education (n, %) 
   
5.6(2) 0.06 
Less than High School 82(37) 46(45) 36(30) 
High School Diploma or 
GED 103(47) 42(42) 61(51) 
Some College/ Technical 
School/College Degree or 
Higher 35(16) 13(13) 22(19) 
Employment Status (n, %) 
   
5.3(2) 0.07 
Able to Work, Employed 30(13) 10(10) 20(17) 
Able to Work, Unemployed 140(64) 73(72) 67(57) 
Unable to Work  50(23) 19(19) 31(26) 
Income (n, %) 
   
1.9(1) 0.16 
< 15K 187(85) 92(89) 95(81) 
      >15 K 33(15) 11(11) 22(19) 
  Marital Status (n, %) 
   
0.28(1) 0.87 
Single/Separated/Divorced/
Widowed 169(75) 79(76) 90(75) 
  Partnered/Married  55(25) 25(24) 30(25) 
  Medical Home (n, %) 
   
0.51(1) 0.48 
No 63(32) 32(34) 32(29) 
  Yes 137(68) 60(66) 77(71) 
  Health Insurance n, %) 
   
0.36(1) 0.56 
No 21(10) 11(11) 10(9) 
  Yes 191(90) 87(89) 104(91) 
  Engagement in HIV Medical 
Care (n, %) 
     No 59(26) 32(31) 27(23) 1.9(1) 0.16 
Yes 165(74) 72(69) 93(77) 
  Engagement     4.04(1) 0.04 




No 61(27) 35(34) 26(22)   
Engagement – 45 day    3.5(1) 0.60 
Yes 154(69) 65(63) 89(74)   
No 70(31) 39(37) 31(26)   
Engagement -90 day    1.3(1) 0.26 
Yes 82(37) 34(33) 48(40)   
No 142(63) 70(67) 72(60)   
Note: a The columns may not sum to total due to missing data  
 
Table 4.14 examines continuous variables by disclosure status in the total sample. 
Significant differences were found for CD4 count and denial.  Disclosed persons had higher CD4 
count, than non-disclosed persons (p=. 03). Disclosed persons had lower mean denial scale 
scores compared to non-disclosed persons (p=. 001). 
 












(Mean, SD) t(df) 
p-
value 





(12.87) 0.33(221) 0.74 
       





(324.19) -2.15(205) 0.03 
       





(44446.84) -0.35(188) 0.72 
       
Client Reported 






(1.99) -1.24(219) 0.22 








(1.42) 1.35(222) 0.18 
       





(1.9) -0.29(204) 0.77 
       







(0.72) 1.73(217) 0.09 
       





(0.71) 3.44(215) 0.001 
       






Table 4.15 presents the categorical variables for persons who disclosed their HIV status 
by engagement in HIV medical care.  There were significant gender differences between 
engaged and not engaged persons in HIV medical care (p=. 03).  Women were less likely to be 
engaged in HIV medical care than men.  
Table 4-15 Participant Characteristics for persons who disclosed HIV status by Engagement in HIV medical 
care (N=120) 















Client Type (n, %)       0.09(1) 0.76 
Newly Diagnosed 26(22) 3(12) 13(14)     
Out of Care 94(78) 23(88) 81(86)     
Gender (n, %)           
Male 55(46) 7(27) 48(52) 4.9(1) 0.03 
Female 64(54) 18(73) 45(48)     
Race (n, %)           
African American  120(100)         
Education (n, %)       5.6(2) 0.06 
Less than High School 36(30) 11(44) 25(27) 
High School Diploma or 
GED 61(51) 13(52) 48(51) 
Some College or Technical 
School/College Degree or 
Higher 
22(19) 1(4) 21(22) 
Employment Status (n, %)       3.6(2) 0.16 
Able to Work, Employed 20(17) 3(12) 17(19) 
Able to Work, Unemployed 67(57) 19(73) 48(52) 
Unable to Work  31(26) 4(14) 25(29) 
Income (n, %)       2.4(1) 0.12 
< 15K 95(81) 23(92) 72(78)     
   >15 K 22(19) 2(8) 20(22)     
Marital Status (n, %)       0.59(1) 0.44 
Single / Separated/Divorced/ 
Widowed 90(75) 21(81) 69(73) 
Partnered/Married  30(25) 5(19) 25(27) 
Medical Home (n, %)       0.82(1)  0.37 
No 32(29) 5(22) 27(31)     
Yes 77(71) 18(78) 59(69)     
Health Insurance (n, %)       0.61(1) 0.44 
No 22(19) 1(5) 9(10)     
Yes 92(81) 21(95) 83(90)     





Table 4.16 illustrates the differences in engagement in HIV medical care for the disclosed 
sample on the continuous variables. Perceived HIV stigma mean scores were higher for non-
engaged persons compared to persons engaged in HIV medical care (p=. 05).  
 
Table 4-16 Participant Characteristics for persons who disclosed HIV status by Engagement in HIV medical 
























(12.78) 0.33(117) 0.75 
       






(329.24) -0.04(108) 0.97 
       






(47687.38) -0.75(96) 0.45 








(1.96) -0.03(115) 0.08 
       
Client Reported 






(1.39) 0.77(118) 0.44 
       






(1.2) 0.97(106) 0.33 
       
Barriers to care 






(0.65) 0.60(116) 0.55 
       






(0.71) 1.17(116) 0.25 
       
Perceived HIV 






(0.76) 1.95(118) 0.05 







Denial in Disclosed Sample (N=120) 
 
Rate of Denial  
 Table 4.17 presents the rate of denial in the disclosed sample which was calculated using 
the four items contained in the COPE-denial subscale.  A mean denial scale was created with the 
4 items. After the creation of the mean denial scale the responses were dichotomized with “1” set 
to “0” and all other scores greater than 1, were set to “1”. All scores of “0” represented ‘no 
denial’ and any score greater than 1” denoted the ‘presence of denial’. Denial was defined as a 
participant saying yes to at least 1 of the denial items.  The total responses reported for no denial 
was (N=81) and the total that reported some level of denial was (N=37). The total sample was 
118. To calculate the rate of denial in the population the frequencies were summed to obtain the 
total numbers of ‘yes’ responses to each of the items along the scale and the total of ‘no’ 
responses. The total yes responses were divided by the total sample (yes responses + no 
responses) to obtain the total rate of denial in the population. The rate of denial in the disclosed 
sample was calculated at 31%. Almost one-third of the disclosed population had experienced 
some level of denial in the month before enrollment. 
 




I say to myself this isn't real 24(21) 
I refuse to believe that is has happened 16(13) 
I pretend that it really hasn't happened 20(16) 
I act as though it hasn't even happened 20(17) 





Differences in Denial by Client Type (N=120) 
To examine the differences in the level of denial by client type for persons who disclosed 
HIV status to others. A t-test was conducted. The out of care persons reported higher levels of 
denial than newly diagnosed persons (1.39 vs.1.14) respectively. This difference was not 
significant (t (116) =-1.3, p=. 19).   Results are presented in Table 4.12. 
Descriptive Statistics and Cronbach’s alpha for Denial Scale (N=120)  
 Descriptive statistics and Cronbach’s alpha were calculated for the denial scale score on 
the disclosed sample. This scale was created by taking the mean of the 4 items and creating a 
total scale score that was used in all subsequent analyses. The mean for this scale was 1.36 
(SD=0.71). The scale had good internal consistency with a Cronbach’s alpha of 0.88. 
 
 
Table 4-18 Descriptive statistics and Cronbach’s alpha for Denial scale of persons who Disclosed HIV status 
(N=120) 







Denial Mean Scale 118 1.36(0.71) 1-4 1-4 0.88 
 
 
Pearson’s correlations for Disclosed Sample (N=120) 
Pearson’s correlations were conducted with the disclosed sample (N=120) to determine 
the relationship between denial, perceived HIV stigma, and all other study variables (Table 
4.21). Denial was positively correlated with gender, perceived HIV stigma mean scale and BAC 
mean scale (p<. 05).  The variables positively correlated with the perceived HIV stigma mean 




(p<. 01). The variables that were negatively correlated with perceived HIV stigma were medical 
home and employment status(able to work, employed) (p<. 05).  
 
Table 4-19 Pearson’s Correlation analysis between denial and perceived HIV stigma and study variables for 
persons who disclosed HIV status (N=120) 
 Variables Denial 
 Perceived HIV 
stigma 
1.Client Type .12 .13 
2.Age .11 .14 
3. Female Gender .33** .29** 
4. Health Insurance -.01 .07 
5. Medical Home -.07 -.23* 
6. CD4 Count -.008 -.07 
7. HIV Viral Load .13 .01 
8. Engagement -.11 -.18 
9.Income -.12 -.12 
10.Client Needs .14 .16 
11.Client Barriers .14 .22* 
12. Able to Work, Employed vs. Unable to 
Work -.11 -.22
* 
13. Able to Work, Unemployed vs. Unable to 
Work  .09 .11 
14. Single Separated/Divorced /Widowed vs. 
Partnered /Married -.08 .09 
15. Some College/Tech School/College 
Education or Higher vs. less than High School -.04 .04 
16.High school/GED vs. less than High School .06 -.01 
17. Quality of Life -.07 -.17 
18.Denial Mean Scale  1 .49** 
19. Perceived HIV Stigma Mean Scale  .49** 1 




Perceived HIV Stigma in Disclosed Sample (N=120) 
 
Rate of Perceived HIV Stigma Disclosed sample (N=120)  
 
The rate of perceived HIV stigma in the disclosed sample was calculated using the 18 
items contained in the Berger’s HIV Stigma scale-perceived stigma subscale. A mean perceived 




were dichotomized with “1” set to “0” and all other scores greater than 1, were set to “1”. All 
scores of 0 represented ‘no perceived HIV stigma’ and any score 1 or greater denoted the 
‘presence of perceived HIV stigma’. The total responses for no perceived HIV stigma was 
(N=49) and the total participants that reported some level of perceived HIV stigma was (N=71). 
The total sample size was 120. Perceived HIV stigma was defined as a participant saying yes to 
at least 1 of the perceived HIV stigma items.   To calculate the rate of perceived HIV stigma in 
the population, the frequencies were summed to obtain the total numbers of ‘yes’ responses to 
each of the items along the scale and the total of ‘no’ responses. The total yes responses were 
divided by the total (yes responses + no responses) to obtain the total rate of barriers in the 
population. The rate of perceived HIV stigma reported was calculated at 59% in this population. 
More than half of the disclosed sample had perceived a level of HIV stigma from others at 
enrollment. 
Table 4-20 Rate of Perceived HIV stigma in persons who disclosed HIV status (N=120) 
Perceived HIV Stigma Items 
Yes* 
N (%) 
I have lost friends by telling them I have HIV 30(26) 
I have been hurt by how people reacted to learning I have 
HIV 
36(30) 
People avoid touching me if they know I have HIV 12(10) 
I stopped socializing with some due to their reactions 32(27) 
People I care about stopped calling after learning I have 
HIV 
16(13) 
People seem afraid of me because I have HIV 17(15) 
Some people who know my HIV status have grown more 
distant 
23(20) 
People have physically backed away from me 
 
25(20) 
People who know my HIV status tend to ignore my good 
points 
21(18) 
Some People don't want me around children once they know 





I feel set apart, isolated from the rest of the world 31(26) 
I regret having told people that I have HIV 30(24) 
Some people feel they will be rejected because of my HIV 
status 
24(20) 
Some people act as though it’s my fault I have HIV 20(17) 
As a rule, telling others about my HIV Status has been a 
mistake 
23(19) 
Most people with HIV are rejected when others learn of 
their HIV status 
33(27) 
People have told me that getting HIV is what I deserve for 
how I lived my life 
15(13) 
When people learn you have HIV they look for flaws in 
your character 
20(16) 
Note: *Perceived HIV stigma= agree and strongly agree. 
 
 
Differences in Perceived HIV Stigma by client type (N=120) 
 
To determine whether there were differences in the level of perceived HIV stigma by 
client type, t-test analysis was conducted. The out of care persons reported higher levels of 
perceived HIV stigma than newly diagnosed persons (1.76 vs.1.46) respectively.  This difference 
was not statistically significant t (116) =-1.3, p=0.19. Results are presented in Table 4.12. 
 
Perceived HIV stigma scale characteristics and Cronbach’s alpha (N=120) 
 
Table 4.21 presents the descriptive statistics and Cronbach’s analysis for the perceived 
HIV stigma measure for the disclosed sample.  The perceived HIV stigma scale score was 
created by averaging the individual response items.  The average score on the perceived HIV 
stigma mean scale was 1.71(SD=. 76). The perceived HIV stigma mean scale scores ranged from 
1 to 4. Cronbach’s alpha was calculated to confirm the internal reliability for the scale in this 






Table 4-21 Descriptive statistics and Cronbach’s alpha for perceived HIV stigma scale of persons who 
disclosed HIV status (N=120) 
















Unadjusted logistic regression analysis was conducted for the disclosed sample, 
regressing engagement in HIV medical care on the perceived HIV stigma mean scale (Table 
4.22). Perceived HIV stigma was not a significant predictor of engagement in HIV medical care 
for this population, (OR=0.66; 95 % CI [0.40-1.01]; p=. 10). 
Table 4-22 Unadjusted Logistic regression analysis of perceived HIV stigma on engagement in HIV medical 
care for persons who disclosed HIV status (N=120) 
Variables B S.E. Wald df p-value O.R. 95% CI 
Perceived HIV 
Stigma Mean Scale -0.41 0.25 2.71 1 0.10 0.66 0.40-1.01 




Summary of perceived HIV stigma in disclosed sample 
 
Perceived HIV stigma was not a significant predictor of engagement in HIV medical 
care. Next, the final models are presented using hierarchical logistic regression with the 
disclosed sample examining whether denial was the most significant predictor of engagement in 
HIV medical care over all other variables. In addition, the interaction analysis was conducted to 
examine whether denial and perceived HIV stigma act synergistically to predict engagement in 
HIV medical care.  





Hierarchical logistic regression models were conducted to examine how each set of 
predisposing, enabling, need and psychosocial variables independently predicted engagement in 
HIV medical care. The disclosed sample was used in these analyses as all study research 
questions and hypotheses could be addressed. Predisposing, enabling and need variables 
significantly associated with engagement in HIV medical care from the bivariate analysis were 
included in the model. Gender, employment status and educational level were included in the 
models. 
Final Hierarchical Logistic Regression Models, Disclosed Sample (N=120) 
Forward Stepwise 
 
Hierarchical logistic regression was conducted using forward stepwise method on each 
block with only the variables significantly correlated with engagement in HIV medical care, to 
determine the effect of denial on engagement in HIV medical care in the disclosed sample. The 
variables were entered into each block and maintained in the model only if they were 
significantly associated with engagement in HIV medical care. The criterion for a variable to be 
entered into the model at each step was p<. 05 and for a variable to be removed was p>.10. In 
block one, the predisposing variables (client type, gender and education) were added. In block 
two, the enabling variable (employment status); block three, perceived HIV stigma mean scale 
and the final block, denial mean scale was added to the model.  The predisposing variables, 
gender and educational level were significant predictors of engagement in HIV medical care (p<. 
05). Women were less likely to engage in HIV medical care than men (OR=0.29; 95% CI [0.11, 
0.79]; p<. 05). Participants who had some college education or higher were more likely to have 
engaged in HIV medical care compared to persons with less high school education (OR=8.3; 




of engagement in HIV medical care. Participants who were able to work but unemployed were 
less likely to have engaged in HIV medical care compared to persons who were unable to work 
(OR=.34; 95% CI [.12-.93, 67.1]; p= 04).   Denial was not a significant predictor of engagement 
in HIV medical care. 
 
Table 4-23 Hierarchical Logistic Regression analysis (Stepwise Method) for denial on Engagement in HIV 
medical care (N=120) 
Variables B S.E. Wald df p-value O.R. 95 % C.I 
Gender -1.2 0.51 5.8 1 0.02 0.29 0.11-0.79 
Some College/Tech 
School/College Education or 
Higher 
2.1 1.1 4.4 1 0.05 8.28 1.0-67.1 
Able to Work, Unemployed -1.1 0.51 4.4 1 0.04 0.34 0.12-0.93 




       
        
Enter Model 
 
Hierarchical logistic regression was conducted using the enter method, to determine the 
effect of denial on engagement in HIV medical care in the disclosed sample. For the enter 
method all variables are kept in the model and are not removed at each step.   In block one, the 
predisposing variables (client type, gender and education) were added. In block two, the enabling 
variable (employment status); block three, perceived HIV stigma mean scale and the final block, 
denial mean scale was added to the model.  The predisposing variables, gender and educational 
level were significant predictors of engagement in HIV medical care over and above the denial 
mean scale variable (p<. 05). Women were less likely to engage in HIV medical care than men 
(OR=0.31; 95% CI [0.10, 0.90]; p<. 05). Participants who had some college education or higher 
were more likely to have engaged in HIV medical care compared to persons with less high 




were not found to significant predictors of engagement in HIV medical care among persons who 
have disclosed their HIV status to others.   
 
Table 4-24 Hierarchical Logistic Regression analysis (Enter Method) of denial on Engagement in HIV 
medical care (N=120) 
Variables B S.E. Wald df p-value O.R. 95 % C.I 
Client Type 0.13 0.78 0.27 1 0.87 1.13 0.25-5.2 
Gender -1.2 0.54 4.6 1 0.03 0.31 0.10-0.90 
Some College/Tech 
School/College 
Education or Higher 




Able to Work, 
Unemployed -0.99 0.53 3.5 1 0.06 0.37 0.13-1.0 
Perceived HIV Stigma 
Mean Scale -0.43 0.34 1.6 1 0.20 0.65 0.33-1.3 
Denial Mean Scale 0.17 0.36 0.22 1 0.64 1.18 0.59-2.4 






The following models were conducted to determine if denial and perceived HIV stigma 
had a synergistic relationship in predicting engagement in HIV medical care. Hierarchical 
logistic regression analyses were conducted with both the forward stepwise and enter method. 
Forward Stepwise Model  
 
Hierarchical logistic regression was conducted using forward stepwise method on each 
block, with the disclosed sample, to determine the interaction effect of denial and perceived HIV 
stigma on engagement in HIV medical care (Table 4.25). The variables were entered into each 
block and maintained in the model only if they were significantly associated with engagement in 




05 and for a variable to be removed was p>.10. In block one, the predisposing variables (client 
type, gender and education) were added. In block two, the enabling variable (employment 
status); block three, perceived HIV stigma mean scale, block four denial mean scale. In the final 
block, the interaction term for denial mean scale and perceived HIV stigma mean scale were 
added to the model. The predisposing and enabling variables gender, educational level and 
employment status were significant predictors of engagement in HIV medical care (p<. 05).  The 
interaction term of denial and perceived HIV stigma was not included in the stepwise model and 
thus was not a significant predictor of engagement in HIV medical care.  
 
Table 4-25 Hierarchical Logistic Regression analysis (Stepwise Method) of the interaction effect of denial and 
perceived HIV stigma on Engagement in HIV medical care (N=120) 
Variables B S.E. Wald df p-value O.R. 95 % C.I 




2.1 1.1 3.9 1 0.05 8.28 1.0-67.1 
Able to Work, 
Unemployed 
-1.1 0.51 4.4 1 0.04 0.34 0.12-0.93 




Enter Model  
 
Table 4.26 summarizes the results of the hierarchical logistic regression with the enter 
method examining the interaction effect of denial mean scale and perceived HIV stigma mean 
scale on engagement in HIV medical care. For the enter method all variables are kept in the 
model and are not removed at each step.  In block one, the predisposing variables (client type, 
gender and education) were added. In block two, the enabling variable (employment status); 




the interaction term for denial mean scale and perceived HIV stigma mean scale were added to 
the model.  Similar to the stepwise model, gender and educational level were predictors of 
engagement in HIV medical care for persons who have disclosed HIV status to others. Denial 
and perceived HIV stigma were not significant predictors of engagement in HIV medical care. 
The interaction term also was not associated with engagement in HIV medical care (p=.88). 
 
Table 4-26 Hierarchical Logistic Regression analysis (Enter Method) of the moderation effect of denial and 
perceived HIV stigma on Engagement in HIV medical care (N=120) 
Variables B S.E. Wald df p-value O.R. 95 % C.I 
Client Type 0.14 0.78 0.03 1 0.86 1.15 0.25-5.2 
Gender -1.2 0.55 4.5 1 0.03 0.31 0.11-0.91 
Some College/Tech 
School/College Education or 
Higher 
2.1 1.1 3.8 1 0.05 8.26  0.99-68.5 
Able to Work, Unemployed -0.99 0.53 3.5 1 0.06 0.37 0.13-1.0 
Perceived HIV Stigma Mean 
Scale 
-0.54 0.79 0.49 1 0.49 0.58 0.13-2.6 
Denial Mean Scale -0.35 1.3 0.01 1 0.98 0.97 0.07-13.0 
Denial *Perceived HIV 
Stigma Scale 
0.08 0.53 0.03 1 0.88 1.09 0.39-3.0 
Constant 3.0 1.8 2.8 1 0.09 20.71  
 
 
Summary of Findings: 
The results for the analyses in this chapter were presented for two samples (total and disclosed). 
In the total sample, disclosure of HIV status was a significant predictor of engagement in HIV 
medical care. In the disclosed sample, the two predisposing variables (gender and educational 
level) and enabling variable (employment status) were significant predictors of engagement in 




denial and perceived HIV stigma were greater predictors of engagement in HIV medical care 





Chapter 5: Discussion 
This chapter includes a summary of key findings as they relate to each research questions 
and hypotheses, summary of results, significance, study limitation, recommendations for future 
research and finally the conclusion about the study.  
Overview of the Chapter 
The purpose of this study was to examine denial and perceived HIV stigma as barriers to 
persons living with HIV engaging in HIV medical care. This study builds upon previous 
research, particularly qualitative research that identified psychosocial variables (denial and 
perceived HIV stigma) as being among the main barriers to PLWHA engagement in HIV 
medical care.  A few studies have examined denial (Nam et al., 2008) and stigma independently 
(Sayles, Wong, Kinsler, Martin & Cunningham, 2009; Vanable, Carey, Blair & Littlewood, 
2006) as well as together qualitatively (Beer et al., 2009; Konkle-Parker et al., 2008/2011) to 
determine their effect on the health and treatment adherence outcomes for PLWHA. This study 
sought to add to the literature by studying these two quantitatively, to assess the degree to which 
denial and perceived HIV stigma from others both separately and together affect PLWHA’s 
engagement or lack of in HIV medical care. The results of this study are presented for two 
different samples, the total sample (N=262) and the disclosed sample (N=120). The reason for 
the separation of the results was because almost half the participants (46%) had not disclosed 




Summary of Findings in Total Sample   
  The total sample includes the analysis for research questions (one, three and five) and 
hypotheses (one, three and four). The disclosed sample will examine the remaining research 





Denial in the Total Sample 
 
 
Rate of Denial in Total Sample 
 
The overall rate of denial of HIV status in the total population was found to be to 38%. 
These findings are consistent with previous research by Vosvick and colleagues, who examined 
denial using the COPE scale in PLWHA, but as it related to their quality of life. They found that 
37% of the 142 participants used denial as a coping strategy. They also found that denial was not 
a significant predictor of quality of life (Vosvick et al, 2003). 
The rates of denial in this population varied by disclosure status, where persons who 
disclosed HIV status reported a lower rate of denial as compared to persons who had not 
disclosed their HIV status.  This was calculated using bivariate analysis and did not account for 
potential confounders. The rates of denial could possibly differ between the two groups, because 
persons who disclosed HIV status may have come to terms with their HIV diagnosis, whereas 
people who not disclosed HIV status may be having a difficult time believing that they are really 
HIV positive.  
Disclosure and non-disclosure of HIV status may be a way for PLWHA to cope with 
diagnosis.  For example, previous research by Hult and colleagues, with newly diagnosed 




participants at 1, 3, and 9 months after diagnosis. They found that people who disclosed their 
HIV status early after diagnosis did so as a way to cope with diagnosis and gain social support 
from others. Whereas people who did not disclose HIV status, but kept their HIV status a secret 
did so because they feared possible stigma they would from others (Hult et al., 2012). 
 
   
Hypothesis 1 Out of care PLWHA will have higher rates of denial than newly diagnosed 
PLWHA. 
It was hypothesized that out of care persons would report higher rates of denial than 
newly diagnosed persons. This hypothesis was not supported in the total sample.  In the bivariate 
analysis out of care persons reported lower rates of denial as compared to newly diagnosed 
persons.  
 
Denial and Engagement in HIV Medical Care  
 
Hypothesis 3 Denial will be an independent predictor of engagement in HIV medical care. 
 
The second hypothesis for denial was that it would be an independent predictor of 
engagement in HIV medical care. This hypothesis was not supported based on the results from 
the regression analyses. Denial was not a significant predictor of engagement in HIV medical 
care for this population.  In the total sample, interestingly, disclosure of HIV status emerged as 
the significant predictor of engagement in HIV medical care. The lack of significance for denial 
as a predictor may have been absorbed by the disclosure variable.  
Previous studies have explored denial of HIV status with people living with HIV/AIDS 
using the COPE-denial subscale. These studies were different from this dissertation study in that 
their outcome variables were mainly quality of life (Vosvick et al., 2003; Weaver et al., 2004; 




Weaver and colleagues highlighted the influence of denial on help seeking behaviors. First, they 
conducted a longitudinal randomized trial with HIV positive women to study the effect of stress 
and denial on quality of life (QOL). Denial was found to be a significant predictor of QOL over 
and above demographic characteristics (Weaver et al., 2004). Next, with HIV positive men and 
women they examined the association of stress and denial on antiretroviral medication 
adherence. The findings suggested that denial was a predictor for less medication adherence for 
PLWHA. While previous studies found an association of denial with non-adherence to HIV 
medication, it cannot be inferred that the participants were also not engaging in HIV medical 
care. No differences were reported about how denial affects men and women differently (Weaver 
et al., 2005).   
However, one study examined the association of denial and HIV health service utilization 
for HIV positive women in South African (Luseno et al., 2010).  Health care utilization was 
measured at 3 and 6 months after HIV diagnosis. Denial was reported as a significant barrier for 
health care utilization for these women. However, these results were not tested with a 
standardized measure, but inferred because some participants delayed coming to the initial 
appointment at 3 month but attended the 6-month appointment.  
This dissertation study is similar to previous quantitative studies with PLWHA in that 
denial of HIV status was measured using the COPE-denial-subscale (Vosvick et al., 2003; 
Weaver et al., 2004; Weaver et al., 2005,). However, the studies differ in that many of the 
quantitative studies examined psychosocial variables as outcomes and not engagement in HIV 
medical care. In this dissertation study, the multivariate logistic regression analysis showed that 






Engagement in HIV Medical Care in Total Sample 
 
In the total sample, 72 %( n=190) of sample were engaged in HIV medical care within 90 
days of enrollment. This shows that the majority of the sample attended at least one HIV medical 
visit.  This is lower than the 2015 goals of the National HIV/AIDS strategy which is to have 85% 
of persons in care within 3 months (NHAS). The findings also show that engagement in care 
varied by client type. Out of care people were less likely to engage in HIV medical care 
compared to newly diagnosed persons. These findings points to the need to identify the reasons 
PLWHA tend to fall out of care. The following section discusses the influence of disclosure on 
engagement in HIV medical care. 
Disclosure and Engagement in HIV Medical Care in the Total Sample 
In the current study of African American PLWHA, disclosure was an important factor as 
almost half of participants had not disclosed their HIV status to others.  In the total sample, 
disclosure of HIV status was associated with engagement in HIV medical care. Persons who 
disclosed HIV status to others were 2.2 times more likely to engage in HIV medical care 
compared to those persons who has not disclosed HIV status. Overall, a large number of 
participants did not disclose HIV status to others and this lack of disclosure could be a form of 
HIV stigma.   
Main Findings in the Total Sample (N=262) 
One of the main findings of this study was that disclosure is a major issue for this 
population. This was confirmed by the fact that nearly 50% of the sample had not disclosed their 
HIV status to others. The results for the total sample revealed that disclosure is a significant 
predictor of engagement of HIV medical care. A person who disclosed their HIV status to others 




status to others. There was no relationship between denial and engagement in HIV medical care 
in the disclosed sample.  
Summary of Findings in Disclosed Sample   
The findings in the disclosed sample are presented examining denial and then perceived 
HIV stigma. All research questions and hypotheses are answered but are not presented in 
sequential order.  
 
Denial in the Disclosed Sample  
 
Rate of Denial in the Disclosed Sample  
 
The rate of denial in the disclosed sample was 31%. This rate was a little lower than the 
rate in the total sample.  
 
Hypothesis 1 Out of care PLWHA will have higher rates of denial than newly diagnosed 
PLWHA–Disclosed Sample.   
 
This hypothesis was not supported for the disclosed sample. The results of the bivariate 
analysis revealed there were no significant differences between level of denial in out of care and 
newly diagnosed persons.  Although the results do not indicate significant differences between 
the two populations it does show that both used denial as a way to cope with their HIV diagnosis.   
At least one-fourth of both out of care and newly diagnosed persons reported using denial at 
baseline as a way to cope with their HIV status in the previous month. 
Denial as a Predictor of Engagement in HIV Medical Care   
Hypothesis 4 Denial will be a stronger independent predictor of engagement in HIV medical 
care than other factors. 
 
The next hypothesis was that denial would be a greater predictor of engagement in HIV 




model. This hypothesis was tested using the disclosed sample, and perceived HIV stigma was 
included in the analysis. This hypothesis was also not supported. The results of the hierarchical 
logistic regression analyses revealed that gender, educational level, and employment status were 
the only variables associated with engagement in HIV medical care. This finding was 
unanticipated. Nevertheless, it was not surprising as PLWHA who are typically unengaged in 
HIV medical care are more likely to be women (Rumptz et al., 2007) and have lower education 
(Kalichman, Catz & Ramachandran 1999) and are unemployed (Cunningham et al.,2007) . 
Although the original hypotheses were not confirmed it was important to study the effects of 
denial on HIV medical care, as no studies have examined how the level of denial in PLWHA 
influences engagement in HIV medical care. 
Perceived HIV stigma in the Disclosed Sample  
 
Rate of perceived HIV stigma in Disclosed Sample  
 
The rate of perceived HIV stigma in the disclosed sample is nearly 60 %.  Previous 
research by Sowell et al., (2007) examined perceptions of HIV stigma of women living in rural 
Georgia and they reported that 40% of women felt people looked down on them because of their 
HIV status. Fifty-six percent perceived others were uncomfortable around them because they 
were HIV positive.  The rates of perceived HIV stigma ranged from approximately 40-60 % 
(Sowell et al., 2007). The sample population included women who resided in rural south.  The 
population was different from the current dissertation study in that it contained all women, but 
both showed similar rates of perception of HIV stigma. 
Another study conducted with young people living with HIV to determine predictors of 
HIV stigma in the population, revealed that 89% of participants perceived HIV stigma from 




the current sample. The higher rate of stigma could be attributed to sample consisting of 
predominately of young MSM with different gender, racial and age variations. In a recent study 
by Reif et al., (2015) conducted in Washington D.C., with PLWHA at risk of falling out of 
medical care, they also found slightly higher levels of perceived HIV stigma than participants in 
the current study. One reason for the differences could be the characteristics of their sample, 
which was 78% male and 83% African American, compared to the participants in the current 
study sample were all African American and only 44% male.  In addition, Galvan and associates 
studied HIV stigma and social support in African American PLWHA also using the Berger’s 
HIV stigma scale and they also reported higher level of HIV stigma than the current study 
(Galvan et al., 2008). The sample likewise differed from the current study in that there were 
more males in study (70%) and the study was conducted in a different geographic area of the 
United States.  Level of perceived HIV stigma in the current sample may be lower because of the 
separation of the sample by disclosure status, which reduced the sample size by one-half. If all 
participants were able to answer the perceived HIV stigma questions, results in this study may 
have been comparable to other studies. In the previous studies the samples also consisted of more 
males than females. Additional studies to examine if perceived HIV stigma differs by gender are 
needed. 
 
Hypothesis 2 Out of care PLWHA will have higher rates of perceived HIV stigma than newly 
diagnosed PLWHA. 
 
The current study also hypothesized that out of care persons would have higher rates of 
perceived HIV stigma newly diagnosed persons. The hypothesis was supported in the disclosed 
sample; in the bivariate analysis out of care persons had a higher rate of perceived HIV stigma as 




care persons who have disclosed HIV status to others, have had longer time dealing with HIV 
status and may have perceived or have had negative experiences from others because of their 
HIV status. Research also indicates that HIV stigma is more often found among people who have 
disclosed HIV status to others (Vanable et al., 2006).   
Perceived HIV Stigma and Engagement in HIV Medical Care in the Disclosed Sample 
 
Hypothesis 5 Perceived HIV stigma will be an independent predictor of HIV care engagement 
 
The next hypothesis was that perceived HIV stigma would be an independent predictor of 
engagement in HIV medical care. This hypothesis was not supported. This was examined in the 
disclosed sample only. In the unadjusted logistic regression models, perceived HIV stigma was 
not a predictor of engagement in HIV medical care for PLWHA who had disclosed their HIV 
status to others. This finding was surprising since many researchers have reported that HIV 
stigma is one of the main barriers that keep people out of medical care. Some studies reported 
that PLWHA who feared or experienced HIV stigma were less likely to take HIV medications, 
and attend HIV medical appointments for fear of others finding out about their HIV status 
(Konkle – Parker et al., 2011; McDoom et al., 2014; Rintamaki et al., 2006; Vanable et al., 
2006).  However, many of these studies used qualitative research methods to examine HIV 
stigma in their sample.  
Although very few studies have examined quantitatively perceived HIV stigma and its 
association with engagement in HIV medical care.  One such study by Wolitski et al. (2008), did 
examine HIV stigma, but with unstably housed PLWHA, in Washington DC, and its association 
with engagement in HIV medical care. In this study a modified version of Berger’s HIV stigma-
perceived HIV stigma subscale was used. They reported that perceived HIV stigma was not 




colleagues (2009), in their study with PLWHA in Las Angeles, California also reported that HIV 
stigma was not associated with regular HIV care (Sayles et al., 2009). These results are similar to 
the current dissertation study in that perceived HIV stigma was not associated with engagement 
in HIV medical care. This lack of significance in the current study confirms previous findings, 
but could possibly be attributed to reduced sample size and not enough power to detect a 
difference because many participants had not disclosed HIV status and less than half the sample 
could be included in the analysis. These findings underscore the need for additional quantitative 
research to explain the relationship between perceived HIV stigma and engagement in HIV 
medical care. 
 Hypothesis 6 Denial and stigma have a synergistic relationship when predicting engagement in 
HIV medical care 
 
The final hypothesis was that denial and perceived HIV stigma would have a synergistic 
relationship when predicting engagement in HIV medical care. This hypothesis was not 
supported, as both denial and perceived HIV stigma were not associated with engagement in 
HIV medical care. The results of the hierarchical logistic regression analysis examining the 
interaction effect of denial on perceived HIV stigma and engagement in HIV showed an 
insignificant interaction term. This relationship was only examined in the disclosed sample, and 
this effect may have been difficult to identify because of decreased sample size.  In the bivariate 
analysis, out of care persons did report a greater level of perceived HIV stigma and denial than 
newly diagnosed persons. Therefore, they may have been using denial of HIV status to cope with 









Engagement in HIV medical care in the Disclosed Sample 
In the disclosed sample, 78 % of participant engaged in HIV medical care within 90 days 
of enrollment. The findings did not show that engagement in care varied by client type. In out of 
care and newly diagnosed persons, engagement was reported at similar rates. Low sample sizes 
were probably a factor as to why these findings are different from what was observed in the total 
sample.  In the total sample, out of care persons were less likely to engage in HIV medical care 
than newly diagnosed persons.   
 
Disclosure and Engagement in HIV Medical Care in the Disclosed Sample 
In the disclosed sample, there was a relationship between perceived HIV stigma and 
engagement in HIV medical care. The bivariate analysis showed that persons who disclosed their 
HIV status and were not engaged in HIV medical care reported higher levels of perceived HIV 
stigma than persons who were engaged in HIV medical care. Among persons who had disclosed 
their HIV status, engagement in HIV medical care was associated with being female and 
perceived HIV stigma. Women were less likely to be engaged in HIV medical care as compared 
to men, and persons who did not engage in medical care had higher average mean perceived HIV 
stigma scores than persons who engaged in HIV medical care. 
 
Main Findings in the Disclosed Sample (N=120) 
 
The results for the disclosed sample revealed that gender, educational level and 
employment status were important predictors of engagement in HIV medical care. Woman as 
compared to men, persons with less than a high school diploma as compared to persons with 




work were less likely to engage in HIV medical care. The psychosocial variables, denial and 
perceived HIV stigma were not significant predictors of engagement in HIV medical care as 
hypothesized.  
Lessons Learned: Denial and Perceived HIV Stigma  
Denial of HIV status in this study was examined as a coping mechanism that PLWHA 
use to deal with their HIV status (Carver, Scheier, & Weintraub, 1989). Denial has also been 
found to be a behavioral indicator of delay in entering HIV medical care (Goldbeck, 1997; 
Livneh, 2009). This study did not support denial as such a behavior indicator because denial was 
not related to engagement in HIV medical care. It was shown that a number of participants, 
newly diagnosed and out of care persons, experienced some level of denial in coping with HIV 
their diagnosis. Denial of HIV status and perceived HIV stigma were measured quantitatively in 
this study, but additional measures of qualitative data may help elucidate what PLWHA are 
experiencing after being diagnosis with HIV.   
 
 HIV stigma also affects PLWHA after diagnosis. PLWHA may allow societal and 
community norms to shape how they feel about themselves and subsequently affect their 
engagement in HIV medical care.  Participants in this study may have knowledge or have 
experienced at least 4 types of stigma (1) perceived, (2) disclosure, (3) negative self-image, and 
(4) public attitudes about PLWHA based on the items contained on the perceived HIV stigma 
measure (Berger, Ferrans, & Lashley, 2001). Specifically in this study perceived HIV stigma and 
disclosure were examined. The findings from this study show that perceived HIV stigma and 
non-disclosure of HIV status is widespread in this sample. Thus suggests that PLWHA may fear 




disclose their HIV status to others, this lack of disclosure could be related to a higher perception 
of HIV stigma.  
Previous studies have reported a relationship between HIV stigma and disclosure of HIV 
status. In a meta-analysis examining the relationship between HIV status, stigma and social 
support, it was reported that greater HIV stigma was correlated with less disclosure of HIV status 
(Smith, R., Rossetto, K., & Peterson, B. L. 2008).  In another study with HIV positive women 
with a history of abuse they reported that non-disclosure was a result of their fear of stigma and 
rejection from others (Clum et al., 2013). Perceived HIV stigma was suggested to be associated 
with disclosure of HIV status but depending on the relationship with the person. Derlega and 
colleagues found that PLWHA reported that perceived HIV stigma was one of the reasons they 
would not disclose to a parent, but it did not keep them from disclosing to a close friend (Derlega 
et al., 2002).  HIV stigma in PLWHA is not a one-time event and may possibly cause them to 
experience the “spoiled identify” first theorized by Goffman with each new person that learns of 
their HIV positive status (Goffman, 1963). The experiences with HIV stigma may also differ by 
gender and SES. 
Race, Gender, Socioeconomic Status (SES), Denial and Perceived HIV Stigma 
 
Denial, stigma and fear are major barriers in dealing with HIV/AIDS in the African 
American communities (Foster, 2007). African Americans experience more HIV stigma than 
other races because they bear the greatest burden of the HIV disease (Galvan, et al., 2008).  
Stigma has been suggested to keep people from accessing care and employment opportunities 
that may ultimately affect their SES (CDC, 2011). In the bivariate analysis, there were 
significant gender differences on the denial and perceived stigma mean scale. Women who have 




who have disclosed their HIV status to others. There were no significant differences in income 
by denial and perceived HIV stigma, but persons making less than $15000 per year reported a 
higher mean on the denial and perceived HIV scale than persons making greater than $15,000 
per year. The analysis of variance for employment status showed there were no significant 
differences in denial and perceived HIV stigma, indicating that these three groups experienced 
comparable levels of denial and perceived HIV stigma. Denial and perceived HIV stigma does 
not differ based on a person’s employment status for this sample. 
In summary, among this sample of African American PLWHA, denial and perceived HIV 
stigma were experienced by a majority of participants. PLWHA experience both psychosocial 
factors whether they are out of care or newly diagnosed with HIV. Gender was an important 
variable in explaining how the population that had disclosed to others experienced perceived 
HIV stigma and denial. The results were similar for both variables with women who had 
disclosed to others reporting a greater level of denial and perceived HIV stigma than men who 
had disclosed to others. Women in this population may use denial as a way to cope with their 
HIV status and perceive more HIV stigma than men, and possibly need greater support to help 
them manage their HIV status.  Finally, neither denial nor perceived HIV stigma were associated 
with engagement in HIV medical care. 
 
Predisposing, Enabling and Need (PEN) Factors and Engagement in HIV Medical Care 
  
The predisposing, enabling and need factors were selected because of their association 
with the model as well as with people living with HIV.  The variables that were significantly 




In the total sample, none of the predisposing, enabling, and need factors were associated 
with engagement in HIV medical care.  In the disclosed sample, the predisposing variables, 
gender and educational level variables were associated with engagement in HIV medical care.  
Women compared to men were less likely to engage in HIV medical care.  Participants 
who had less than a high school diploma were also less likely to engage in HIV medical care 
compared to participants with some college education or higher. These findings were similar to 
prior research with that reported gender (Aziz & Smith, 2011) and educational level (Kalichman 
et al., 1999; Rumptz et al., 2007; Saint-Jean et al, 2011) as barriers to utilization of HIV medical 
care for PLWHA.  
  Also in the disclosed sample, the enabling factor (employment status) was associated 
with engagement in HIV medical care. Persons who were able to work, but unemployed were 
less likely to engage in HIV medical care compared to persons who are unable to work. The 
majority of the sample had health insurance, was low income, unemployed and had a medical 
home. For the need factors there were no significant associations with engagement in HIV 
medical care. Also, in this population 86% of persons reported at least one barrier to accessing 
medical need and services. The barriers reported most include: housing, finances and 
transportation.  In the bivariate analysis, out of care persons reported on average more barriers to 
care than newly diagnosed persons. Perhaps the reason no significant associations between 
barriers and engagement in medical care were found in this sample was because almost all 
participants experienced the same barriers to engaging in HIV medical care. In addition, they 
were African American, low income, had health insurance and a medical home.  Also, the 
geographic location of this study could also be a reason there were no association of engagement 




organizations.  These findings may be different from what might be found in rural areas where 
HIV resources are not as plentiful.  
 
Andersen Behavioral Model and Engagement in HIV Medical Care 
 
This study was guided by an adapted version of the Andersen Behavioral Model of 
Health Care Utilization.  The model was adapted by adding psychosocial constructs denial and 
stigma to the predisposing factors and barriers to care scale and clinical indicators to the need 
factors.  The study suggested that there is limited usefulness of adding these standardized 
measures to the ABM model when exploring how different factors influence engagement in HIV 
medical care for PLWHA.  
First, adding denial to the Andersen Behavioral Model did not increase explanation of 
why PLWHA delay engaging in HIV medical care. Denial was not a significant predictor of 
engagement in HIV medical care for this population. Second, HIV stigma was added as a 
predisposing factor, and was tested for its influence on engagement in HIV medical care. 
Previously, Ulett and colleagues constructed a” blueprint to HIV treatment for success” which 
was also an adaptation of the ABM. In this blueprint, they suggested adding HIV stigma to the 
predisposing factors to evaluate its influence on HIV treatment in care (Ulett et al., 2009). The 
current tested HIV stigma as a predisposing factor and found that it had no significant 
relationship with engagement in HIV medical care, perhaps due to the limited sample size.   
Significance of the Study  
The continuum of engagement in HIV medical care describes the stages of care PLWHA 
can go through after being diagnosed with HIV. The continuum begins with HIV diagnosis to 




The continuum of care does not always progress from one step to the next and can be a very 
dynamic process. A PLWHA can be engaged in HIV medical care after diagnosis, fall out of 
care, and then be reengaged after a period of time. 
This study looked at two population groups (out of care and newly diagnosed) across the 
HIV care continuum from diagnosis to engagement in HIV medical care. In this study, 28% of 
participants had not engaged in HIV medical care after 90 days. Examining engagement in care 
for newly diagnosed and out of care persons, 32% of out of care participants, and 18% of newly 
diagnosed participants had not engaged in HIV medical care. The results show that out of care 
persons were more likely at the end of 90 days to have not engaged in HIV medical care as 
compared to newly diagnosed persons. This population was categorized as out of care at 
enrollment and continued to remain less engaged in HIV medical care.  It is important to break 
the cycle of low engagement among this population as well as keep newly diagnosed persons 
engaged in care. This research shows that gaps in care remain along the continuum of care for 
this population and the barriers associated with lack of engagement need to be identified and 
addressed. 
While this dissertation assumed that the psychosocial variables denial and perceived HIV 
stigma were the reasons for the gaps in care, and they would be significant predictors of 
engagement in HIV medical care, this was not supported in this population.  Denial and 
perceived HIV stigma did not predict engagement in HIV medical care. The results did reveal 
that disclosure of HIV status, the predisposing factors (gender and educational level) and the 
enabling factor (employment status) were associated with engagement in HIV medical care.  The 
results suggest that in this population, different groups (newly diagnosed vs. out of care, men vs. 




keep them engaged in medical care as they progress along the continuum of HIV care. 
Engagement in care is a public health concern because if people are not engaged in HIV medical 
care, they are not receiving the benefits of treatment. This can lead to higher HIV viral loads, 
which are associated with poorer health outcomes and increase likelihood of transmission of HIV 
virus to others resulting in new HIV infections (Cheever, 2007; Cohen et al., 2011; Giordano et 
al., 2007). 
 
  There are approximately fifty thousand new HIV infections each year in the United States 
and according to the CDC, 90% of new infections in the U.S are the result of PLWHA who are 
not engaged in HIV medical care (CDC, 2003; Skarbinski et al., 2015).  Lack of engagement in 
HIV medical care for PLWHA makes it difficult to reach the goals of the UNAIDS 2010 strategy 
of no new HIV infections.  This was also the goal of World AIDS Day 2012, and a campaign 
initiated by AIDS United called “Getting to Zero (G2Zero)”. The goals of these campaigns are, 
zero new HIV infections, zero stigma and discrimination against PLWHA, and no more deaths 
from HIV/AIDS.  In order to reach these goals set forth by these initiatives, it is important to that 
PLWHA are engaged and retained in HIV medical care.  This dissertation study suggests that 
more attention should be aimed at out of care persons, people who have not disclosed their HIV 
status, and woman to strengthen treatment outcomes among persons who are at risk for not 
remaining in HIV medical care.  
In this research study, it was found that both newly diagnosed and out of care persons 
experienced some level of denial and perceived HIV stigma. .  This study administered the 
Berger’s HIV stigma scale, a standardized measure to examine HIV stigma, in this population 
but did not find any associations with engagement in HIV medical care. Examining how HIV 




National HIV/AIDS Strategy 2020 goals is to develop and annually report on measures designed 
to assess HIV related stigma experienced by persons living with HIV.  If this this policy is 
implemented and HIV stigma screening is performed in medical care settings, new information 
about the relationship between HIV stigma  and PLWHA’s engagement in HIV medical care 
may be identified (Holtgrave, 2011).  
  
Limitations of the Study  
Findings should be interpreted in light of study limitations. First, only African-American 
PLWHA, newly diagnosed or out of care persons were recruited into the study; this may limit 
generalization of the findings to other races of HIV positive populations, PLWHA who are in 
continuous HIV medical care, and persons who are not enrolled in Positive Pathways.  
Second, the sample was drawn from one urban geographic area in the United States with 
more HIV medical care and resources to engage PLWHA in medical care than many other urban 
areas; hence the results may not be generalizable to other metropolitan areas within the United 
States. Future studies with more variability in respect to race/ethnicity, healthcare systems, and 
geographic locations are needed.  
Third, participant’s self-reported answers to CHWs may have introduced social 
desirability bias. Participants may report answers that they think are more desirable to the CHW. 
Also, in regard to the dependent variable, participants could have introduced recall bias, where 
they may not recall the exact dates of their HIV medical visits or they could have falsely 
remembered dates. Hence, some engagement may not have been correctly revealed in the self-
reports which could have introduced error into this measurement.  CHW medical record review 
was used when participants could not recall or clearly report their medical visit history.  The mix 




dependent variable. Participants self-report of medical appointments may not be as accurate as 
the medical record review and therefore less reliable.  Hence, these mixed methods could also 
have introduced error into the measurement of engagement in medical care.  This could diminish 
or inflate the effect found between the independent and dependent variables. The ideal method of 
data collection would have been to ask the CHW to provide medical record information for all 
clients but this was not feasible and would have placed an undue burden on them as many have 
large client caseloads.  
Fourth, the 45-day assessment for collection of medical visits refers to the last 30 days 
although the period needed for measurement was 45 days. This may have reduced the number of 
appointments reported if participants were immediately linked to care within the first 15 days. 
Also, engagement in medical care was coded as no engagement if the participant was loss to 
follow-up or the medical visit information could not be obtained. Treating lost to follow-up as no 
engagement inflates the number of persons in this category and may affect the outcome. This 
decision was made because it was assumed that these individuals were not engaged in HIV 
medical care.  Fortunately, there were few persons in this category and from all indications of 
reasons for loss to follow-up, engagement appeared highly unlikely among these persons. 
 Next, having a CHW in the study may diminish the extent of the association found 
between denial, perceived stigma and engagement in HIV medical care. The community health 
workers could have been instrumental in helping participants overcome denial, handle stigma, 
and engage in care, and this would possibly lessen the ability to detect associations between the 
study variables.  Finally, the perceived HIV stigma scale was modified to include response items 
that were not included in the original scale. These response items include: don’t know, refused 




substantially increased the number of cases for whom stigma could not be measured. This 
reduced the sample size and limited the power for evaluating the association between both 
stigma and the outcome variable.  
Recommendations for Future Research 
The findings from this study warrant further exploration. First, to better evaluate the 
degree to which perceived HIV stigma is associated with engagement in HIV medical care, 
future studies should include the Berger’s HIV stigma subscale measure modified to include only 
those items that are applicable to all participants, which examines the level of perceived HIV 
stigma and not whether a person has disclosed their HIV status. 
 Second, inclusion of questions about disclosure status could help to determine if the 
PLWHA has ever disclosed their HIV status to others and if so, to whom they have disclosed to 
(i.e. parent, sexual partner, or close friend). This could provide a greater understanding of how 
perceived HIV stigma and disclosure may influence engagement in HIV medical care. 
Interventions can be developed aimed at increasing disclosure among African American 
PLWHA, as decreased disclosure leads to lower engagement in HIV medical care and can 
negatively affect the health outcomes of PLWHA. 
Third, a longitudinal study that follows participants for longer than 90 days would help to 
better examine any causal relationships between variables.  This study could also be conducted 
with and without a community health worker. Such a study could help determine if a CHW has 
an effect on the engagement in care and on the level of denial and perceived stigma experienced 
by participants. Finally, the development of gender based interventions, specifically for African 
American women with low educational level could help address specific barriers that this 




PLWHA in this country, and are more likely to delay entry into HIV medical care, it is important 
to develop interventions that will improve their engagement and retention in HIV medical care 
(Squires et al., 2011) 
Conclusion  
In summary, HIV treatment is lifelong and for PLWHA to benefit from treatment they 
must remain engaged in HIV medical care. The goal of this study was to determine whether the 
psychosocial factors denial and stigma were the main barriers keeping PLWHA from engaging 
in HIV medical care for PLWHA. The findings demonstrated that denial and perceived HIV 
stigma were not associated with engagement in HIV medical care for this population of African-
American PLWHA when controlling for many other predisposing, enabling and need variables. 
However, the findings did reveal that disclosure of HIV status to others was related to 
engagement in the overall study sample.  Among those who had disclosed their HIV status to 
others; gender, educational level, and employment status were significantly associated with 
engagement in HIV medical care. Denial, perceived stigma, and non-disclosure were found at 
high rates among the study sample.  The research revealed the need to investigate further how 
denial, perceived HIV stigma, and disclosure together and separately affect engagement in HIV 
medical care. Understanding factors that decrease engagement in HIV medical care can inform 





















Appendix C: Baseline Assessment  
Date: 
CHW ID:                                                   
Client Type/ Category: 
Site ID:                                                    
Date client enrolled: 
Positive Pathways HEALTH HISTORY QUESTIONNAIRE 
All questions contained in this questionnaire are strictly confidential  
and will become part of your medical record. 
 
CLIENT ID (XXXXXXX): 
 
 
Age:                 DOB:  
  
Marital status:              Single      Partnered      Married      Separated      
Divorced      Widowed 
Race/Ethnicity: (Check one or check “multiple races” if more than one race) :  
 
 American Indian/ Alaska Native      Asian      Black, non-Hispanic      
Hispanic      Native Hawaiian/Other Pacific Islander      White, non-Hispanic  
Multiple races    Don’t Know  Refused 
Sex/Gender (Check One)  Male   Female   Transgender Male to Female    
Transgender Female to Male    Don’t Know  Refused 
Education ( Check one – Highest level reached/ completed)  Less than HS   HS 
Diploma or equivalent    Some college or technical school  College or Higher 
education    Don’t Know  Refused 
 
Income – Client’s individual  Less than $15,000  $15,000 to $24,999   $25,000 
to $49,000  $50,000 to $74,999    75,000 and up  Don’t Know   Refused 
 
Client’s Health Insurance:  None  Yes: Specify type or name of plan 
________________________________________________________ 
Is client eligible for Medicaid?  No  Yes 
Does this client have a medical home (medical provider)  No  Yes 
Employment status:  Able to work, employed  Able to work, not-employed  
Retired  Unable to work 
City:                         State:                       Ward:           Zip Code: 
 
(only answer about first meeting) How Did CHW First Engage Client (if multiple 
ways check “multimodal”) :  Street Outreach  Social Media  Peer outreach 
Multimodal  No outreach conducted  Don’t Know  Internal Referral 
 




Date of first positive HIV test (Mth/year):
 
 If the client does not have proof of 
HIV status was a test conducted?  No  Yes                Date of that confirmatory Test: 
     Date of Lab Confirmation:  
Has client’s current partner(s) been tested for HIV? :  No  Yes  Don’t Know   
No current partner           
Is partner seropositive?  No  Yes  Don’t Know   N/A               
Have you been to a medical visit with a provider who can prescribe medicine in an 
HIV care setting in the past 12 months?  No  Yes  Don’t Know 
What were the dates of your HIV medical visits within the last 12 months? Please list 
all that apply:  
___March 2011 ___April 2011 __May 2011__June 2011__ July 2011     __August 
2011    __Sept 2011    __Oct 2011   __Nov 2011   __Dec 2011   __Jan 2012   __Feb 
2012  __Mar 2012 __Apr 2012   __May 2012  __Jun 2012 ___ July 2012 ___ Aug 
2012 ____Sep 2012 ___Oct 2012 ___Nov2012____Dec 2012 
 
 
What is the client’s CD4 count? (record either or both “self 
reported” or “clinic/lab”)  
 
CD4 count –Self Reported? ________ Date of Count from self-
report ___/___/_______ 
 
CD4 Count –Clinic/lab data? _______ Date of count from 
clinic/lab___/____/_______ 
 
Is client’s CD4 
count less than 
500? 
 No  Yes                 
 
Has client been 
prescribed 
HAART? 
 No  Yes    
 
 
What is the client’s Viral load? (record either or both “self-reported” or “clinic/lab”)  
 
Viral load–Self Reported? ________ Date of Count from self-report ___/___/_______ 
 
Viral load–Clinic/lab data? _______ Date of count from clinic/lab___/____/_______ 
 
STIGMA- These questions ask about some of your experiences, feelings, and opinions about how people with HIV 
feel and they you been treated. 
I’ve felt that people avoided me because I have HIV :  Not at all  Rarely   
Sometimes  Often   Don’t Know  I Haven’t told anyone  Refused 
 
I’ve feared I would lose friends if they learned about my HIV:  Not at all  Rarely  
 Sometimes  Often   Don’t Know  Refused 
             
I’ve thought other people were uncomfortable being with me because of my HIV:  
Not at all  Rarely   Sometimes  Often   Don’t Know  I Haven’t told anyone  
Refused 
 
I’ve avoided getting treatment because someone might find out about my HIV:    





What services do you currently need? 
 Drug and alcohol abuse 
treatment  Dental services 
 Food or other 
subsistence 
 Housing or shelter  HIV-related medical services 
 Mental health 
services 
 Employment training 
  Non-HIV related medical 
services (for HIV or non-HIV 
reasons) 
 Assistance 
with job seeking 
 Child care  Transportation 






 Other (specify “other) 
________________________
___ 
 Pharmacy or 
medication 
services (for HIV 
or non HIV 
reasons) 
 Don’t know  Refused  
Of the services the client said they need (those checked above) what services does the 
client report as needed most urgently? (Check only ONE most urgent response) 
 Drug and alcohol abuse 
treatment  Dental services 
 Food or other 
subsistence 
 
 Housing or shelter  HIV-related medical services 
 Mental health 
services 
 
 Employment training 
  Non-HIV related medical 
services (for HIV or non-HIV 
reasons) 
 Assistance 
with job seeking 
 Child care  Transportation 






 Other (specify “other) 
________________________
___ 
 Pharmacy or 
medication 
services (for 
HIV or non HIV 
reasons) 
 Don’t know  Refused   




Often people with HIV face barriers to getting HIV care. What factors make it hard for 
you to get care? Don’t read the categories below- let the client answer. If more than 
one factor is identified, ask: Of those factors which one poses the greatest barrier to 
care for you now? And check the box for question 2. 
 Lack of Money  Distrust of medical system  Immigration  
 Homelessness  Lack of perceived need  Incarceration 
 Drug use  Stigma  Competing priorities 
 Fear  Denial  Transportation 
 Location of care  Lack of additional services  
 Structure of HIV testing 




If more than one factor is identified as a barrier, which of these is the greatest barrier 
for the client now?  
 Lack of Money  Distrust of medical system  Immigration  
 Homelessness  Lack of perceived need  Incarceration 
 Drug use  Stigma  Competing priorities 
 Fear  Denial  Transportation 
 Location of care  Lack of additional services  
 Structure of HIV testing 




Would you say in general your health is?  Excellent   Very good   Good  Fair 
 Poor  Don’t Know  Refused 
DENIAL 
The questions below focus on how you deal with your HIV disease. Select the answer 
that best describes how often in the past month you have used each of the following to 
cope with your HIV. 
I say to myself “this isn’t real”.                            Not at all    Rarely    Sometimes   
 Often     Don’t Know    Refused 
 
I refuse to believe that it has happened.             Not at all    Rarely    Sometimes    
 Often     Don’t Know   Refused 
 
I pretend that it hasn’t really happened.             Not at all    Rarely    Sometimes    
 Often     Don’t Know   Refused 
     
I act as though it hasn’t even happened.            Not at all    Rarely    Sometimes    
 Often     Don’t Know   Refused 
BARRIERS TO CARE 




for you to receive the care, services or opportunities you wish to obtain.  
Long distances to medical facilities and personnel. 
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
Medical personnel (e.g. physicians, nurses), who decline to provide direct care to 
persons with HIV/AIDS.                                       No problem at all      Very slight 
problem  Somewhat of a problem  Major Problem  Don’t Know  Refused 
 
The lack of health care professionals who are adequately trained and competent in 
AIDS care  
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
The lack of transportation to access the services I need.    
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
The shortage of psychologists, social workers and mental health counselors who can 
help address mental health issues.   
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
The lack of psychological support groups for persons with HIV/AIDS. 
  No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
       
The level of knowledge about HIV/AIDS among residents in the community.    
  No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
Community residents' stigma against persons living with HIV/AIDS.  
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
The lack of employment opportunities for people living with HIV/AIDS.  
  No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
The lack of supportive and understanding work environments for people living with 
HIV/AIDS.  
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 
My personal financial resources.  




Problem  Don’t Know  Refused 
 
Lack of adequate and affordable housing.  
 No problem at all  Very slight problem  Somewhat of a problem  Major 
Problem  Don’t Know  Refused 
 PERCEIVED HIV STIGMA 
These questions asks about some experiences, feelings, and opinions as to how people 
with HIV feel and how they are treated.  
Have lost friends by telling them I have HIV. 
 Strongly disagree  Disagree  Agree Strongly agree  I Haven’t told anyone 
 
Hurt by how people reacted to learning I have HIV.   
  Strongly disagree  Disagree  Agree Strongly agree  I Haven’t told anyone 
 
People avoid touching me if they know I have HIV. 
  Strongly disagree  Disagree  Agree Strongly agree  I Haven’t told anyone 
 
Stopped socializing with some due to their reactions.  
 Strongly disagree  Disagree   Agree   Strongly agree  I Haven’t told anyone 
 
People I care about stopped calling after learning.   
  Strongly disagree   Disagree   Agree    Strongly agree  I Haven’t told 
anyone 
 
People seem afraid of me because I have HIV.  
  Strongly disagree    Disagree   Agree    Strongly agree  I Haven’t told 
anyone 
 
People have physically backed away from me.  
   Strongly disagree    Disagree   Agree   Strongly agree  I Haven’t told 
anyone 
 
 Some people who know have grown more distant.  
  Strongly disagree    Disagree   Agree   Strongly agree  I Haven’t told 
anyone 
 
People who know tend to ignore my good points.   
  Strongly disagree  Disagree   Agree  Strongly agree  I Haven’t told anyone 
 
Don't want me around their children once they know. 
  Strongly disagree  Disagree   Agree    Strongly agree  I Haven’t told anyone 
 
I feel set apart, isolated from the rest of the world. 
  Strongly disagree  Disagree   Agree    Strongly agree  I Haven’t told anyone 
 




  Strongly disagree  Disagree   Agree   Strongly agree  I Haven’t told anyone 
 
 Some fear they'll be rejected because of my HIV.  
  Strongly disagree  Disagree   Agree   Strongly agree  I Haven’t told anyone 
 
Some people act as though it's my fault I have HIV. 
  Strongly disagree  Disagree  Agree    Strongly agree  I Haven’t told anyone 
 
As a rule, telling others has been a mistake.   
  Strongly disagree  Disagree  Agree Strongly agree    I Haven’t told anyone 
 
Most with HIV are rejected when others learn.  
  Strongly disagree  Disagree  Agree Strongly agree  I Haven’t told anyone 
 
People have told me that getting HIV is what I deserve for how I lived my life.  
  Strongly disagree  Disagree  Agree Strongly agree  I Haven’t told anyone 
 
When People learn you have HIV they look for flaws in your character  









Appendix D: 45, 90-day Assessments 
 
Client ID:  
Client Type /Category: 
Client Status:  (active, lost to care, graduated, re-engaged) 
Client Status Comments:  
CHW ID: 
Site ID:  
Date Client enrolled: 
Positive Pathways Enrolled Client 45, 90-day Day Check IN 
All questions contained in this questionnaire are strictly confidential  
and will become part of your medical record. 
 
CLIENT ID (XXXXXXX): 
 
 
Age:                 DOB:  
  
Please note any changes to client Demographics:  
Marital status:              Single      Partnered      Married      Separated      
Divorced      Widowed 
Education ( Check one – Highest level reached/ completed)  Less than HS   HS 
Diploma or equivalent    Some college or technical school  College or Higher 
education    Don’t Know  Refused 
 
Income – Client’s individual  Less than $15,000  $15,000 to $24,999   $25,000 to 
$49,000  $50,000 to $74,999    75,000 and up  Don’t Know   Refused 
 
Client’s Health Insurance:  None  Yes: Specify type or name of plan 
________________________________________________________ 
Is client eligible for Medicaid?  No  Yes 
Does this client have a medical home (medical provider)  No  Yes 
Employment status:  Able to work, employed  Able to work, not-employed  Retired 
 Unable to work 
City:                         State:                       Ward:           Zip Code:  
 HEALTH Check –IN 




Has client’s partner(s) been tested for HIV? :  No  Yes  Don’t Know     
             
Is partner seropositive?  No  Yes  Don’t Know                 
Have you been to a medical visit with a provider who can prescribe medicine in an HIV 
care setting?  No  Yes  Don’t Know 
 
What was the date of your first HIV medical visit since we first met? ___/___/____ 
(CHW should verify this date) 
 
What were the dates of your HIV medical visits with a provider with prescribing 
privileges within the last 30 days? Please list all that apply:  ___/_____/____    
____/_____/____    ____/____/______ 
 
Have you met with an HIV case manager?  No  Yes  Don’t Know 
 
Does the client have a case management strategy/plan?  No  Yes  Don’t Know 
 
What was the date of this case management plan? ___/___/______ 
 
What is the client’s CD4 count? (record either or both “self 
reported” or “clinic/lab”)  
 
CD4 count –Self Reported? ________ Date of Count from self-
report ___/___/_______ 
 
CD4 Count –Clinic/lab data? _______ Date of count from 
clinic/lab___/____/_______ 
 
Is client’s CD4 count 
less than 500? 
 No  Yes                 
 
Has client been 
prescribed HAART? 
 No  Yes    
 
What is the client’s Viral load? (record either or both “self reported” or “clinic/lab”)  
 
Viral load–Self Reported? ________ Date of Count from self-report ___/___/_______ 
 
Viral load–Clinic/lab data? _______ Date of count from clinic/lab___/____/______ 
 
STIGMA 
I’ve felt that people avoided me because I have HIV :  Not at all  Rarely   
Sometimes  Often   Don’t Know  I Haven’t told anyone  Refused 
 
I’ve feared I would lose friends if they learned about my HIV:  Not at all  Rarely   
Sometimes  Often   Don’t Know  Refused 
             
I’ve thought other people were uncomfortable being with me because of my HIV:  Not 






I’ve avoided getting treatment because someone might find out about my HIV:    Not at 
all  Rarely   Sometimes  Often   Don’t Know  Refused                            
 
CLIENT NEEDS 
Since our last meeting, have accessed any of the services that you needed? (CHW can list 
services that the client described at initial intake)  No  Yes  Don’t Know  
What services did you access? 
 Drug and alcohol abuse 
treatment  Dental services 
 Food or other 
subsistence 
 Housing or shelter  HIV-related medical services  Mental health services 
 Employment training 
  Non-HIV related medical 
services (for HIV or non-HIV 
reasons) 
 Assistance with job 
seeking 
 Child care  Transportation 




 Other (specify “other) 
__________________________
_ 
 Pharmacy or 
medication services 
(for HIV or non HIV 
reasons) 
 Don’t know  Refused  
What services do you currently need? 
 Drug and alcohol abuse 
treatment  Dental services 
 Food or other 
subsistence 
 Housing or shelter  HIV-related medical services  Mental health services 
 Employment training 
  Non-HIV related medical 
services (for HIV or non-HIV 
reasons) 
 Assistance with job 
seeking 
 Child care  Transportation 




 Other (specify “other) 
__________________________
_ 
 Pharmacy or 
medication services (for 
HIV or non HIV 
reasons) 
 Don’t know  Refused  
Of the services the client said they need (those checked above) what services does the 
client report as needed most urgently? ( check only ONE most urgent response) 
 Drug and alcohol abuse 
treatment  Dental services 






 Housing or shelter  HIV-related medical services 
 Mental health 
services 
 
 Employment training 
  Non-HIV related medical 
services (for HIV or non-HIV 
reasons) 
 Assistance with job 
seeking 
 Child care  Transportation 




 Other (specify “other) 
__________________________
_ 
 Pharmacy or 
medication services 
(for HIV or non HIV 
reasons) 
 Don’t know  Refused   
BARRIERS TO CARE 
Since our last meeting, have any of the barriers that you discussed been 
reduced/addressed? (CHW can list barriers that the client described at initial intake)  No 
 Yes  Don’t Know 
What Barriers have been addressed/reduced? 
 Lack of Money  Distrust of medical system  Immigration  
 Homelessness  Lack of perceived need  Incarceration 
 Drug use  Stigma  Competing priorities 
 Fear  Denial  Transportation 
 Location of care  Lack of additional services  
 Structure of HIV testing  Other (specify) __________________________  
 
What are the client’s barriers to getting HIV care? 
 Lack of Money  Distrust of medical system  Immigration  
 Homelessness  Lack of perceived need  Incarceration 
 Drug use  Stigma  Competing priorities 
 Fear  Denial  Transportation 
 Location of care  Lack of additional services  
 Structure of HIV testing  Other (specify) __________________________  
If more than one factor is identified as a barrier, which of these is the greatest barrier to 
care for you now?  
 Lack of Money  Distrust of medical system  Immigration  
 Homelessness  Lack of perceived need  Incarceration 
 Drug use  Stigma  Competing priorities 




 Location of care  Lack of additional services  
 Structure of HIV testing  Other (specify) __________________________  
Would you say in general your health is?  Excellent   Very good  Good  Fair  





Appendix E:  Participant Responses to Denial and Perceived HIV Stigma Measures  
 
TableE.1 Responses to Denial scale reported by participants  (N=262) 
Denial 
Not at all 
N (%) 
Rarely                   
N (%) 
Sometimes              
N (%) 
Often               
N (%) 
Missing                                
N (%) 
 I say to myself this isn't 
real 
163(62) 8(3) 39(15) 20(7) 32(12) 
      
I refuse to believe that is has 
happened 
175(67) 6(2) 29(11) 20(7) 32(12) 
      
I pretend that it really 
hasn't happened 
174(66) 6(2) 31(12) 21(8) 30(12) 
      
I act as though it hasn't 
even happened  








Table E.2 Responses to Perceived HIV stigma Scale reported by percentage of participants (N=262) 






N (%)                   
Agree N 
(%)                   
Strongly 
Agree  




N (%)  
Missing   
N (%) 
 
I have lost friends by 




23(19) 21(18) 9(8) 104(40) 0 
I have lost friends by 
telling them I have 
HIV 
67(26) 23(9) 21(8) 9(3) 104(40) 38(15) 
       
I have been hurt by 
how people reacted to 
learning I have HIV 
63(24) 16(6) 22(8) 19(7) 104(40) 38(15) 
       
People avoid touching 
me if they know I have 
HIV 
73(28) 28(11) 9(3) 7(3) 101(39) 44(17) 
       
I stopped socializing 
with some due to their 
reactions  
67(26) 18(7) 20(8) 15(6) 102(39) 40(15) 
       
People I care about 
stopped calling after 
learning I have HIV 
73(28) 27(10) 11(4) 9(3) 101(39) 41(16) 
 
       
People seem afraid of 
me because I have 
HIV 
75(29) 20(8) 14(5) 8(3) 102(39) 43(16) 
       
Some people who 
know my HIV status 
have grown more 
distant 
72(28) 22(8) 19(7) 10(4) 101(39) 38(14) 
 
       
People have physically 
backed away from me  
66(25) 30(12) 15(6) 14(5) 97(37) 40(15) 
       
People who know my 
HIV status tend to 
ignore my good points 




       
 Some People Don't 
want me around 
children once they 
know my HIV status 
76(29) 23(9) 11(4) 5(2) 104(40) 43(16) 
       
I feel set apart, 
isolated from the rest 
of the world 
68(26) 22(8) 26(10) 22(8) 83(38) 41(16) 
       
I regret having told 
people that I have HIV 
70(27) 18(7) 15(6) 22(8) 96(37) 41(16) 
       
Some people feel they 
will be rejected 
because of my HIV 
status 
69(26) 20(8) 17(7) 10(4) 98(37) 48(18) 
       
Some people act as 
though it’s my fault I 
have HIV 
69(26) 22(8) 14(5) 8(3) 103(39) 46(18) 
       
As a rule, telling 
others about my HIV 
Status has been a 
mistake 
68(26) 24(9) 12(5) 22(8) 96(37) 40(15) 
       
Most people with HIV 
are rejected when 
others learn of their 
HIV status 
62(24) 20(8) 33(13) 25(10) 82(31) 40(15) 
       
People have told me 
that getting HIV is 
what I deserve for how 
I lived my life 
74(28) 25(10) 9(3) 14(5) 98(37) 42(16) 
       
When people learn 
you have HIV they 
look for flaws in your 
character 





Participant Responses on Denial Scale (N=120) 
 
Table describes the participant responses on the denial mean scale for the disclosed 
sample. The respondents were asked to select the answer that best describes, “How often in the 
past month have you used each of the following to cope with their HIV.” The majority of the 
sample (69%) responded that they had not been doing any of the four items in the denial scale. 
The item mentioned the most by participants was “I say to myself this is not real” (22%). 
Table E.3 Responses to Denial Scale by persons who disclosed HIV status (N=120) 
Denial  Not at all 
N (%) 
Rarely                   
N (%) 
Sometimes              
N (%) 
Often               
N (%) 
Missing                                
N (%) 
I say to myself this isn't 
real 
94(78) 3(3) 15(13) 6(5) 2(1) 
I refuse to believe that is 
has happened 
102(85) 5(4) 6(5) 5(4) 2(2) 
I pretend that it really 
hasn't happened 
98(82) 4(3) 12(10) 4(3) 2(2) 
I act as though it hasn't 
even happened  





















Perceived HIV  
Stigma  
Strongly 
Disagree               
N (%)  
Disagree                  
N (%) 
Agree                   
N (%) 
Strongly 
Agree                
N (%) 
Missing   
N (%) 
 I have lost friends by 
telling them I have 
HIV 
68(56) 23(19) 21(18) 9(8)  ve lost friends 




 I have been hurt by 
how people reacted 
to learning I have 
HIV 
 
63(53) 16(13) 20(17) 16(13) 5(4) 
People avoid 
touching me if they 
know I have HIV 
 
72(60) 28(23) 8(7) 4(3) 8(7) 
I stopped socializing 
with some due to 
their reactions  
 
65(54) 18(15) 18(15) 14(12) 5(4) 
People I care about 
stopped calling after 
learning I have HIV 
 
70(58) 26(22) 11(9) 5(4) 8(7) 
People seem afraid 
of me because I 
have HIV 
 
74(62) 20(17) 14(12) 4(3) 8(7) 
Some people who 
know my HIV status 
have grown more 
distant 
 
70(58) 22(18) 17(15) 6(5) 5(4) 
People have 
physically backed 
away from me  
 
64(52) 26(22) 15(13) 8(7) 7(6) 
People who know 
my HIV status tend 
to ignore my good 
points 
 
69(58) 20(17) 13(11) 8(7) 10(8) 
Some People don't 
want me around 
children once they 
know my HIV status 





I feel set apart, 
isolated from the 
rest of the world 
 
62(52) 21(18) 19(16) 12(10) 6(5) 
I regret having told 
people that I have 
HIV 
 
64(53) 17(14) 13(11) 17(14) 9(8) 
Some people feel 
they will be rejected 
because of my HIV 
status 
 
67(56) 17(14) 17(14) 7(6) 12(10) 
Some people act as 
though it’s my fault 
I have HIV 
 
67(56) 21(18) 14(12) 6(5) 12(10) 
As a rule, telling 
others about my 
HIV Status has been 
a mistake 
 
68(57) 22(8) 12(10) 11(9) 7(6) 
Most people with 
HIV are rejected 
when others learn of 
their HIV status 
 
62(52) 19(16) 23(19) 10(8) 6(5) 
People have told me 
that getting HIV is 
what I deserve for 
how I lived my life 
 
73(61) 24(20) 9(8) 6(5) 8(7) 
When people learn 
you have HIV they 
look for flaws in 
your character 
 





Appendix F: Barriers to Care Scale Results 
 
Table 1 presents the participants responses on the barriers to care scale. Participants reported the 
extent that each of the following circumstances made it difficult for them to receive the HIV 
medical care, services or opportunities they wished to obtain. The most reported barriers for this 
population were related to their personal finances, followed by housing and transportation. The 
four items pertaining to community stigma and work environment knowledge were removed 
from the barriers to care scale for the analysis. These items contained a high number of missing 
values, because participants answered ‘refused’ or ‘don’t know. The researcher believed that the 
participants did not fully understand the questions or they did not apply to them. The modified 8-
item scale was used in all subsequent analysis. 
 
Table 1 Responses for Barriers to care scale reported by participants (N=262) 
Barriers to Care No problem 
at all                      
N (%) 
Very slight 
problem                  
N (%) 
Somewhat of 
a problem                   
N (%) 
Major 
Problem       
N (%) 
Missing                                    
N (%) 
Long distances to medical 
facilities and personnel 
181(69) 19(7) 21(8) 8(3) 33(13) 
      
Medical personnel (e.g. 
physicians, nurses), who 
decline to provide direct 
care to persons with 
HIV/AIDS 
195(74) 13(5) 5(2) 8(3) 41(16) 
      
The lack of health care 
professionals who are 
adequately trained and 
competent in AIDS care 
196(75) 12(5) 4(2) 6(2) 44(16) 
      
The lack of transportation 
to access the services I 
need.  




The shortage of 
psychologists, social 
workers and mental health 
counselors who can help 
address mental health 
issues 
188(72) 12(5) 7(3) 5(2) 50(19) 
      
The lack of psychological 
support groups for 
persons with HIV/AIDS 
171(65) 10(4) 11(4) 9(3) 61(23) 
      
The level of knowledge 
about HIV/AIDS among 
residents in the 
community 
101(38) 12(5) 20(8) 34(13) 95(36)** 
      
Community residents' 
stigma against persons 
living with HIV/AIDS 
89(34) 14(5) 23(9) 41(16) 95(36)** 
      
The lack of employment 
opportunities for people 
living with HIV/AIDS 
100(38) 12(5) 13(5) 17(7) 120(46)** 
      
The lack of supportive and 
understanding work 
environments for people 
living with HIV/AIDS 
106(41) 6(2) 12(5) 20(8) 118(45)** 
      
My personal financial 
resources 
65(25) 32(12) 35(13) 98(37) 32(12) 
Lack of adequate and 
affordable housing 
73(28) 23(9) 41(16) 88(34) 37(14) 
 Note: ** items that will be removed from scale and not used in data analysis  
 
 
Rate of Barriers to Care in total sample  
  
The rate of barriers to care in total population was calculated using the 12 items contained in the 
Barriers to Care Scale. A mean BAC scale was created with the 12 items. After the creation of 
the scale the responses were dichotomized with “1” set to “0” and all other scores greater than 1, 
were set to “1”. All scores of 0 represented ‘no barriers to care’ and any score 1 or greater 
denoted the ‘presence of a barrier’. The total participants that reported no barriers was (N=33) 




as participant saying yes to at least 1 of the BAC items. **The total sample size was 237. To 
calculate the rate of barriers in the population the frequencies were summed to obtain the total 
numbers of ‘yes’ responses to each of the items and the total of ‘no’ responses. The total yes 
responses were divided by the total (yes responses + no responses) to obtain the total rate of 
barriers in the population. The rate of barriers reported in the population was calculated at 86%. 
The majority of the population has experienced at least one barrier to engagement in medical 
care and services in the month before enrollment.  
 
 
Table 2. Rate of barriers to care within the total sample (N=262) 
BAC N (%)* 
Long distances to medical facilities and personnel 48(18) 
  
Medical personnel (e.g. physicians, nurses), who 




The lack of health care professionals who are 
adequately trained and competent in AIDS care 
22(9) 
  
The lack of transportation to access the services I need 111(42) 
  
The shortage of psychologists, social workers and 








The level of knowledge about HIV/AIDS among 
residents in the community 
66(26) 
  








The lack of supportive and understanding work 






My personal financial resources 165(62) 
  
Lack of adequate and affordable housing 152(59) 
Note:* Very Slight Problem, Somewhat of a problem, Major Problem 
 
 
Difference in BAC by client type with total sample 
To determine whether there were differences in the level of BAC by client type chi-
square analysis was conducted. The out of care persons reported higher levels of barriers to care 
than newly diagnosed persons (88% vs. 79%) respectively. This difference was not statistically 
significant. X2 (1) =3.2, p=0.06.  
 
Table 3. Difference in BAC by client type with total sample (N=262) 
 Participant Response, N (%)  
Responses Client Type Total 
 Newly Diagnosed Out of Care  
No BAC 12(21%) 21(12%) 33(14%) 
Yes BAC 45(79%) 159(88%) 204(86%) 
Note: X2 (1) =3.2, p=0.06  
 
Descriptive statistics and Cronbach’s alpha for BAC Scale (N=262) 
Table 4. presents the descriptive statistics and Cronbach’s analysis for the BAC measure. The 
scale was created by taking the mean of the 12 items for the total mean BAC scale. The reported 
average score on the BAC mean scale was 1.83(SD=.75). The BAC total scale scores ranged 
from 1 to 4. Higher scores indicate more barriers to obtaining HIV medical care and services for 
participants. Cronbach’s alpha was calculated to confirm the internal reliability for the scale in 
this population, which was .91. 
Table 4. Descriptive statistics and Cronbach’s alpha for BAC Scale (N=262) 















Correlations with BAC Mean Scale   
 
Pearson’s correlations were conducted to determine the relationship between the BAC Mean 
scale and study variables (Table 5). The BAC mean scale was negatively correlated to medical 
home, income, being employed p<.01. In addition ,BAC mean scale was positively correlated 
with gender, client needs, client barriers, marital status, denial mean scale and perceived HIV 
stigma mean scale p<.01.   
Table 5 Pearson Correlations between BAC and study variables (N=262) 
Variable BAC Scale 
1.Client Type 0.05 
2.Age 0.12 
3.Female Gender 0.17** 
4. Health Insurance -0.06 
5. Medical Home -0.13 
6. CD4 Count 0.009 
7. HIV Viral Load 0.03 
8. Engagement -0.28** 
9.Income 0.25** 
10.Client Needs 0.26** 
11.Client Barriers -.024** 
12. Able to Work, Employed vs. Unable to 
work 0.07 
13.Able to Work, Unemployed vs. Unable to 
Work  0.27
** 
14. Single/Separated/Divorced /Widowed vs. 
Partnered Married -0.04 
15. Some College/Tech School /College 
Education or Higher vs. less than High 
School 
0.005 
16.High school/GED vs. less than High 
School 
-0.13 
17. Quality of Life -0.12 
18.Disclosure 0.25** 
19.Denial Mean Scale 0.44** 









Logistic regression analysis was conducted to examine the effects of Barriers to care on 
engagement in HIV medical care. 
 
Unadjusted Model  
Unadjusted Logistic regression analysis was conducted to assess the direct association of 
BAC and engagement in HIV medical care. Engagement in HIV medical care was regressed on 
the BAC mean scale (Table 6). Barriers to care was not a significant predictor of engagement in 
HIV medical care for this population, (OR=1.1; 95%CI [0.72, 1.7]; p=.64).  
 
Table 6: Unadjusted Logistic regression analysis examining the direct effect of BAC on engagement 
in HIV medical care (N=262).  
Variables B S.E. Wald Df p-value O.R. 95% CI 
BAC Mean Scale  0.10 0.22 0.22 1 0.64 1.1 0.72- 1.7 
Constant 0.85 0.41 4.2 1 0.04 2.4  
 
Adjusted Models 
Forward Stepwise Model   
Adjusted logistic regression was conducted using forward stepwise method, engagement 
in HIV medical care was regressed on BAC, client type and all variables significantly associated 
with engagement in HIV medical care from the bivariate analysis. Disclosure of HIV status to 
others was the only significant predictor of engagement in HIV medical care (OR= 2.2; 95% CI 
[1.1, 4.2]; p=0.02). Persons who disclosed HIV status to others were 2.2 times more likely to 
engage in HIV medical care compared to those persons who had not disclosed their HIV status to 





 Table 7 Adjusted Logistic regression analysis examining the effect of BAC on engagement in HIV medical 
care Adjusted for variables associated with BAC (N=262) 
Variables B S.E. Wald df Sig. O.R. 95% CI 
Disclosure 0.78 0.34 5.4 1 0.02 2.2 1.1- 4.2 




Adjusted logistic regression model using the enter method was conducted with all 
variables identified as significantly associated with engagement in HIV medical care from the 
bivariate analysis. Engagement in HIV medical care was regressed on BAC mean scale with the 
covariates (client type, medical home, marital status (partnered/married), mean denial scale and 
disclosure). Disclosure of HIV status to others was a significant predictor of engagement in HIV 
medical care (OR= 2.6; 95% CI [1.3, 5.3]; p=.007). Mean BAC scale was not a significant 
predictor of engagement in HIV medical care (p=.31). 
 
Table 8. Adjusted Logistic Regression(Enter Method )Engagement in HIV medical Care with Barriers to 
Care with total sample (N=262) 
Variables B S.E. Wald df p-value O.R. 95% CI 
Client Type  -0.78 0.46 2.9 1 0.09 0.46 0.18-1.1 
Medical Home  -0.42 0.40 1.1 1 0.29 0.66 0.30-1.4 
Partnered/Married 0.89 0.49 3.3 1 0.68 2.43 0.94-6.3 
Disclosure 0.96 0.36 7.2 1 0.007 2.61 1.3-5.3 
BAC Mean Scale 0.26 0.26 1.0 1 0.31 1.30 0.78-2.2 






BARRIERS TO CARE (N=120)  
Table 9. presents the participants responses on the modified-barriers to care scale.  The 
community related and work environment barriers to care questions were removed from analysis 
because of high number of missing data.  Participants reported the extent that each of the 
following circumstances made it difficult for them to receive the HIV medical care, services or 
opportunities they wished to obtain. The most reported barriers for this population were related 
to personal finances, housing and transportation. The four items pertaining to community stigma 
and work environment knowledge were removed from the barriers to care scale. These items 
contained high numbers of missing values, where participants answered ‘refused’ or ‘don’t 
know’. This lead the researcher to believe that participants did not fully understand the questions 
or that they did not apply to participants. The modified 8-item scale was used in all subsequent 
analysis. 
Table 9 .Responses to modified-BAC by persons who Disclosed HIV status (N=120) 
Barriers to Care  No 
problem at 
all                      
N (%) 
Very slight 
problem                  
N (%) 
Somewhat of a 
problem                   
N (%) 
Major 
Problem       
N (%) 
Missing                                
N (%) 
Long distances to medical 
facilities and personnel 
89(74) 13(11) 11(9) 3(3) 4(3) 
      
Medical personnel who 
decline to provide direct care 
to persons with HIV/AIDS 
98(82) 9(8) 4(3) 4(3) 5(4) 
      
The lack of health care 
professionals who are 
adequately trained and 
competent in AIDS care 
98(82) 10(8) 2(2) 5(4) 5(4) 
      
The lack of transportation to 
access the services I need 
79(66) 12(10) 11(9) 15(13) 3(3) 




The shortage of 
psychologists, social workers 
and mental health counselors 
who can help address mental 
health issues 
97(81) 9(8) 4(3) 3(3) 7(6) 
      
The lack of psychological 
support groups for persons 
with HIV/AIDS 
92(77) 6(5) 8(7) 4(3) 10(8) 
      
My personal financial 
resources 
45(38) 18(15) 17(14) 38(32) 2(2) 
      
Lack of adequate and 
affordable housing 
30(25) 13(11) 21(18) 50(42) 6(5) 
** Note- community related barriers to care questions were removed from analysis because of high number of missing data.  
 
Rate of BAC-Disclosed Sample (N=120) 
 
The rate of barriers to care in total population was calculated using the 8 items contained 
in the modified Barriers to Care Scale. A mean BAC scale was created with the 8 items. After 
the creation of the scale the responses were dichotomized with “1” set to “0” and all other scores 
greater than 1, were set to “1”. All scores of 0 represented ‘no barriers to care’ and any score 1 or 
greater denoted the ‘presence of a barrier’. BAC was defined as a participant saying yes to at 
least 1 of the BAC items. The total responses reported for no barriers was (N=37) and the total 
that reported some barriers had a score of greater than 1 was (N=83). The total sample was 120. 
To calculate the rate of barriers to care in the population the frequencies were summed to obtain 
the total numbers of ‘yes’ responses to each of the items  and the total of ‘no’ responses. The 
total yes responses were divided by the total (yes responses + no responses) to obtain the total 
rate of barriers in the population. The rate of barriers reported in the population was calculated at 
69% in this population.  A large number of participants had experienced at least one barrier to 









Table 10. Rate of modified BAC among participants who disclosed their HIV status (N=120) 
BAC  N (%)* 
Long distances to medical facilities and personnel 27(23) 
Medical personnel who decline to provide direct care to persons 
with HIV/AIDS 
17(14) 
The lack of health care professionals who are adequately trained 
and competent in AIDS care 
17(14) 
The lack of transportation to access the services I need 38(32) 
The shortage of psychologists, social workers and mental health 
counselors who can help address mental health issues 
16(10) 
The lack of psychological support groups for persons with 
HIV/AIDS 
18(14) 
My personal financial resources 73(61) 
Lack of adequate and affordable housing 84(71) 





Difference in BAC by client type among persons who disclosed HIV status 
To determine whether there were differences in the level of BAC by client type chi-
square analysis was conducted. The out of care persons reported higher level of barriers to care 
than newly diagnosed persons (86 vs. 56%) respectively. This difference was statistically 
significant. (X2 (1) =8.5, p=0.009). Out of care persons reported greater barriers when trying to 
access HIV medical care and services then newly diagnosed persons.  
 
     
Table 11. Difference in BAC, by client type among persons who disclosed HIV status (N=120).  
 Participant Response, N (%)  
Responses Client Type Total 
 Newly Diagnosed Out of Care  
No BAC 7(44%) 14(14%) 21(18%) 
Yes BAC 9(56%) 88(86%) 97(82%) 
X2 (1) =8.5, p=0.009 
 
 
Table 12 presents the descriptive statistics and Cronbach’s analysis was calculated for the 
modified-BAC scale with the disclosed sample. The reported average score on the modified 
BAC mean scale was 1.69(SD=.65).The modified- BAC mean total scale scores ranged from 1 to 
4. Cronbach’s alpha was calculated to confirm the internal reliability for the scale in this 
population, which was 0.81.  
 
Table 12. Descriptive statistics and Cronbach’s alpha for BAC Scale disclosed sample (N=120) 


















Correlations analysis with BAC and other study variables (N=120) 
 
 Bivariate correlations were conducted with the disclosed sample (N=120) to determine 
the relationship between modified BAC mean scale and all other study variables (Table 13). 
BAC was positively correlated client type, gender, client needs, client barriers, denial mean 
scale, HIV perceived stigma mean scale (p<.05).  BAC was negatively correlated with medical 
home, income, able to work, employed, and engagement in HIV medical care. Higher BAC 
scores were associated with higher perceived HIV stigma mean and denial mean scores (p<0.01).  
Table 13 Correlation analysis of study variables with Denial and Perceived HIV stigma, BAC for persons who 
Disclosed HIV status (N=120)   
 Variables BAC 
1.Client Type .18* 
2.Age -.009 
3.Female Gender .19* 
4. Health Insurance .06 
5. Medical Home -.22* 
6. CD4 Count -.09 
7. HIV Viral Load .07 
8. Engagement -.06 
9.Income -.29** 
10.Client Needs .28** 
11.Client Barriers .22* 
12. Able to Work, Employed vs. Unable to 
work -.27
** 
13.Able to Work, Unemployed vs. Unable to 
Work  .09 
14.Single/Separated/Divorced /Widowed vs. 
Partnered Married .09 
15. Some College/Tech School /College 
Education or Higher vs. less than High 
School 
.02 
16.High school/GED vs. less than High School -.005 
17. Quality of Life .03 
18.Disclosure .34** 
19.Denial Mean Scale .58** 
20.BAC Mean Scale  1 







Logistic Regression Analysis with BAC-disclosed sample (N=120) 
 
Unadjusted Model  
 
Unadjusted logistic regression analysis was conducted to assess the direct association of 
BAC and engagement in HIV medical care.  Engagement in HIV medical care was regressed on 
the modified-BAC mean scale (Table 14). Barriers to care was not a significant predictor of 
engagement in HIV medical care for this population (OR=0.90; 95 % CI [0.49, 1.6]; p=.74).  
 
Table 14. Unadjusted Logistic regression analysis examining the direct effect of BAC on engagement 
in HIV medical care for disclosed sample (N=120). 
Variables B S.E. Wald df p-value O.R. 95% CI 
BAC Mean 
Scale  
-0.10 0.31 0.11 1 0.74 0.90 0.49-1.6 
Constant 1.5 0.57 6.7 1 0.009 4.43  
 
 
Adjusted Models  
 
Forward step wise  
 
Adjusted logistic regression was conducted using forward stepwise method examining 
the effect of BAC on engagement in HIV medical care for persons who disclosed their HIV 
status.  Engagement in HIV medical care was regressed on the modified BAC scale. The 
covariates in the model included client type, gender, medical home, educational level, and 
employment status. Educational level was the only significant predictor of engagement in HIV 
medical care OR=4.5; 95%CI [1.3, 15.4]; p=.02.  
 
Table 15. Adjusted Logistic regression (Forward Stepwise model) for BAC and Engagement in HIV medical 
care for persons who disclosed HIV status (N=120) 




1.5 0.63 5.8 1 0.02 4.5 1.3-15.4 





Enter method  
 
Adjusted logistic regression model using the enter method was conducted with the 
modified BAC scale and covariates (Table 16). Engagement in HIV medical care was regressed 
on the modified- BAC mean scale and the following covariates (client type, gender, medical 
home, employment status, and educational level). Mean BAC scale was not a significant 
predictor of engagement in HIV medical care (p=. 53). 
 
 Table 16. Adjusted Logistic regression of BAC and engagement in HIV medical care for persons who 
Disclosed HIV status (N=120) 
Variables   B S.E. Wald df p-value O.R. 95% CI 
Client Type -0.65 0.42 2.38 1 0.12 0.52 0.23-1.2 
Gender -0.84 0.33 0.06 1 0.80 0.92 0.48-1.8 




1.53 0.63 5.88 1 0.02 4.63 1.3-15.9 
Able to Work, Unemployed -0.36 0.34 1.15 1 0.28 0.69 0.36-1.3 
BAC Mean Scale  0.16 0.26 0.39 1 0.53 1.18 0.71-1.9 
Constant 1.72 0.69 6.14 1 0.01 5.58  
 
 
Barriers to care was not an independent predictor of engagement in HIV medical care. In 
the adjusted models with the disclosed sample, educational level was the only the significant 
predictor of engagement in HIV medical care. Persons with some college or higher were more 
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